| Northeast Medical Group, Inc. | |
|
226 Mill Hill Avenue 3rd Flr Bridgeport CT 06610 | |
| (203) 384-3975 | |
| (203) 384-3829 |
| Full Name | Northeast Medical Group, Inc. |
|---|---|
| Speciality | Internal Medicine |
| Location | 226 Mill Hill Avenue, Bridgeport, Connecticut |
| Authorized Official Name and Position | Beata Bialczak (MANAGER) |
| Authorized Official Contact | 2033843975 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Northeast Medical Group, Inc. Po Box 415126 Boston MA 02241-0001 Ph: (203) 384-3975 | Northeast Medical Group, Inc. 226 Mill Hill Avenue 3rd Flr Bridgeport CT 06610 Ph: (203) 384-3975 |
| NPI Number | 1043278351 |
|---|---|
| Provider Enumeration Date | 05/03/2006 |
| Last Update Date | 12/22/2021 |
| Certification Date | 12/22/2021 |
| Medicare PECOS PAC ID | 1254233836 |
|---|---|
| Medicare Enrollment ID | O20040123000522 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043278351 | NPI | - | NPPES |
| 004112257 | Medicaid | CT | |
| 008008038 | Medicaid | CT | |
| 004118388 | Medicaid | CT | |
| 004223517 | Medicaid | CT | |
| 004118396 | Medicaid | CT | |
| 008001858 | Medicaid | CT | |
| 004212958 | Medicaid | CT | |
| 004229317 | Medicaid | CT | |
| 008002043 | Medicaid | CT | |
| 004216984 | Medicaid | CT | |
| 004269173 | Medicaid | CT | |
| 004271631 | Medicaid | CT |
| Provider Name | Belinda J Chan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1134154917 PECOS PAC ID: 4981517240 Enrollment ID: I20031112000074 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jon C Gaudio |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1205885258 PECOS PAC ID: 4183538309 Enrollment ID: I20031113000013 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Edward Watson |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1528031804 PECOS PAC ID: 2062316219 Enrollment ID: I20031120000582 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Magdalen S Mauriello |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1770666059 PECOS PAC ID: 0749186393 Enrollment ID: I20031212000298 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jodonna S Scala |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1942341656 PECOS PAC ID: 3971401647 Enrollment ID: I20031219000620 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John A Flores |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1154341659 PECOS PAC ID: 6305744236 Enrollment ID: I20031230000110 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karen M Petrok |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1962423392 PECOS PAC ID: 7810895778 Enrollment ID: I20031230000226 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Diane M Johnson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1316957285 PECOS PAC ID: 5799685590 Enrollment ID: I20040109000244 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ernest D Moritz |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1689659898 PECOS PAC ID: 8426958000 Enrollment ID: I20040110000131 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert Henry |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1417055211 PECOS PAC ID: 4880598598 Enrollment ID: I20040113000352 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Adil Salam |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1508850959 PECOS PAC ID: 4385546977 Enrollment ID: I20040123000560 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tracy-ann M. Clarke-leconte |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1730157694 PECOS PAC ID: 9335041870 Enrollment ID: I20040123000934 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Farzana Begum |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1720092190 PECOS PAC ID: 3678466893 Enrollment ID: I20040203000499 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Edward George Mckiernan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1497866107 PECOS PAC ID: 8921991985 Enrollment ID: I20040204000188 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Dickerman Hollister |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1063420669 PECOS PAC ID: 6103710496 Enrollment ID: I20040209000877 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Merlin S Lee |
|---|---|
| Provider Type | Practitioner - Hematology |
| Provider Identifiers | NPI Number: 1730292608 PECOS PAC ID: 3476447772 Enrollment ID: I20040209000927 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gerard J Kerins |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1952332199 PECOS PAC ID: 1759276231 Enrollment ID: I20040216000666 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Donald Barry Boyd |
|---|---|
| Provider Type | Practitioner - Medical Oncology |
| Provider Identifiers | NPI Number: 1396826376 PECOS PAC ID: 2769378934 Enrollment ID: I20040225000053 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elaine Shea |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1649341587 PECOS PAC ID: 9830086495 Enrollment ID: I20040301000217 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anthony W D Souza |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1073560736 PECOS PAC ID: 9537061130 Enrollment ID: I20040308000229 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steven M Cassell |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1447270632 PECOS PAC ID: 0840189502 Enrollment ID: I20040318000162 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Emily E Blair |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1467472654 PECOS PAC ID: 0941199608 Enrollment ID: I20040318000186 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sapna Tandon |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1679593818 PECOS PAC ID: 4587553243 Enrollment ID: I20040318000224 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joseph Tortorello |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1114974417 PECOS PAC ID: 4183616048 Enrollment ID: I20040331001117 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Scott A Weiss |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1134189384 PECOS PAC ID: 1759374986 Enrollment ID: I20040405001175 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ryan T O'connell |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1487618369 PECOS PAC ID: 8527051010 Enrollment ID: I20040408000668 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John M Beiner |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1770570921 PECOS PAC ID: 2466446695 Enrollment ID: I20040412000899 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | William R Butler |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1124087226 PECOS PAC ID: 8921092024 Enrollment ID: I20040412001439 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Diane Merkle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1255382446 PECOS PAC ID: 5890789499 Enrollment ID: I20040414000917 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joseph F Fickes |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1902838329 PECOS PAC ID: 4981690286 Enrollment ID: I20040422000552 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joanne Passalacqua |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1710946678 PECOS PAC ID: 2567459837 Enrollment ID: I20040428000950 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rebecca K Koenigsberg |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1982647087 PECOS PAC ID: 2264429570 Enrollment ID: I20040428001249 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bhupesh Mangla |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1649272949 PECOS PAC ID: 9032106067 Enrollment ID: I20040429001308 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Barbara T Corvello |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1407081128 PECOS PAC ID: 6002805157 Enrollment ID: I20040512000527 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alon Ronen |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1629075676 PECOS PAC ID: 6002806015 Enrollment ID: I20040513000110 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christopher B Lynch |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1952307456 PECOS PAC ID: 1254322035 Enrollment ID: I20040520000691 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ann R Datunashvili |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1376544932 PECOS PAC ID: 2264423078 Enrollment ID: I20040520000919 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Barbara A Ward |
|---|---|
| Provider Type | Practitioner - Surgical Oncology |
| Provider Identifiers | NPI Number: 1356378426 PECOS PAC ID: 9436140159 Enrollment ID: I20040521000154 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Farid Force |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1952318669 PECOS PAC ID: 3779574322 Enrollment ID: I20040521000445 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pietro G Andres |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1588607386 PECOS PAC ID: 9739170069 Enrollment ID: I20040524000980 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Richard Breier |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1104871888 PECOS PAC ID: 3072594001 Enrollment ID: I20040526000829 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Louis A Rosen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1316956915 PECOS PAC ID: 8224010723 Enrollment ID: I20040607000786 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael E Ivy |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1780693630 PECOS PAC ID: 2961485495 Enrollment ID: I20040608000126 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Angela Younger |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790898021 PECOS PAC ID: 3971586314 Enrollment ID: I20040608000956 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Niall J Duhig |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1578503967 PECOS PAC ID: 6103800669 Enrollment ID: I20040614001412 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Surani R Fernando |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1750355137 PECOS PAC ID: 2264416049 Enrollment ID: I20040617001185 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jeptha Pelham Curtis |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1700876273 PECOS PAC ID: 2961489588 Enrollment ID: I20040701001025 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Benjamin J Zigun |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1083682900 PECOS PAC ID: 2668452228 Enrollment ID: I20040723000318 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert M Moskowitz |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1679578496 PECOS PAC ID: 9436055621 Enrollment ID: I20040728000705 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John E Rivera |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1720044811 PECOS PAC ID: 6204806193 Enrollment ID: I20040728000950 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marshal Mandelkern |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1487786927 PECOS PAC ID: 3971573866 Enrollment ID: I20040728000999 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Emily Peluso |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598730095 PECOS PAC ID: 9739159260 Enrollment ID: I20040730000340 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Eileen Geraci |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144390295 PECOS PAC ID: 8628040896 Enrollment ID: I20040809000623 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alexander Delvecchio |
|---|---|
| Provider Type | Practitioner - Cardiac Electrophysiology |
| Provider Identifiers | NPI Number: 1053321950 PECOS PAC ID: 5597737445 Enrollment ID: I20040811000066 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mary L Gaeta |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1922080647 PECOS PAC ID: 7012989965 Enrollment ID: I20040811000095 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marina R Ionita |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1386639268 PECOS PAC ID: 0042282642 Enrollment ID: I20040812000481 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Olutayo T Imevbore |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1750447421 PECOS PAC ID: 2365415478 Enrollment ID: I20040817000812 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristen Lichtenberg |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1558337121 PECOS PAC ID: 7315911104 Enrollment ID: I20040826000184 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Walter M Cholewczynski |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1679542666 PECOS PAC ID: 7214902584 Enrollment ID: I20040831000165 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marianne Vahey |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1467458075 PECOS PAC ID: 0749255925 Enrollment ID: I20040831001039 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Paul Bourguignon |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1154372175 PECOS PAC ID: 7911972096 Enrollment ID: I20040901000373 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Molly Kunka |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1952315210 PECOS PAC ID: 3779559620 Enrollment ID: I20040902000715 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ronika D Choudhary |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1407803778 PECOS PAC ID: 1850367400 Enrollment ID: I20040907000196 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Thomas Pellechi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1912077918 PECOS PAC ID: 2466428941 Enrollment ID: I20040907000503 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tammy Marie Higgins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1629097431 PECOS PAC ID: 9032185558 Enrollment ID: I20040907000837 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Richard L Danehower |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1750496683 PECOS PAC ID: 0941276349 Enrollment ID: I20040909000175 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lana I Bernstein |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1912012857 PECOS PAC ID: 5799751806 Enrollment ID: I20040909000189 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pamela J Hetherington |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1760457485 PECOS PAC ID: 6406823988 Enrollment ID: I20040914000728 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ronald Raymond |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1720013949 PECOS PAC ID: 1456329267 Enrollment ID: I20040920000963 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bradford C Lavigne |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1992759005 PECOS PAC ID: 0749241354 Enrollment ID: I20041026000630 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steven Yolen |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1376582692 PECOS PAC ID: 3375504988 Enrollment ID: I20041026000711 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stephanie L Esposito |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750334801 PECOS PAC ID: 5597727818 Enrollment ID: I20041029000300 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael N Waltzman |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1497784995 PECOS PAC ID: 4183686041 Enrollment ID: I20041102000890 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mirela Dumitrescu |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1497768006 PECOS PAC ID: 7618931809 Enrollment ID: I20041119000541 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Germano A Guadagnoli |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1962415562 PECOS PAC ID: 2668437567 Enrollment ID: I20041119000558 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ipshita Vashist |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1588726731 PECOS PAC ID: 7416912217 Enrollment ID: I20041122000183 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Angeliapia P Degirolamo |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1023087996 PECOS PAC ID: 5496710881 Enrollment ID: I20041124000613 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brian Priest |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1477619153 PECOS PAC ID: 3577528983 Enrollment ID: I20041124000791 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lori A Pace |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1649713579 PECOS PAC ID: 6709841083 Enrollment ID: I20041129000455 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Arina R Cadariu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1922141969 PECOS PAC ID: 9739144981 Enrollment ID: I20041130000049 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marina L Blagodatny |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1447291497 PECOS PAC ID: 2163484767 Enrollment ID: I20041130000340 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Andrew Onshing Chow |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1376583245 PECOS PAC ID: 3375509284 Enrollment ID: I20041202000578 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marianne Pascale |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1740344407 PECOS PAC ID: 7618926858 Enrollment ID: I20050114000463 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mark P Altman |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1689652711 PECOS PAC ID: 7012966716 Enrollment ID: I20050120000321 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Susan M Barba |
|---|---|
| Provider Type | Practitioner - Certified Clinical Nurse Specialist (cns) |
| Provider Identifiers | NPI Number: 1699858886 PECOS PAC ID: 5092764506 Enrollment ID: I20050121000203 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karine Toumanian |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1306882675 PECOS PAC ID: 6002865565 Enrollment ID: I20050121000645 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Victor Morris |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1407919863 PECOS PAC ID: 5496746257 Enrollment ID: I20050121000723 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Yaw Adjepong |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1831168996 PECOS PAC ID: 3072564228 Enrollment ID: I20050204000028 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael W Cleman |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1023006269 PECOS PAC ID: 6507818481 Enrollment ID: I20050218000607 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joseph J Brennan |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1528057304 PECOS PAC ID: 3577515451 Enrollment ID: I20050218000630 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Henry S Cabin |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1881684116 PECOS PAC ID: 4880646777 Enrollment ID: I20050218000670 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John F Setaro |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1932199494 PECOS PAC ID: 2668424557 Enrollment ID: I20050218000715 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christopher J Howes |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1346238557 PECOS PAC ID: 4183676075 Enrollment ID: I20050218000733 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael S Remetz |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1568450641 PECOS PAC ID: 5496707226 Enrollment ID: I20050221000071 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Frank R Giordano |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1366430456 PECOS PAC ID: 4789636523 Enrollment ID: I20050221000153 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gregory N Soloway |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1649219221 PECOS PAC ID: 1254384753 Enrollment ID: I20050224000513 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shuta Ishibe |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1932166659 PECOS PAC ID: 4183677586 Enrollment ID: I20050225000218 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Beverly J Drucker |
|---|---|
| Provider Type | Practitioner - Medical Oncology |
| Provider Identifiers | NPI Number: 1104834704 PECOS PAC ID: 7911950035 Enrollment ID: I20050301000197 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steven Pfau |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1114915162 PECOS PAC ID: 4082668793 Enrollment ID: I20050307000022 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Janet E Rimm |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437276805 PECOS PAC ID: 6103870258 Enrollment ID: I20050310000891 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alexander G Slater |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1851332308 PECOS PAC ID: 5597710251 Enrollment ID: I20050315000770 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jill S Waldman |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1386634129 PECOS PAC ID: 6901851419 Enrollment ID: I20050317000626 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stephen J Urciuoli |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1710926811 PECOS PAC ID: 3678528098 Enrollment ID: I20050318000472 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jay Meizlish |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1225033046 PECOS PAC ID: 0042265308 Enrollment ID: I20050318000831 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Yin Hung |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1588651822 PECOS PAC ID: 1153377353 Enrollment ID: I20050330000414 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Toby R Mcpherson |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1801843081 PECOS PAC ID: 8729035613 Enrollment ID: I20050404000064 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elizabeth Bekui |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1912945932 PECOS PAC ID: 9739126657 Enrollment ID: I20050412001423 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Philip M Ginsburg |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1679554539 PECOS PAC ID: 7618967928 Enrollment ID: I20050421001149 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gordon S Latzman |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1780647115 PECOS PAC ID: 1759320427 Enrollment ID: I20050502001004 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jitesh Vachhani |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1205815487 PECOS PAC ID: 3274594585 Enrollment ID: I20050509000020 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Timothy Barczak |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1427032200 PECOS PAC ID: 6709826696 Enrollment ID: I20050510001012 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael T Lipcan |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1770624447 PECOS PAC ID: 6103878293 Enrollment ID: I20050526000263 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rey F Ramos |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1689601395 PECOS PAC ID: 0446292528 Enrollment ID: I20050531000213 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karen E Brown |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1285609412 PECOS PAC ID: 7911949904 Enrollment ID: I20050601000078 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stephen E Possick |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1033142047 PECOS PAC ID: 7214970045 Enrollment ID: I20050602001011 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michelle M Glidden |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790899680 PECOS PAC ID: 4082657853 Enrollment ID: I20050603000155 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Judith Deshpande |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528008489 PECOS PAC ID: 4981647245 Enrollment ID: I20050607001116 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kurt C Bellhorn |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1558324434 PECOS PAC ID: 8921042482 Enrollment ID: I20050615000456 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Andrew S Kenler |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1104885169 PECOS PAC ID: 1153367297 Enrollment ID: I20050629000712 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Doru Daniel D Bordea |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1912945429 PECOS PAC ID: 9537105572 Enrollment ID: I20050630000156 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Polly M Sather |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144341496 PECOS PAC ID: 9931145869 Enrollment ID: I20050630000955 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amit Lahav |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1518054113 PECOS PAC ID: 6305814559 Enrollment ID: I20050719000987 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christopher Illick |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1609836998 PECOS PAC ID: 6406884279 Enrollment ID: I20050802000896 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Athanassios Petrotos |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1861566002 PECOS PAC ID: 6800824517 Enrollment ID: I20050802001256 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kerrie Fisette |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1831260579 PECOS PAC ID: 1052340320 Enrollment ID: I20050808000020 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sidney T Bogardus |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1730131103 PECOS PAC ID: 2860421534 Enrollment ID: I20050812000087 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Scott Credit |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811976111 PECOS PAC ID: 1456332683 Enrollment ID: I20050818000060 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Carlos I Mena-hurtado |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1205800273 PECOS PAC ID: 1951331032 Enrollment ID: I20050818000213 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Laima M Karosas |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356343099 PECOS PAC ID: 6507897337 Enrollment ID: I20050822001131 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Vittorio Ferrero |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1609935840 PECOS PAC ID: 7012948458 Enrollment ID: I20050825000837 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Beth A Moore |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1558408245 PECOS PAC ID: 7012948771 Enrollment ID: I20050829000005 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karen A Discepolo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174634885 PECOS PAC ID: 6608807607 Enrollment ID: I20050830000379 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christopher Brant Sankey |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1588647713 PECOS PAC ID: 9638101017 Enrollment ID: I20050907000266 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rogelio Perez |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1265456438 PECOS PAC ID: 1052392024 Enrollment ID: I20050930000711 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lirim Ameti |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1316009608 PECOS PAC ID: 3476578485 Enrollment ID: I20051010000252 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Peter M Jenei |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1508952359 PECOS PAC ID: 2365467388 Enrollment ID: I20051010000357 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Keith P Swan |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1124181904 PECOS PAC ID: 9133144165 Enrollment ID: I20051010000412 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shireen Donaldson-ramos |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1275535346 PECOS PAC ID: 5698790566 Enrollment ID: I20051010000811 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nidhi Shah |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1063507416 PECOS PAC ID: 7416848031 Enrollment ID: I20051011000034 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael Cackovic |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1962485045 PECOS PAC ID: 4082630983 Enrollment ID: I20051020000271 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sharon Kay Evans-benard |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1881631265 PECOS PAC ID: 0345267886 Enrollment ID: I20051025000169 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Daphne E Evans |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1740342930 PECOS PAC ID: 4183641632 Enrollment ID: I20051025000243 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David H Gibson |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1649259581 PECOS PAC ID: 9537149885 Enrollment ID: I20051103000007 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Laura Pham |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1457464372 PECOS PAC ID: 0749208486 Enrollment ID: I20051110000593 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lawrence I Fisher |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1265427751 PECOS PAC ID: 9436058823 Enrollment ID: I20051128000589 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brian D Pollack |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1558355347 PECOS PAC ID: 1254230626 Enrollment ID: I20051128000616 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rita Gonzalez |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1669586947 PECOS PAC ID: 3173545167 Enrollment ID: I20051219000489 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elizabeth K Allard |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1326155367 PECOS PAC ID: 9133143886 Enrollment ID: I20060120000209 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Laina L Braasch |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1528209657 PECOS PAC ID: 1759305386 Enrollment ID: I20060121000009 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Vicky Amon-perpetua |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437378809 PECOS PAC ID: 7214951813 Enrollment ID: I20060123000479 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lynn C Winther |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1245206556 PECOS PAC ID: 8224043500 Enrollment ID: I20060207000875 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Adam E Schussheim |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1104821925 PECOS PAC ID: 9739194192 Enrollment ID: I20060217000090 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stephen C Lattanzi |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1801894555 PECOS PAC ID: 5496748147 Enrollment ID: I20060221000501 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Peter Morgan |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1952320673 PECOS PAC ID: 4385650738 Enrollment ID: I20060222000824 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Scott Thornton |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1750351995 PECOS PAC ID: 3779597141 Enrollment ID: I20060224000625 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert Sidman |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1174633838 PECOS PAC ID: 5991796609 Enrollment ID: I20060323000459 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lori J Cretella |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1619934130 PECOS PAC ID: 2163430190 Enrollment ID: I20060331000555 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christine Chen |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1134189707 PECOS PAC ID: 9739197708 Enrollment ID: I20060403000233 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jeffrey Sumner |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1457330318 PECOS PAC ID: 5395753396 Enrollment ID: I20060404000291 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mary M Kane Brock |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1245312305 PECOS PAC ID: 7315956943 Enrollment ID: I20060411000024 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cary A Caldwell |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1194866038 PECOS PAC ID: 2163431636 Enrollment ID: I20060411000410 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Glenn Brady |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1881618890 PECOS PAC ID: 9739088014 Enrollment ID: I20060419000505 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Judy A Kleinstein |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1831187319 PECOS PAC ID: 2769447028 Enrollment ID: I20060425000316 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Emmanuel B Logiadis |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1801874474 PECOS PAC ID: 8224048954 Enrollment ID: I20060426000221 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amarilis Talavera Briggs |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1952499733 PECOS PAC ID: 9234191602 Enrollment ID: I20060426000599 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Wayne Warren |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1447220496 PECOS PAC ID: 4880614296 Enrollment ID: I20060517000057 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Patrick Asiedu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1922078914 PECOS PAC ID: 7618997024 Enrollment ID: I20060517000060 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sunil Menon |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1295705770 PECOS PAC ID: 6709806110 Enrollment ID: I20060517000079 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joseph W Peters |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1992746325 PECOS PAC ID: 5698661718 Enrollment ID: I20060614000226 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alan Eric Landau |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1003876368 PECOS PAC ID: 0345252953 Enrollment ID: I20060626000026 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John Paul M Ayala |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1740239912 PECOS PAC ID: 1759393986 Enrollment ID: I20060707000002 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karen Dufour |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1609859842 PECOS PAC ID: 3173416245 Enrollment ID: I20060714000138 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sheikh Hoq |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1265470561 PECOS PAC ID: 7618980384 Enrollment ID: I20060725000043 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Vivian Argento |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1285684720 PECOS PAC ID: 1951343581 Enrollment ID: I20060727000174 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Charles Landau |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1639176597 PECOS PAC ID: 5890744122 Enrollment ID: I20060801000366 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Craig S Werner |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1427057991 PECOS PAC ID: 0446209779 Enrollment ID: I20060801000375 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Victor Mejia |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1245228956 PECOS PAC ID: 2365346772 Enrollment ID: I20060802000465 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stephen Woodworth |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1043283302 PECOS PAC ID: 3577531086 Enrollment ID: I20060810000198 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steven T Benaderet |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1699719724 PECOS PAC ID: 1557364403 Enrollment ID: I20060814000383 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Barry J Wu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1669407383 PECOS PAC ID: 0941204374 Enrollment ID: I20060828000080 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stephen A Atlas |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1871527333 PECOS PAC ID: 5698779031 Enrollment ID: I20060828000144 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amenuve M Bekui |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1851339949 PECOS PAC ID: 0345244166 Enrollment ID: I20060911000344 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Danielle P Benaviv-meskin |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1730106519 PECOS PAC ID: 8820092547 Enrollment ID: I20060911000461 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Geraldine M Fabregas |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1477583540 PECOS PAC ID: 4981609161 Enrollment ID: I20060921000288 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Francis W Chan |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1326140674 PECOS PAC ID: 4082610308 Enrollment ID: I20061010000560 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Costin Nicolae Ionescu |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1063513703 PECOS PAC ID: 2365449956 Enrollment ID: I20061024000195 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jude F Clancy |
|---|---|
| Provider Type | Practitioner - Cardiac Electrophysiology |
| Provider Identifiers | NPI Number: 1124016217 PECOS PAC ID: 1557368156 Enrollment ID: I20061024000294 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kalman Lewis Watsky |
|---|---|
| Provider Type | Practitioner - Dermatology |
| Provider Identifiers | NPI Number: 1649298142 PECOS PAC ID: 6103823547 Enrollment ID: I20061027000431 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Neal Zomback |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1730101635 PECOS PAC ID: 4486651684 Enrollment ID: I20061101000131 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Javier Lopez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1023025327 PECOS PAC ID: 6002813011 Enrollment ID: I20061106000380 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alisa Savetamal |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1245342575 PECOS PAC ID: 4183677560 Enrollment ID: I20061127000069 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Leon Rapko |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1619925377 PECOS PAC ID: 3375541592 Enrollment ID: I20061127000208 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stephanie Rowe |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1275585705 PECOS PAC ID: 1557369774 Enrollment ID: I20061127000217 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sandhya V Kanade |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1689787301 PECOS PAC ID: 7911905070 Enrollment ID: I20061128000177 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David H Bushell |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1144301839 PECOS PAC ID: 0446222624 Enrollment ID: I20061130000353 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Eric I Gentry |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1134200827 PECOS PAC ID: 5395743298 Enrollment ID: I20061130000368 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Philip E Greenspan |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1568543288 PECOS PAC ID: 1557369451 Enrollment ID: I20061130000395 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Neil P Dolan |
|---|---|
| Provider Type | Practitioner - Geriatric Psychiatry |
| Provider Identifiers | NPI Number: 1073542890 PECOS PAC ID: 1254332950 Enrollment ID: I20070124000035 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stasia J Wieber |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1366461477 PECOS PAC ID: 6901796804 Enrollment ID: I20070201000008 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Denise M Romano |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1740332402 PECOS PAC ID: 4183626062 Enrollment ID: I20070206000144 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alexandra E Usdavin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558425785 PECOS PAC ID: 6002918000 Enrollment ID: I20070222000031 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Peter A Blume |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1376526814 PECOS PAC ID: 0749182582 Enrollment ID: I20070222000575 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steven B Silverstein |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1679555106 PECOS PAC ID: 9436251337 Enrollment ID: I20070223000328 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Antoine M Ferneini |
|---|---|
| Provider Type | Practitioner - Vascular Surgery |
| Provider Identifiers | NPI Number: 1053344424 PECOS PAC ID: 9234231028 Enrollment ID: I20070226000321 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rowland B Mayor |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1073591053 PECOS PAC ID: 7618070442 Enrollment ID: I20070314000585 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | James G Krantz |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1710912449 PECOS PAC ID: 1658367289 Enrollment ID: I20070316000198 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David C Novicki |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1093789349 PECOS PAC ID: 7416050075 Enrollment ID: I20070320000303 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Martin M Pressman |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1568448249 PECOS PAC ID: 4981690518 Enrollment ID: I20070320000416 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Richard B Feldman |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1881693513 PECOS PAC ID: 0446353049 Enrollment ID: I20070320000663 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Chinenye H Kalu |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700928124 PECOS PAC ID: 4880797364 Enrollment ID: I20070321000655 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pamela E Jackson |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1811091960 PECOS PAC ID: 9032213293 Enrollment ID: I20070327000614 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brian L Beaulieu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1588608384 PECOS PAC ID: 7214032341 Enrollment ID: I20070419000046 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shabnam M Kashani |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1588781850 PECOS PAC ID: 1355446329 Enrollment ID: I20070419000439 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pritee Gada |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1093840092 PECOS PAC ID: 7113022104 Enrollment ID: I20070419000588 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Richard Garvey |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1841350964 PECOS PAC ID: 0547365405 Enrollment ID: I20070420000468 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ralph Denatale |
|---|---|
| Provider Type | Practitioner - Vascular Surgery |
| Provider Identifiers | NPI Number: 1497790026 PECOS PAC ID: 5890751184 Enrollment ID: I20070424000664 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cristina D Tiago |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689760910 PECOS PAC ID: 0547365223 Enrollment ID: I20070425000445 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Agnes Czibulka |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1407969686 PECOS PAC ID: 8729184775 Enrollment ID: I20070508000232 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David S Caminear |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1841287091 PECOS PAC ID: 5496851479 Enrollment ID: I20070508000514 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Paul W Alberti |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1821101080 PECOS PAC ID: 7517063597 Enrollment ID: I20070508000558 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gary N Grippo |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1013943448 PECOS PAC ID: 2769453554 Enrollment ID: I20070515000172 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David I Astrachan |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1225009046 PECOS PAC ID: 3072610708 Enrollment ID: I20070515000179 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Santhi Chinni |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1780788182 PECOS PAC ID: 6608973706 Enrollment ID: I20070524000523 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Daniel F Hartman |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1609977784 PECOS PAC ID: 7416051040 Enrollment ID: I20070529000029 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Harish K Gundluru |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1952405359 PECOS PAC ID: 2961500780 Enrollment ID: I20070601000392 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jose Salvana |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1598827149 PECOS PAC ID: 6204934995 Enrollment ID: I20070604000445 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Olubunmi I Otolorin |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1336208677 PECOS PAC ID: 5698873347 Enrollment ID: I20070605000085 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gregory Bloom |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1316088248 PECOS PAC ID: 7416055173 Enrollment ID: I20070605000181 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristine Olson |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1043372600 PECOS PAC ID: 5799883229 Enrollment ID: I20070607000250 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David J Hass |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1225177769 PECOS PAC ID: 9931207388 Enrollment ID: I20070607000576 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anshu Taneja |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1437257003 PECOS PAC ID: 1254439599 Enrollment ID: I20070609000028 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kenneth Nori |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1134283195 PECOS PAC ID: 5496853731 Enrollment ID: I20070609000064 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ashok K Maheshwari |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1760543813 PECOS PAC ID: 1254439516 Enrollment ID: I20070611000082 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karen Pawelek |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568408433 PECOS PAC ID: 6608879556 Enrollment ID: I20070613000140 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karie L Siljamaki |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205054319 PECOS PAC ID: 4688772718 Enrollment ID: I20070613000184 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert D Winslow |
|---|---|
| Provider Type | Practitioner - Cardiac Electrophysiology |
| Provider Identifiers | NPI Number: 1538106299 PECOS PAC ID: 8628089448 Enrollment ID: I20070614000690 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ann M Bassett |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1053368217 PECOS PAC ID: 4284733270 Enrollment ID: I20070615000080 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Catherine Morneault |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1528124278 PECOS PAC ID: 4082713730 Enrollment ID: I20070621000457 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Julie L Laifer |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1174614879 PECOS PAC ID: 7911007927 Enrollment ID: I20070705000107 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pamela A Iava |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952383036 PECOS PAC ID: 8628178118 Enrollment ID: I20070712000762 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Simina C Ionescu |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1396952024 PECOS PAC ID: 1658471875 Enrollment ID: I20070717000240 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ellen C Rubin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497871669 PECOS PAC ID: 4082715297 Enrollment ID: I20070718000309 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Caroline S Loeser |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1972715290 PECOS PAC ID: 7113958331 Enrollment ID: I20070813000507 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brian Cambi |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1003033390 PECOS PAC ID: 1759474927 Enrollment ID: I20070904000383 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marcella Nunez Smith |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1093925646 PECOS PAC ID: 8224121355 Enrollment ID: I20070906000313 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Janet Gillis-toffolo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1972629475 PECOS PAC ID: 3274626213 Enrollment ID: I20070906000558 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Andrew F Cutney |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1114939758 PECOS PAC ID: 9931292950 Enrollment ID: I20070907000329 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bhawna Gupta |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1700885100 PECOS PAC ID: 8022916360 Enrollment ID: I20070921000255 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Monique Misra |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1033319793 PECOS PAC ID: 5799879698 Enrollment ID: I20070924000090 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Glen Henry |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1720077324 PECOS PAC ID: 3870688336 Enrollment ID: I20070928000599 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jaya A Gobin |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1134321904 PECOS PAC ID: 1951497742 Enrollment ID: I20071009000740 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rita Ohene-adjei |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1326248980 PECOS PAC ID: 9638265390 Enrollment ID: I20071011000423 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Krista E Wise |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730374430 PECOS PAC ID: 9335235936 Enrollment ID: I20071012000080 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Swarupa R Vedere |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1770703423 PECOS PAC ID: 8325134422 Enrollment ID: I20071022000096 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sandra K Wainwright |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1982894614 PECOS PAC ID: 9335237379 Enrollment ID: I20071108000651 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marina Torbey |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1619084225 PECOS PAC ID: 2163510058 Enrollment ID: I20071109000341 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joseph S Feuerstein |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1619067162 PECOS PAC ID: 8426146853 Enrollment ID: I20071117000101 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sanjay Malhotra |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1497946339 PECOS PAC ID: 4082702311 Enrollment ID: I20071120000075 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Diana S Lindahl |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1619165545 PECOS PAC ID: 8820187313 Enrollment ID: I20071207000124 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Timothy J Murphy |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1366466393 PECOS PAC ID: 5294825154 Enrollment ID: I20071214000601 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Manisha Gupta |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1336250505 PECOS PAC ID: 2769386465 Enrollment ID: I20080118000031 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Collin C Watson |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1083896088 PECOS PAC ID: 5890878540 Enrollment ID: I20080219000185 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Andrea J Adimando |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1801936448 PECOS PAC ID: 9638252315 Enrollment ID: I20080219000414 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stephen J Moses |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1003804600 PECOS PAC ID: 6709960750 Enrollment ID: I20080228000585 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert Lamberton |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1205949658 PECOS PAC ID: 3577648955 Enrollment ID: I20080310000324 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gregory K Buller |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1154321768 PECOS PAC ID: 4284736711 Enrollment ID: I20080310000600 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael B Rudolph |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1700999000 PECOS PAC ID: 5092890921 Enrollment ID: I20080317000291 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alison G Cameron |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1407827256 PECOS PAC ID: 0143209452 Enrollment ID: I20080326000232 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brenda Applegate |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1255437752 PECOS PAC ID: 0648356782 Enrollment ID: I20080328000601 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Catherine P Wright |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174718126 PECOS PAC ID: 2163508193 Enrollment ID: I20080331000365 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karim Namek |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1598786428 PECOS PAC ID: 3072690742 Enrollment ID: I20080404000329 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Regan J Welsh |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1770702995 PECOS PAC ID: 8426136383 Enrollment ID: I20080418000044 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lisa M Bishop |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1205012713 PECOS PAC ID: 1254419609 Enrollment ID: I20080424000748 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pawel T. Pomianowski |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1659586352 PECOS PAC ID: 5496833634 Enrollment ID: I20080429000207 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maureen Dana |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1780666834 PECOS PAC ID: 7618046319 Enrollment ID: I20080521000485 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Donna M Doxsey-mcgrew |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1366650764 PECOS PAC ID: 6709955420 Enrollment ID: I20080521000564 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David M Aversa |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1669655726 PECOS PAC ID: 8123197746 Enrollment ID: I20080521000687 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Claudia C Bemis |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1952416299 PECOS PAC ID: 1052481843 Enrollment ID: I20080605000514 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Vasudev G Kanade |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1407032386 PECOS PAC ID: 1355411166 Enrollment ID: I20080605000690 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kathleen R Bonaventura |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1821062175 PECOS PAC ID: 0749350213 Enrollment ID: I20080610000579 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ceasar Irby |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1316121726 PECOS PAC ID: 1355412818 Enrollment ID: I20080611000662 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mustapha Kemal |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1942281662 PECOS PAC ID: 5193896876 Enrollment ID: I20080624000573 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steven Archer |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1588701445 PECOS PAC ID: 0042268245 Enrollment ID: I20080625000275 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Hanna Huey-jiun Chao |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1376581991 PECOS PAC ID: 9739123100 Enrollment ID: I20080625000356 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Olukemi Akande |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1073709259 PECOS PAC ID: 1759452303 Enrollment ID: I20080625000394 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Leonard Lois Calo |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1033305545 PECOS PAC ID: 2860564440 Enrollment ID: I20080627000034 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marie E Mccormick |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376517631 PECOS PAC ID: 5991877466 Enrollment ID: I20080630000111 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Muziana S Quadir |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1093995615 PECOS PAC ID: 6901978287 Enrollment ID: I20080701000449 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Judith M Castillo |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1205034600 PECOS PAC ID: 3577636281 Enrollment ID: I20080714000390 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Henry S Amdur |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1700920022 PECOS PAC ID: 3476626730 Enrollment ID: I20080718000575 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Armand J Wolff |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1093719700 PECOS PAC ID: 5890747000 Enrollment ID: I20080719000066 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Denis Tereb |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1457493751 PECOS PAC ID: 7517927882 Enrollment ID: I20080719000113 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael A Ayepah |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1114109485 PECOS PAC ID: 9739252040 Enrollment ID: I20080721000163 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Howard P Boey |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1306868229 PECOS PAC ID: 5193898336 Enrollment ID: I20080721000540 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael Cafaro |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1457446692 PECOS PAC ID: 3173696176 Enrollment ID: I20080724000396 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anoli Borad |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1699881532 PECOS PAC ID: 8426121302 Enrollment ID: I20080725000318 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stephen J Phelan |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1326142332 PECOS PAC ID: 0143262154 Enrollment ID: I20080814000203 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maria N Byrne |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1750303764 PECOS PAC ID: 9739255779 Enrollment ID: I20080827000611 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robin L Phillips |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1821090507 PECOS PAC ID: 6204884166 Enrollment ID: I20080929000363 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Susan M Dagostino |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1093743908 PECOS PAC ID: 4284702960 Enrollment ID: I20081008000141 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Muhammad E Qadir |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1356340319 PECOS PAC ID: 1153499462 Enrollment ID: I20081013000628 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Allison K Trombly |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497901961 PECOS PAC ID: 4486713070 Enrollment ID: I20081112000091 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Allan J Rodrigues |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1871531269 PECOS PAC ID: 8123187622 Enrollment ID: I20081112000293 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Frederick L Apiado |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1225211097 PECOS PAC ID: 9436219474 Enrollment ID: I20081120000028 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pamela A Mclaughlin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750358644 PECOS PAC ID: 5991865909 Enrollment ID: I20081120000749 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John M Willett |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1295749752 PECOS PAC ID: 2163581760 Enrollment ID: I20081124000168 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jesse P Parks |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1578738621 PECOS PAC ID: 1254491061 Enrollment ID: I20081125000016 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | James C Mcveety |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1700812427 PECOS PAC ID: 5890791305 Enrollment ID: I20081204000673 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Franklin A Loria |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1497741235 PECOS PAC ID: 3375604515 Enrollment ID: I20081208000028 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristina M Rath |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1699790469 PECOS PAC ID: 3779644851 Enrollment ID: I20081208000444 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Resul Dalipi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1295994127 PECOS PAC ID: 8123180890 Enrollment ID: I20081215000673 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Laura F Wilson |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1790930923 PECOS PAC ID: 9739241332 Enrollment ID: I20081216000195 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brooke L Davidson |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1730338039 PECOS PAC ID: 2860554367 Enrollment ID: I20081217000404 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jodi E Indes |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1871566638 PECOS PAC ID: 9436162765 Enrollment ID: I20081229000032 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert P Novicki |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1316975592 PECOS PAC ID: 7214923846 Enrollment ID: I20090107000440 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Paul J Fortgang |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1649292566 PECOS PAC ID: 8224191630 Enrollment ID: I20090112000427 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Peter R Ouellette |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1932350527 PECOS PAC ID: 9931262268 Enrollment ID: I20090113000825 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nirmala L Monteiro |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1558346338 PECOS PAC ID: 5496818411 Enrollment ID: I20090116000157 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Herralan Noel-vulpe |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1316192354 PECOS PAC ID: 4688737653 Enrollment ID: I20090116000529 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joseph Evangelista |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1093711343 PECOS PAC ID: 1254495138 Enrollment ID: I20090122000223 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gloriann Albini |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730134107 PECOS PAC ID: 2264596006 Enrollment ID: I20090123000065 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Francis P Alcedo |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1225091713 PECOS PAC ID: 4385703479 Enrollment ID: I20090123000321 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Debasish Das |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1598728099 PECOS PAC ID: 7214096387 Enrollment ID: I20090127000052 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lenore Snowden Opalak |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1033163605 PECOS PAC ID: 0749344349 Enrollment ID: I20090127000114 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kellie A Watkins-colwell |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1083669113 PECOS PAC ID: 7113086281 Enrollment ID: I20090127000122 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Arnold Dorosario |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1154380079 PECOS PAC ID: 3476612540 Enrollment ID: I20090127000158 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joseph A Rosa |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1568421469 PECOS PAC ID: 0648339721 Enrollment ID: I20090127000166 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lucia Chou |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1114986130 PECOS PAC ID: 9830258920 Enrollment ID: I20090128000030 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Vasudha Vallabhaneni |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1568421352 PECOS PAC ID: 9931268018 Enrollment ID: I20090128000348 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Douglas Duchen |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1952360885 PECOS PAC ID: 7810056991 Enrollment ID: I20090128000442 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brenda J Ganser |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215983705 PECOS PAC ID: 7810051349 Enrollment ID: I20090129000002 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joseph A Saracco |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1366436594 PECOS PAC ID: 7315001773 Enrollment ID: I20090129000325 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anthony J Mongillo |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1558324228 PECOS PAC ID: 7113086299 Enrollment ID: I20090129000360 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nicholas Bertini |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1952360588 PECOS PAC ID: 5395646590 Enrollment ID: I20090129000368 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristin Ruszkowski |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1982706768 PECOS PAC ID: 7113081589 Enrollment ID: I20090129000435 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pamela M Gau |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770695843 PECOS PAC ID: 2365506698 Enrollment ID: I20090130000359 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Edwin Levine |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1760441224 PECOS PAC ID: 0648339739 Enrollment ID: I20090203000203 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Arcangelo Distefano |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1902869415 PECOS PAC ID: 8628137700 Enrollment ID: I20090203000314 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pasquale Masone |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1003879446 PECOS PAC ID: 8022177104 Enrollment ID: I20090203000376 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cosmo Filiberto |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1144209321 PECOS PAC ID: 6800955980 Enrollment ID: I20090203000452 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Milla Stelman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1538113139 PECOS PAC ID: 3173682259 Enrollment ID: I20090203000477 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christian Heineken |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1003875931 PECOS PAC ID: 7618036799 Enrollment ID: I20090203000478 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rebecca P Streeter |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1376703736 PECOS PAC ID: 8325102304 Enrollment ID: I20090206000054 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Daniel T Kocinsky |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1548223969 PECOS PAC ID: 5193884286 Enrollment ID: I20090209000563 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bryan J Burns |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1790748739 PECOS PAC ID: 5092874180 Enrollment ID: I20090209000604 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Chun Wang Lam |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1255394680 PECOS PAC ID: 6002706835 Enrollment ID: I20090209000623 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sakena Abedin |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1891949954 PECOS PAC ID: 8729143409 Enrollment ID: I20090212000184 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tulasi Perali |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1376721449 PECOS PAC ID: 2264597731 Enrollment ID: I20090217000271 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nancy D Olson |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1003832049 PECOS PAC ID: 4183789373 Enrollment ID: I20090224000003 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael J Connolly |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1255390555 PECOS PAC ID: 3476612557 Enrollment ID: I20090302000560 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert S Prewitt |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1184683443 PECOS PAC ID: 1759440837 Enrollment ID: I20090302000650 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elizabeth Cusano |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871794271 PECOS PAC ID: 5991861684 Enrollment ID: I20090304000605 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ioana S Preda |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1164481024 PECOS PAC ID: 4183783269 Enrollment ID: I20090310000385 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ronald Miller |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1972740124 PECOS PAC ID: 2668538976 Enrollment ID: I20090311000226 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Dean Chang |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1770564247 PECOS PAC ID: 7214933886 Enrollment ID: I20090330000037 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ramin Ahmadi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1124009451 PECOS PAC ID: 0547224032 Enrollment ID: I20090408000504 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joseph A Cuteri |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1790727154 PECOS PAC ID: 4284600941 Enrollment ID: I20090413000360 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jeremy D Kaufman |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1659575405 PECOS PAC ID: 7810044567 Enrollment ID: I20090415000135 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Larry E Novik |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1295794634 PECOS PAC ID: 0941369011 Enrollment ID: I20090416000184 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Latha C Alaparthi |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1588645410 PECOS PAC ID: 4587660154 Enrollment ID: I20090420000675 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Renuka Umashanker |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1437130309 PECOS PAC ID: 9032115605 Enrollment ID: I20090421000603 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mark B Taylor |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1790766525 PECOS PAC ID: 9133125701 Enrollment ID: I20090421000626 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lisa Panzini |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1821132432 PECOS PAC ID: 5597813709 Enrollment ID: I20090428000162 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jane P Genido-trujillo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1184876708 PECOS PAC ID: 4880742592 Enrollment ID: I20090507000459 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Naomi Mendelovicz |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1487710141 PECOS PAC ID: 3577598218 Enrollment ID: I20090507000584 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Susan Grillo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1962584284 PECOS PAC ID: 2961551338 Enrollment ID: I20090514000568 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Matthew B Lubin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1538117692 PECOS PAC ID: 3173672136 Enrollment ID: I20090521000258 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Guita E Epstein-wilf |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1528261294 PECOS PAC ID: 4284783127 Enrollment ID: I20090522000363 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lara Colabelli |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1407054844 PECOS PAC ID: 4385794833 Enrollment ID: I20090604000278 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elizabeth Ofori-mante |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1659553113 PECOS PAC ID: 3072663400 Enrollment ID: I20090605000443 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Leah S Samson |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1215046883 PECOS PAC ID: 5597853572 Enrollment ID: I20090605000452 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Murali Chiravuri |
|---|---|
| Provider Type | Practitioner - Cardiac Electrophysiology |
| Provider Identifiers | NPI Number: 1952411704 PECOS PAC ID: 4688724966 Enrollment ID: I20090608000375 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rupert Dogbey |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1063694131 PECOS PAC ID: 8628128923 Enrollment ID: I20090608000546 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jolene R Martin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1508011883 PECOS PAC ID: 5799835971 Enrollment ID: I20090609000629 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kerstin E Calia |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1386627503 PECOS PAC ID: 1951451822 Enrollment ID: I20090616000025 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Frank Angelo Ciminiello |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1396788410 PECOS PAC ID: 7618991100 Enrollment ID: I20090618000174 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Allison S Cable |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1265532063 PECOS PAC ID: 1658422209 Enrollment ID: I20090623000025 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joann Hong Curtis |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1770626483 PECOS PAC ID: 4587715149 Enrollment ID: I20090623000091 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David M Wolfsohn |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1073653705 PECOS PAC ID: 9931250438 Enrollment ID: I20090623000624 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nicholas Lodato |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1225280498 PECOS PAC ID: 9133270689 Enrollment ID: I20090624000236 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Catharine Ann Arnold |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1306909742 PECOS PAC ID: 4880745280 Enrollment ID: I20090625000012 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gary Plotke |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1376715078 PECOS PAC ID: 0143371377 Enrollment ID: I20090630000276 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Benjamin R Newton |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1265520191 PECOS PAC ID: 5294807137 Enrollment ID: I20090713000072 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mithil Choksey |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1477788404 PECOS PAC ID: 2264584895 Enrollment ID: I20090713000592 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Eaton Chen |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1619991015 PECOS PAC ID: 1658423009 Enrollment ID: I20090715000470 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ken Yanagisawa |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1225055064 PECOS PAC ID: 2466504816 Enrollment ID: I20090715000561 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ronald Hisao Hirokawa |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1346267200 PECOS PAC ID: 9739231119 Enrollment ID: I20090715000647 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mark Dagostino |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1144230749 PECOS PAC ID: 9638221096 Enrollment ID: I20090715000682 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bruce A Mcgibbon |
|---|---|
| Provider Type | Practitioner - Radiation Oncology |
| Provider Identifiers | NPI Number: 1285878447 PECOS PAC ID: 2062564172 Enrollment ID: I20090721000703 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Irina G Rosewater |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1477793529 PECOS PAC ID: 1456404912 Enrollment ID: I20090730000310 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Leen Bakkali |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1629261193 PECOS PAC ID: 9436202686 Enrollment ID: I20090805000383 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ajay K Kota |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1942413646 PECOS PAC ID: 0941353106 Enrollment ID: I20090805000521 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kevin J Torres |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1023063849 PECOS PAC ID: 3577509645 Enrollment ID: I20090813000767 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Charles E Kochan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1467473298 PECOS PAC ID: 5698829869 Enrollment ID: I20090822000080 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | William Cheuk |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1275798761 PECOS PAC ID: 2163576224 Enrollment ID: I20090825000129 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Paige James Brennan |
|---|---|
| Provider Type | Practitioner - Cardiac Electrophysiology |
| Provider Identifiers | NPI Number: 1740365659 PECOS PAC ID: 2668527730 Enrollment ID: I20090826000504 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rina Ayepah |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1386826659 PECOS PAC ID: 1456406446 Enrollment ID: I20090826000751 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lynette C Murray |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1992750574 PECOS PAC ID: 9032126131 Enrollment ID: I20090828000386 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sachin K Majumdar |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1639201650 PECOS PAC ID: 5698873917 Enrollment ID: I20090831000000 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rolando Ruiz Santos |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1760689061 PECOS PAC ID: 5991850687 Enrollment ID: I20090901000683 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Louis Iovino |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1396825097 PECOS PAC ID: 2860547403 Enrollment ID: I20090902000482 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jeff S Kwon |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1972633741 PECOS PAC ID: 4385799949 Enrollment ID: I20090902000729 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Wayne Panullo |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1679616593 PECOS PAC ID: 9537214887 Enrollment ID: I20090910000074 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gregory Vornovitskiy |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1407031768 PECOS PAC ID: 6103896873 Enrollment ID: I20090916000272 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Linda R Casale |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1396740346 PECOS PAC ID: 7810085891 Enrollment ID: I20090917000278 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert F Fishman |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1366447179 PECOS PAC ID: 0547358525 Enrollment ID: I20090917000330 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steven H Kunkes |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1437154242 PECOS PAC ID: 1456449438 Enrollment ID: I20090918000033 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mitchell H Driesman |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1578568382 PECOS PAC ID: 8123929239 Enrollment ID: I20090918000077 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Richard L Taikowski |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1649275462 PECOS PAC ID: 4082702964 Enrollment ID: I20090922000042 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brandi L Iovino |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1639303324 PECOS PAC ID: 1658427281 Enrollment ID: I20090923000021 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Edward R Tuohy |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1174528905 PECOS PAC ID: 5991893877 Enrollment ID: I20090923000091 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lisa Kurian |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1003876228 PECOS PAC ID: 8022056431 Enrollment ID: I20090924000731 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sara L Richer |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1760676696 PECOS PAC ID: 5890831507 Enrollment ID: I20091012000143 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alin O Bortan |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1154545754 PECOS PAC ID: 1355487950 Enrollment ID: I20091013000484 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Roxanne C Abder |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1790840809 PECOS PAC ID: 2466504436 Enrollment ID: I20091023000190 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Donna Leonardo |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1134267727 PECOS PAC ID: 2466599006 Enrollment ID: I20091030000029 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jill Monda |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336125335 PECOS PAC ID: 0648318048 Enrollment ID: I20091104000573 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rachel T Kinzler |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952542334 PECOS PAC ID: 8729126404 Enrollment ID: I20091118000167 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Denise Buonocore |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437193760 PECOS PAC ID: 6204974876 Enrollment ID: I20091119000256 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sheila A Turner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1639317787 PECOS PAC ID: 0648319277 Enrollment ID: I20091120000173 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amit Khanna |
|---|---|
| Provider Type | Practitioner - Sleep Medicine |
| Provider Identifiers | NPI Number: 1013012723 PECOS PAC ID: 1153320296 Enrollment ID: I20091123000425 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mamta Patel |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1427381615 PECOS PAC ID: 5092854208 Enrollment ID: I20091201000618 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Asini E Gunawardana |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1437136017 PECOS PAC ID: 3173528445 Enrollment ID: I20091203000671 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Peter C Tortora |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1235190984 PECOS PAC ID: 5496644254 Enrollment ID: I20091204000275 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nimesh Patel |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1902947658 PECOS PAC ID: 1759420680 Enrollment ID: I20091205000017 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert A Eterno |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1538272943 PECOS PAC ID: 0143361576 Enrollment ID: I20100107000637 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Clive Lloyd Johnson |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1053500447 PECOS PAC ID: 4183713142 Enrollment ID: I20100111000634 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Irene Haight |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437330602 PECOS PAC ID: 9032251665 Enrollment ID: I20100120000705 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Andrew Bedford |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1548209125 PECOS PAC ID: 9032100359 Enrollment ID: I20100121000575 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gretchen Kimberly Berland |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1417974221 PECOS PAC ID: 4385787191 Enrollment ID: I20100202000509 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rochelle A Turetsky |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1215985262 PECOS PAC ID: 3476696923 Enrollment ID: I20100205000099 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Vijayant Singh |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1881821429 PECOS PAC ID: 1052454311 Enrollment ID: I20100209000202 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Adam B Mayerson |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1457451015 PECOS PAC ID: 7719944065 Enrollment ID: I20100209000216 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kendall L Dyer |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1124355946 PECOS PAC ID: 4486797669 Enrollment ID: I20100210000532 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Irma M Fotjadhi |
|---|---|
| Provider Type | Practitioner - Nuclear Medicine |
| Provider Identifiers | NPI Number: 1154503209 PECOS PAC ID: 1850435769 Enrollment ID: I20100216000508 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lee Jung |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1932199288 PECOS PAC ID: 6709920366 Enrollment ID: I20100219000464 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John L Maiocco |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1154382968 PECOS PAC ID: 8921143033 Enrollment ID: I20100301000414 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mark Somers |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1255374864 PECOS PAC ID: 6507956778 Enrollment ID: I20100303001079 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Valerie B Popkin |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1275575409 PECOS PAC ID: 4789774951 Enrollment ID: I20100304000140 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brian S Ehrlich |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1659329688 PECOS PAC ID: 9830087212 Enrollment ID: I20100304000804 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Katherine M Powell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1124359476 PECOS PAC ID: 5092850446 Enrollment ID: I20100310000030 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maureen V Jones |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1972825669 PECOS PAC ID: 3274678560 Enrollment ID: I20100311000516 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Francis J Neeson |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1083685226 PECOS PAC ID: 3870634686 Enrollment ID: I20100315000278 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anthony A Alleva |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1518938778 PECOS PAC ID: 7416098223 Enrollment ID: I20100315000378 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jay Graves |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1083771745 PECOS PAC ID: 6305971441 Enrollment ID: I20100315000943 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert J Stiller |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1801855804 PECOS PAC ID: 3971638610 Enrollment ID: I20100319000000 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jacob Hen |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1992774384 PECOS PAC ID: 7517092273 Enrollment ID: I20100319000255 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kai H Yang |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1093851321 PECOS PAC ID: 3577698257 Enrollment ID: I20100319000416 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gilead I Lancaster |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1396714564 PECOS PAC ID: 6406982867 Enrollment ID: I20100325000209 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joanna Zolkowski-wynne |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1033178306 PECOS PAC ID: 2365578648 Enrollment ID: I20100325000557 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gina A Dunston-boone |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1871562827 PECOS PAC ID: 2466588751 Enrollment ID: I20100325000658 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert T Ciotola |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1285791046 PECOS PAC ID: 2062555154 Enrollment ID: I20100326000525 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Craig A Mcpherson |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1982673117 PECOS PAC ID: 8224164249 Enrollment ID: I20100330000212 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Suresh Dmello |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1144387838 PECOS PAC ID: 8921134461 Enrollment ID: I20100410000109 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Megan E Watts St Germain |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1740517374 PECOS PAC ID: 5395872741 Enrollment ID: I20100416000428 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karen A Hutchinson |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1013986363 PECOS PAC ID: 6901933027 Enrollment ID: I20100422000065 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rowena Saga-abrina |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1093948408 PECOS PAC ID: 6608903323 Enrollment ID: I20100428000478 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nabil A Atweh |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1881662286 PECOS PAC ID: 7012044795 Enrollment ID: I20100429000184 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stuart W Zarich |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1689633596 PECOS PAC ID: 7012973498 Enrollment ID: I20100430000468 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael J Smith |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1376502914 PECOS PAC ID: 9830227263 Enrollment ID: I20100505001005 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cheryl A Menzies |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1760468573 PECOS PAC ID: 1951439314 Enrollment ID: I20100506000195 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gary E Kleinman |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1063471092 PECOS PAC ID: 2961530779 Enrollment ID: I20100514000105 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steven A Laifer |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1255300497 PECOS PAC ID: 2365570181 Enrollment ID: I20100514000175 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Wigneswaran W Paramanathan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1982663126 PECOS PAC ID: 2062541360 Enrollment ID: I20100525000764 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David Holland Burchenal |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1922050632 PECOS PAC ID: 6800895731 Enrollment ID: I20100607000655 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristiane N Proto |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548418080 PECOS PAC ID: 5799814620 Enrollment ID: I20100609000089 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Wendy J Cleare |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1356305148 PECOS PAC ID: 8921138959 Enrollment ID: I20100617000377 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kenneth Eli Mancher |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1255348025 PECOS PAC ID: 7719017706 Enrollment ID: I20100618000207 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bernard T D'souza |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1104098789 PECOS PAC ID: 0749311355 Enrollment ID: I20100625000633 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Paul E Feuerstadt |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1386975928 PECOS PAC ID: 3072645845 Enrollment ID: I20100714000031 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael Liu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1376735662 PECOS PAC ID: 8022173293 Enrollment ID: I20100714000209 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Roshanak Bagheri |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1023222650 PECOS PAC ID: 5395878417 Enrollment ID: I20100727000120 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brian M Cohen |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1386826790 PECOS PAC ID: 8325171374 Enrollment ID: I20100728000648 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Eliza M Fantarella |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1437319019 PECOS PAC ID: 7810011830 Enrollment ID: I20100827000580 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cynthia I Gentes |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1164434668 PECOS PAC ID: 2264406537 Enrollment ID: I20100831000478 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Eugenia M Vining |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1700999869 PECOS PAC ID: 5294891487 Enrollment ID: I20100831001000 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christopher Jennings Regan |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1841468709 PECOS PAC ID: 7113041930 Enrollment ID: I20100901000017 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Geoffrey S Gladstein |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1427060938 PECOS PAC ID: 6800860172 Enrollment ID: I20100901000152 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sudhir K Kadian |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1366497182 PECOS PAC ID: 8729102470 Enrollment ID: I20100901000475 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joseph A Cecere |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1528015088 PECOS PAC ID: 1951425602 Enrollment ID: I20100901000542 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kenneth Lipow |
|---|---|
| Provider Type | Practitioner - Neurosurgery |
| Provider Identifiers | NPI Number: 1427083674 PECOS PAC ID: 3678537446 Enrollment ID: I20100902001048 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Syeda F Afrin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1689993446 PECOS PAC ID: 2567586035 Enrollment ID: I20100907000153 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert J Keltner |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1154436483 PECOS PAC ID: 3072638360 Enrollment ID: I20100909000794 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kaberi Chanda |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1932111481 PECOS PAC ID: 5890810063 Enrollment ID: I20100910000601 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lawrence Daniel Muldoon |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1598861528 PECOS PAC ID: 4183706146 Enrollment ID: I20100910000824 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kenneth Alan Kingsly |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1932112547 PECOS PAC ID: 8325163520 Enrollment ID: I20100910001042 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | William Schreiber |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1366441826 PECOS PAC ID: 0143300905 Enrollment ID: I20100911000095 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sylvester E Dijeh |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1750532883 PECOS PAC ID: 3274658497 Enrollment ID: I20100911000105 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert P Weinstein |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1578588661 PECOS PAC ID: 1951426899 Enrollment ID: I20100915000408 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brian W Coyle |
|---|---|
| Provider Type | Practitioner - Vascular Surgery |
| Provider Identifiers | NPI Number: 1043492028 PECOS PAC ID: 7315062262 Enrollment ID: I20100915000525 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Edward B Paraiso |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1740212141 PECOS PAC ID: 3779608492 Enrollment ID: I20100917000185 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Slava I Kulakov |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1073524104 PECOS PAC ID: 1951491158 Enrollment ID: I20100920000212 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Adrian Dafcik |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1043221179 PECOS PAC ID: 7214027416 Enrollment ID: I20100920000252 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Senai Asefaw |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1801939343 PECOS PAC ID: 4183740475 Enrollment ID: I20100923000994 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sameer Syed |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1760647176 PECOS PAC ID: 3870639941 Enrollment ID: I20100924000050 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lynn D Wilson |
|---|---|
| Provider Type | Practitioner - Radiation Oncology |
| Provider Identifiers | NPI Number: 1770571770 PECOS PAC ID: 4385760438 Enrollment ID: I20100925000294 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maria Chung Rhee |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1518965888 PECOS PAC ID: 6901922053 Enrollment ID: I20100925000327 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Farlyn R Charlot-wadley |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1538339080 PECOS PAC ID: 5597881458 Enrollment ID: I20100928001346 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David John Lobo |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1811968258 PECOS PAC ID: 4385760206 Enrollment ID: I20100929000277 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Thomas S Long |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1114231677 PECOS PAC ID: 3274725676 Enrollment ID: I20101004000874 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David I Riccio |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1083613509 PECOS PAC ID: 1052491818 Enrollment ID: I20101005000945 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lora S Hahn Schubert |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1649355108 PECOS PAC ID: 4789876970 Enrollment ID: I20101006000604 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Patricia Hotsky-cikatz |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1275621815 PECOS PAC ID: 1759573827 Enrollment ID: I20101007000546 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Paul K Clarke |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1548292279 PECOS PAC ID: 0143412197 Enrollment ID: I20101008000166 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Andrew C Wormser |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1649279167 PECOS PAC ID: 9032299896 Enrollment ID: I20101008000265 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael Howard Bloch |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1770743064 PECOS PAC ID: 5193917177 Enrollment ID: I20101008000525 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Thomas G Takoudes |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1205949369 PECOS PAC ID: 1850457045 Enrollment ID: I20101008000594 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Daniel Jay Rudolph |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1356335707 PECOS PAC ID: 1759573595 Enrollment ID: I20101012000309 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kevin J Twohig |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1972588911 PECOS PAC ID: 4082794664 Enrollment ID: I20101013000052 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kenneth B Roberts |
|---|---|
| Provider Type | Practitioner - Radiation Oncology |
| Provider Identifiers | NPI Number: 1275522047 PECOS PAC ID: 0840482501 Enrollment ID: I20101013000418 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marc Eliot Mann |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1205800711 PECOS PAC ID: 5092757088 Enrollment ID: I20101013000640 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Charles R Rethy |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1982602884 PECOS PAC ID: 5395825152 Enrollment ID: I20101014001004 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Richard J Mangi |
|---|---|
| Provider Type | Practitioner - Allergy/immunology |
| Provider Identifiers | NPI Number: 1619976917 PECOS PAC ID: 4385610609 Enrollment ID: I20101015000321 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Daniel M Helburn |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1558307025 PECOS PAC ID: 7416037270 Enrollment ID: I20101015000404 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sarah Smith Gerritz |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1699886036 PECOS PAC ID: 9638362031 Enrollment ID: I20101018001096 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anca Bulgaru |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1659356640 PECOS PAC ID: 9335332550 Enrollment ID: I20101020001199 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael J Franco |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1750305686 PECOS PAC ID: 1658564752 Enrollment ID: I20101021000701 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Charles B Watson |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1245258474 PECOS PAC ID: 1951208461 Enrollment ID: I20101022000763 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jensa C Morris |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1508928797 PECOS PAC ID: 4688868342 Enrollment ID: I20101027000616 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Carly Burgess Brown |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1386811289 PECOS PAC ID: 8527252196 Enrollment ID: I20101028000425 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David Reisfeld |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1366536526 PECOS PAC ID: 0042405615 Enrollment ID: I20101109000307 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David Jonathan Eilbott |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1720094188 PECOS PAC ID: 1951494970 Enrollment ID: I20101111000864 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steven Schoenberger |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1477551034 PECOS PAC ID: 7911934971 Enrollment ID: I20101112000939 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ryan J Dadasovich |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1639390750 PECOS PAC ID: 1355536541 Enrollment ID: I20101113000011 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert C Deal |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1134123797 PECOS PAC ID: 4385839505 Enrollment ID: I20101115000304 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Richard S Rhee |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1033127337 PECOS PAC ID: 2062608961 Enrollment ID: I20101117001461 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Denis J Miller |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1578570594 PECOS PAC ID: 7416040431 Enrollment ID: I20101117001478 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Adiba A Geeti |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1053542928 PECOS PAC ID: 7618015009 Enrollment ID: I20101124000449 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Patrick J Benton |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1467673558 PECOS PAC ID: 0244427367 Enrollment ID: I20101215000031 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Valentine Edusa |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1588827653 PECOS PAC ID: 5496943532 Enrollment ID: I20101216000247 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Irem Nasir |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1205018124 PECOS PAC ID: 9739261363 Enrollment ID: I20101217000292 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Edward R Pinto |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1346207727 PECOS PAC ID: 1355539107 Enrollment ID: I20101221000997 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Benjamin Yeboah |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1174705636 PECOS PAC ID: 6800085945 Enrollment ID: I20110105000888 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jennifer L Brackett |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1942279773 PECOS PAC ID: 4486843539 Enrollment ID: I20110105000964 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert W Hill |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528036944 PECOS PAC ID: 1759570658 Enrollment ID: I20110107000323 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristin E. Edwards |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1346203213 PECOS PAC ID: 1052399771 Enrollment ID: I20110110000003 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Richard F Desouza |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1952503179 PECOS PAC ID: 5294914610 Enrollment ID: I20110131000956 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amelita L Richard |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700187192 PECOS PAC ID: 9830379262 Enrollment ID: I20110202000286 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Leah A Burke |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1245415959 PECOS PAC ID: 5193905990 Enrollment ID: I20110211000107 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Roselle E Crombie |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1477724300 PECOS PAC ID: 9830379361 Enrollment ID: I20110215000806 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Zadie N Kenkare |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1033281977 PECOS PAC ID: 1557541083 Enrollment ID: I20110215000818 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jill M Banatoski |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1982760542 PECOS PAC ID: 9436330628 Enrollment ID: I20110222000036 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Holly D Craig |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1942275557 PECOS PAC ID: 3577744663 Enrollment ID: I20110222001197 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kelly Nelson |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1659396737 PECOS PAC ID: 1153502943 Enrollment ID: I20110228000418 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lei Zou |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1992843676 PECOS PAC ID: 8224219951 Enrollment ID: I20110228000904 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael Rubinstein |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1083702633 PECOS PAC ID: 7113021338 Enrollment ID: I20110304000008 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert M Mclean |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1356340814 PECOS PAC ID: 2860453750 Enrollment ID: I20110307000036 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Daniel Moalli |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1427053958 PECOS PAC ID: 2860675196 Enrollment ID: I20110324000397 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | William Kober |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1396724134 PECOS PAC ID: 7113900044 Enrollment ID: I20110329000823 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Francis K Amoo |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1326223728 PECOS PAC ID: 6608059449 Enrollment ID: I20110331000642 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alan Weiss |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1477658821 PECOS PAC ID: 9234123969 Enrollment ID: I20110401000234 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jolene M Oliver |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1154630275 PECOS PAC ID: 6709060288 Enrollment ID: I20110407000139 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John Oshlick |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1942483888 PECOS PAC ID: 5698959955 Enrollment ID: I20110411000577 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cynthia N Wilson |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1295882181 PECOS PAC ID: 4880878057 Enrollment ID: I20110413000036 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Arnold Zuckman |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1790857969 PECOS PAC ID: 4587770839 Enrollment ID: I20110413001043 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Judith Weiss-rivera |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1386755429 PECOS PAC ID: 2264616168 Enrollment ID: I20110418000115 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gina Williams |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1023094158 PECOS PAC ID: 3476589953 Enrollment ID: I20110419000085 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anne Zylick |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356449243 PECOS PAC ID: 5294910006 Enrollment ID: I20110420000699 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Iulian C Giuran Benetato |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1568691152 PECOS PAC ID: 7012050958 Enrollment ID: I20110421000186 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Abhay M Dhond |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1669424669 PECOS PAC ID: 4385776541 Enrollment ID: I20110422000388 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Terrence A Doherty |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1255435558 PECOS PAC ID: 0345425781 Enrollment ID: I20110428000020 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Diane M Sheehan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1295030369 PECOS PAC ID: 6507041837 Enrollment ID: I20110429000412 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Richard Miller Hellman |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1821097601 PECOS PAC ID: 2062424211 Enrollment ID: I20110502000172 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jason Haldas |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1275532541 PECOS PAC ID: 8325241912 Enrollment ID: I20110502000215 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cindy Irene Boutilier |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1710280136 PECOS PAC ID: 2668657982 Enrollment ID: I20110503000000 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Susan Storck |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1962700252 PECOS PAC ID: 1850576968 Enrollment ID: I20110504000398 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Flora Zarcu-power |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1790716736 PECOS PAC ID: 6204012297 Enrollment ID: I20110509000245 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brian L Williams |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1518945351 PECOS PAC ID: 6406741115 Enrollment ID: I20110511000122 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Zeba T Syed |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1801199203 PECOS PAC ID: 7618153412 Enrollment ID: I20110511000837 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Louis Scott S Sussman |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1548365935 PECOS PAC ID: 8022173715 Enrollment ID: I20110512000026 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Diadette I Hernandez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396035382 PECOS PAC ID: 4183800865 Enrollment ID: I20110513000135 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Raymone K Shenouda |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1649326372 PECOS PAC ID: 5890972483 Enrollment ID: I20110608000244 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Katherine E Holmes |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235469677 PECOS PAC ID: 4880871151 Enrollment ID: I20110614000589 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ohm Deshpande |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1255598397 PECOS PAC ID: 3072791235 Enrollment ID: I20110617000439 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Helena Squicciarini |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1487691754 PECOS PAC ID: 7416954466 Enrollment ID: I20110621000158 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kimberly Ann Wills-rinaldi |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1093859019 PECOS PAC ID: 6800074543 Enrollment ID: I20110628000075 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Harshdeep Singh Nat |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1295984672 PECOS PAC ID: 3678751252 Enrollment ID: I20110630000054 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert Fogerty |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1235304270 PECOS PAC ID: 7810175296 Enrollment ID: I20110707000562 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shari Damast |
|---|---|
| Provider Type | Practitioner - Radiation Oncology |
| Provider Identifiers | NPI Number: 1558522060 PECOS PAC ID: 7719165109 Enrollment ID: I20110708000009 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rosy Nat |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1942459334 PECOS PAC ID: 3274701404 Enrollment ID: I20110714000223 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Arnold Peterson |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1881868867 PECOS PAC ID: 4385812106 Enrollment ID: I20110722000116 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shaan R Bhojwani |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1821046632 PECOS PAC ID: 9537337118 Enrollment ID: I20110726000705 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sonia D Hegde |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1487870101 PECOS PAC ID: 2961670385 Enrollment ID: I20110729000129 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nancy Kim |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1700080223 PECOS PAC ID: 2668640087 Enrollment ID: I20110729000159 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristan A Sikorski |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1265694707 PECOS PAC ID: 0345419701 Enrollment ID: I20110802000191 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Liviu Zaha |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1366733750 PECOS PAC ID: 0749459816 Enrollment ID: I20110805000329 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert Drew Sackstein |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1407855927 PECOS PAC ID: 7719936046 Enrollment ID: I20110811000520 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Adam T Lottick |
|---|---|
| Provider Type | Practitioner - Cardiac Electrophysiology |
| Provider Identifiers | NPI Number: 1780683235 PECOS PAC ID: 8224219571 Enrollment ID: I20110811000597 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kevin Kalman Lenhart |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1417956012 PECOS PAC ID: 4789633017 Enrollment ID: I20110811000758 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nycaine A Anderson |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1265692545 PECOS PAC ID: 3375712177 Enrollment ID: I20110812000142 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cassius Iyad N Ochoa Chaar |
|---|---|
| Provider Type | Practitioner - Vascular Surgery |
| Provider Identifiers | NPI Number: 1669600698 PECOS PAC ID: 1850560509 Enrollment ID: I20110815000166 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marc Z Krichavsky |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1457377723 PECOS PAC ID: 0345279816 Enrollment ID: I20110815000580 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jenny Hyppolite |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1003873332 PECOS PAC ID: 1951200385 Enrollment ID: I20110823000378 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Thomas Rank |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1629366398 PECOS PAC ID: 8921278367 Enrollment ID: I20110823000413 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Simona Constantinescu |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1144429465 PECOS PAC ID: 2769506864 Enrollment ID: I20110824000116 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bridget Mejza |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1649565649 PECOS PAC ID: 4981874054 Enrollment ID: I20110826000703 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Manuel C Pun |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1205833167 PECOS PAC ID: 0547219875 Enrollment ID: I20110830000680 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Yi-hao Yu |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1306914957 PECOS PAC ID: 9931265451 Enrollment ID: I20110902000087 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Moe T Kyaw |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1184911455 PECOS PAC ID: 2860662426 Enrollment ID: I20110909002389 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christopher Erb |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1538321138 PECOS PAC ID: 0840461430 Enrollment ID: I20110912000005 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joann R Donnel |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1013031491 PECOS PAC ID: 4587835129 Enrollment ID: I20110912000570 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mary J Scheimann |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1205834447 PECOS PAC ID: 2365528346 Enrollment ID: I20110914000162 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Himal Yadav Rai |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275820482 PECOS PAC ID: 1557532975 Enrollment ID: I20110915000347 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Georgia Ann Kelley |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1013945211 PECOS PAC ID: 7315118056 Enrollment ID: I20110929000110 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert Perry |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1861404402 PECOS PAC ID: 8527067693 Enrollment ID: I20111006000128 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elaine S Campbell |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1568541738 PECOS PAC ID: 1557425246 Enrollment ID: I20111012000329 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rasikh N Tuktamyshov |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1285885855 PECOS PAC ID: 9234301169 Enrollment ID: I20111018000685 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shivi Sharma |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1306092895 PECOS PAC ID: 8921270877 Enrollment ID: I20111019000007 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michelle A Cox |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902187057 PECOS PAC ID: 4385816230 Enrollment ID: I20111019000019 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steven Vyce |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1396743753 PECOS PAC ID: 6507039054 Enrollment ID: I20111029000013 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Edward Curtis Wirth |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1972540094 PECOS PAC ID: 2567635014 Enrollment ID: I20111031000000 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Vanessa Pomarico-denino |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1801832803 PECOS PAC ID: 9931232345 Enrollment ID: I20111101000660 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristen Broedlin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1649277518 PECOS PAC ID: 0749453884 Enrollment ID: I20111104000430 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kelly J Morse |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1982989653 PECOS PAC ID: 4688847775 Enrollment ID: I20111107000152 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Erik Enquist |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1619963535 PECOS PAC ID: 0749269751 Enrollment ID: I20111209000792 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lisa Woods |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1366505711 PECOS PAC ID: 4486827292 Enrollment ID: I20111213000165 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Reza Yavari |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1053477703 PECOS PAC ID: 0244497238 Enrollment ID: I20120202000378 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jerry A Ferrentino |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1740384429 PECOS PAC ID: 1557450236 Enrollment ID: I20120203000374 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brenda L Renzulli |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811289606 PECOS PAC ID: 5799942678 Enrollment ID: I20120203000556 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maribel Cabrera Martinez |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1023261559 PECOS PAC ID: 2860659604 Enrollment ID: I20120206000453 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maryanne Horta |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1124209101 PECOS PAC ID: 9133293061 Enrollment ID: I20120210000373 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shubnum Singh |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205069838 PECOS PAC ID: 0749447142 Enrollment ID: I20120213000255 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Indu Varghese |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1629231758 PECOS PAC ID: 5698933414 Enrollment ID: I20120225000036 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tao Du |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1376704916 PECOS PAC ID: 2365600822 Enrollment ID: I20120301000148 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Unnikrishnan Narayanan Thampy |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1093940843 PECOS PAC ID: 1153461603 Enrollment ID: I20120305000004 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maia B Weed |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922378678 PECOS PAC ID: 9436318516 Enrollment ID: I20120308000633 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nancy Nash Cresap Higbee |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1639472335 PECOS PAC ID: 4486837622 Enrollment ID: I20120316000375 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rebecca Gagne Henderson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851521215 PECOS PAC ID: 5698935237 Enrollment ID: I20120320000192 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Peter Jensen |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1861484917 PECOS PAC ID: 9638138803 Enrollment ID: I20120322000206 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristen Lorraine Velsmid |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275806390 PECOS PAC ID: 0941461610 Enrollment ID: I20120406000006 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anamika Margare Reed |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1588830939 PECOS PAC ID: 3072774629 Enrollment ID: I20120409000526 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Waleska Ortiz Ayala |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548546997 PECOS PAC ID: 6305007758 Enrollment ID: I20120412000275 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Katherine Victoria Kassler |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1386910727 PECOS PAC ID: 0244491298 Enrollment ID: I20120418000436 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Carolyn U Rojo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669745824 PECOS PAC ID: 8224299052 Enrollment ID: I20120423000045 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert J Nordness |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1154360196 PECOS PAC ID: 2961405014 Enrollment ID: I20120424000349 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Avinash R Gulrajani |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1316102247 PECOS PAC ID: 4789749987 Enrollment ID: I20120524000001 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Claudia P Ortiz Cardenas |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1760764674 PECOS PAC ID: 1658535596 Enrollment ID: I20120606000014 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rachana Kanaujia |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1043441439 PECOS PAC ID: 9032373808 Enrollment ID: I20120606000489 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael Phillip Dorfman |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1164658555 PECOS PAC ID: 2769640234 Enrollment ID: I20120607000427 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Camille Alecia Payne |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437433489 PECOS PAC ID: 6406010651 Enrollment ID: I20120619000639 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Paul Fiore |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1669601811 PECOS PAC ID: 7719142884 Enrollment ID: I20120625000117 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Olivia E Coiculescu |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1639338858 PECOS PAC ID: 4082750138 Enrollment ID: I20120629000102 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John K Forrest |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1386827491 PECOS PAC ID: 3375708696 Enrollment ID: I20120711000277 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kevin B Panzer |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1013143130 PECOS PAC ID: 3173788304 Enrollment ID: I20120712000859 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Olga Marsillio |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1841558897 PECOS PAC ID: 0143486357 Enrollment ID: I20120716000293 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mircea S Tamasdan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1386821015 PECOS PAC ID: 1153478136 Enrollment ID: I20120717000565 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steluta Nedelcuta |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1386971463 PECOS PAC ID: 9032375670 Enrollment ID: I20120725000725 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elisa Obrien |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1912262973 PECOS PAC ID: 3274799713 Enrollment ID: I20120727000012 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ram Yosef Gordon |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1295718252 PECOS PAC ID: 9931130325 Enrollment ID: I20120801000210 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David M Antonetti |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1184781031 PECOS PAC ID: 7911154380 Enrollment ID: I20120821000354 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ranee Angeli R Lleva |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1578709143 PECOS PAC ID: 3577710128 Enrollment ID: I20120904000433 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Linsley Beth Sikorski |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1184852261 PECOS PAC ID: 6002064342 Enrollment ID: I20120912000241 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joan E Sommers |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1851460067 PECOS PAC ID: 6305095720 Enrollment ID: I20120928000484 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Fraser Lawrence |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1295084770 PECOS PAC ID: 4587814975 Enrollment ID: I20121019000558 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amanda R Square |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1528220894 PECOS PAC ID: 9739339573 Enrollment ID: I20121101000197 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brooke L Davidson |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1730338039 PECOS PAC ID: 2860554367 Enrollment ID: I20121114000012 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jeannette Rita Koziel |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1912215781 PECOS PAC ID: 2365693512 Enrollment ID: I20121115000419 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mario P Nunez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700134384 PECOS PAC ID: 1355592460 Enrollment ID: I20121120000471 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Evan M Ginsberg |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1649231762 PECOS PAC ID: 2062592827 Enrollment ID: I20121207000240 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sara E Altieri |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1518210558 PECOS PAC ID: 2769634955 Enrollment ID: I20121217000116 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sarah Kathryn Fineberg |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1700100294 PECOS PAC ID: 5890948814 Enrollment ID: I20121226000245 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lois Caldrello |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1275885436 PECOS PAC ID: 0749434728 Enrollment ID: I20130128000309 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Traci Green |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205854213 PECOS PAC ID: 2860647062 Enrollment ID: I20130219000070 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rebecca A Tvardzik |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154674174 PECOS PAC ID: 8325293095 Enrollment ID: I20130311000341 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jessica A Walsh |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871844233 PECOS PAC ID: 1052556941 Enrollment ID: I20130325000503 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Angela Scott |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1114271517 PECOS PAC ID: 1759526569 Enrollment ID: I20130327000499 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Krystin M Uguccioni |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1639417397 PECOS PAC ID: 2769628833 Enrollment ID: I20130416000013 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Melanie Dulce Ricafort |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1659611978 PECOS PAC ID: 0143467944 Enrollment ID: I20130515000535 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sandi Jo Galati |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1437326147 PECOS PAC ID: 5092953398 Enrollment ID: I20130528000536 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Harsha N Naik |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1588934426 PECOS PAC ID: 5294973467 Enrollment ID: I20130529000703 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ashwatha Narayana |
|---|---|
| Provider Type | Practitioner - Radiation Oncology |
| Provider Identifiers | NPI Number: 1639121353 PECOS PAC ID: 4082638085 Enrollment ID: I20130607000213 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gabriel V Gambardella |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1447577309 PECOS PAC ID: 3678712379 Enrollment ID: I20130610000231 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John J Digiacomo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1033460076 PECOS PAC ID: 9133145386 Enrollment ID: I20130626000007 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Vidhya Rao |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1194038224 PECOS PAC ID: 7810136678 Enrollment ID: I20130627000085 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Caroline K Lodato |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1609075324 PECOS PAC ID: 1052551850 Enrollment ID: I20130627000641 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Saurabh Ranjan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1598086506 PECOS PAC ID: 9931349586 Enrollment ID: I20130703000105 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Doralynne R Dipasquale |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1235429697 PECOS PAC ID: 7416197900 Enrollment ID: I20130705000000 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Abdul Bhutta |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1417268566 PECOS PAC ID: 9638319957 Enrollment ID: I20130710000670 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mark T Silvestri |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1831333947 PECOS PAC ID: 1658511571 Enrollment ID: I20130717000158 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kimberly L Johung |
|---|---|
| Provider Type | Practitioner - Radiation Oncology |
| Provider Identifiers | NPI Number: 1255505178 PECOS PAC ID: 8224279989 Enrollment ID: I20130723001031 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sheila R Cord |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1316114374 PECOS PAC ID: 2769623339 Enrollment ID: I20130724000205 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lawrence J Peacock |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1902064173 PECOS PAC ID: 2466601414 Enrollment ID: I20130724000234 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Venu Velagapudi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1629264320 PECOS PAC ID: 2264688209 Enrollment ID: I20130729000602 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Erikka V Baehring |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558613315 PECOS PAC ID: 4284875550 Enrollment ID: I20130729000896 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ramnath Balakrishna Hebbar |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1124045992 PECOS PAC ID: 2163425133 Enrollment ID: I20130802000197 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michelle Johnson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922347335 PECOS PAC ID: 2860639101 Enrollment ID: I20130806000320 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Skerdi Fotjadhi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1417265653 PECOS PAC ID: 3072755867 Enrollment ID: I20130807000267 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Swati Joshi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1144566001 PECOS PAC ID: 2365684099 Enrollment ID: I20130809000110 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shea C Gregg |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1255535670 PECOS PAC ID: 8820156920 Enrollment ID: I20130809000283 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Asma Iftikhar |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1427344761 PECOS PAC ID: 2163664715 Enrollment ID: I20130809000393 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kimberly A Kurey |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1326351032 PECOS PAC ID: 6406045681 Enrollment ID: I20130813000082 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kiyoko Tomita |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1194041947 PECOS PAC ID: 8022250356 Enrollment ID: I20130815000361 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Dana J Power-lewis |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720329469 PECOS PAC ID: 4789826025 Enrollment ID: I20130815000459 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kerry E Wright |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1053572271 PECOS PAC ID: 4486802600 Enrollment ID: I20130816000219 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Praveen K Reddy |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1457663338 PECOS PAC ID: 5890938708 Enrollment ID: I20130826000080 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lotachukwu R Ojide |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1811200025 PECOS PAC ID: 4688817810 Enrollment ID: I20130906000699 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lauren A Pepin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831530419 PECOS PAC ID: 7012150253 Enrollment ID: I20130906000742 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Richard L Wintermute |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1710121389 PECOS PAC ID: 0648414441 Enrollment ID: I20130917000805 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jacqueline Arena-roberts |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1376885657 PECOS PAC ID: 9234363342 Enrollment ID: I20131003000235 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Donna Duris |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1588008007 PECOS PAC ID: 8527292259 Enrollment ID: I20131010001764 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mary Murray |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1861553695 PECOS PAC ID: 9638235112 Enrollment ID: I20131029002062 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kathryn M Graves |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1518390186 PECOS PAC ID: 8628204088 Enrollment ID: I20131114000159 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kelly R Esborn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558794222 PECOS PAC ID: 2163658261 Enrollment ID: I20131120000444 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ralph Benjamin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1891019519 PECOS PAC ID: 4587890512 Enrollment ID: I20131122000630 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Catherine N Kumaradhas |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1326357955 PECOS PAC ID: 5193951127 Enrollment ID: I20131122000730 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jyothi Thentu |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1851605638 PECOS PAC ID: 5597992156 Enrollment ID: I20131206000059 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Matthew Nwosu |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1073776563 PECOS PAC ID: 1456588037 Enrollment ID: I20131206000810 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Diana Adams |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1255300653 PECOS PAC ID: 0446487896 Enrollment ID: I20131211000682 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Veronica R Plasencia |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1053571216 PECOS PAC ID: 0941478655 Enrollment ID: I20131212000895 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christopher T Kolker |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1346292711 PECOS PAC ID: 6002980901 Enrollment ID: I20131219000017 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bobbi J Duffy Hidalgo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1912336462 PECOS PAC ID: 0244467009 Enrollment ID: I20131226001226 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sol Lissette Rodriguez Medina |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1205093929 PECOS PAC ID: 5496938268 Enrollment ID: I20140116000937 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jenifer Khan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1316249485 PECOS PAC ID: 1951539865 Enrollment ID: I20140122000331 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gulden Menderes |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1790072742 PECOS PAC ID: 0648408542 Enrollment ID: I20140123001169 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lisa Cari Vazquez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1942637970 PECOS PAC ID: 0244469963 Enrollment ID: I20140129000883 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Irina Schiopescu |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1396795175 PECOS PAC ID: 5294764155 Enrollment ID: I20140213000243 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Douglas S. Dufore |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1174607113 PECOS PAC ID: 1456580497 Enrollment ID: I20140214001040 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Muhammad Syed |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1104072370 PECOS PAC ID: 6800951351 Enrollment ID: I20140218001415 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ruby E Lekwauwa |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1801186101 PECOS PAC ID: 5496984338 Enrollment ID: I20140219000043 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Andrew M Parad |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1053405605 PECOS PAC ID: 3476783200 Enrollment ID: I20140224000307 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Courtney Sura |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497007629 PECOS PAC ID: 1355571043 Enrollment ID: I20140225000522 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Catherine A Lawlor |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1215379128 PECOS PAC ID: 0042440562 Enrollment ID: I20140303000680 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | H. Anthony Carter |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1487750733 PECOS PAC ID: 5799951265 Enrollment ID: I20140304001317 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Andrew Benjami Cohen |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1255573697 PECOS PAC ID: 2163652108 Enrollment ID: I20140313000468 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tara M Huta |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1093140204 PECOS PAC ID: 0244461002 Enrollment ID: I20140320001832 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Zofia Ramos |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1447268669 PECOS PAC ID: 9537223912 Enrollment ID: I20140423000127 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Francesca Rubin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1346670718 PECOS PAC ID: 9436382363 Enrollment ID: I20140430001507 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Zhong Yang Ker |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1124255112 PECOS PAC ID: 0244377539 Enrollment ID: I20140501001417 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David Altamirano |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1104139963 PECOS PAC ID: 9032342753 Enrollment ID: I20140505001449 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christine S Simpson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023195765 PECOS PAC ID: 5890928139 Enrollment ID: I20140512001578 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sanchita Sharma |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1811275993 PECOS PAC ID: 6406079136 Enrollment ID: I20140527000204 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ronald Castillo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174871719 PECOS PAC ID: 8729202965 Enrollment ID: I20140610001117 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kelly C Goode |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467894170 PECOS PAC ID: 2062636038 Enrollment ID: I20140612001726 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Iwona Lacka |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1477868958 PECOS PAC ID: 2567686546 Enrollment ID: I20140612001954 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Melanie Carol Kraus |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336121367 PECOS PAC ID: 1658595582 Enrollment ID: I20140617000597 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gioiamaria B Berna |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1063647840 PECOS PAC ID: 5991858979 Enrollment ID: I20140617001344 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anthony Manzon |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1770632796 PECOS PAC ID: 1153390273 Enrollment ID: I20140618000537 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Astou Seye |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1679868988 PECOS PAC ID: 0547484230 Enrollment ID: I20140619002242 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nora O Segar |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1548559750 PECOS PAC ID: 7315161999 Enrollment ID: I20140623000847 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert Ramek Attaran |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1629270616 PECOS PAC ID: 5294905089 Enrollment ID: I20140623001027 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karthik Gnanapandithan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1326327651 PECOS PAC ID: 9830314293 Enrollment ID: I20140627001576 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karen Brody |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1144348376 PECOS PAC ID: 9638394091 Enrollment ID: I20140627001657 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sadia K Gazi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1366738221 PECOS PAC ID: 8628293792 Enrollment ID: I20140703000038 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alissa K Greenberg Lee |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1508949694 PECOS PAC ID: 2769589829 Enrollment ID: I20140710000944 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sasanka Nishani Jayasuriya |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1891014148 PECOS PAC ID: 9436337565 Enrollment ID: I20140711001610 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael Chen |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1861649766 PECOS PAC ID: 3173748845 Enrollment ID: I20140714001540 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ruth A Piscitelli |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235476797 PECOS PAC ID: 5496970196 Enrollment ID: I20140715000081 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elena Balica |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1467731091 PECOS PAC ID: 9234356643 Enrollment ID: I20140808000437 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Minori Korn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548671381 PECOS PAC ID: 9830316256 Enrollment ID: I20140808000583 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristen Ashley Mcginness |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1649566092 PECOS PAC ID: 8022235316 Enrollment ID: I20140811000437 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Matthew S Wosnitzer |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1619134269 PECOS PAC ID: 9032336342 Enrollment ID: I20140811001191 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kathleen M Pacheco |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1003042623 PECOS PAC ID: 6608928072 Enrollment ID: I20140811002319 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cynthia A Togawa |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1932425063 PECOS PAC ID: 6608002472 Enrollment ID: I20140813002167 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Imedla Angelica P Cirilo |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1962780940 PECOS PAC ID: 3678714698 Enrollment ID: I20140814000082 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Evelyn Adekolu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1942595855 PECOS PAC ID: 4183841901 Enrollment ID: I20140818002387 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Dione Mbame |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1972895993 PECOS PAC ID: 4981822509 Enrollment ID: I20140823000119 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anthony G Arslan |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1619132800 PECOS PAC ID: 4486872975 Enrollment ID: I20140825002398 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jacqueline M Lagasse |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1255745014 PECOS PAC ID: 4688892912 Enrollment ID: I20140828002102 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Arshad Kamal |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1487939369 PECOS PAC ID: 8123273547 Enrollment ID: I20140904000531 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Carrie Ann Cuomo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174937239 PECOS PAC ID: 2769600683 Enrollment ID: I20140905001087 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Adrienne Parad |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1467659227 PECOS PAC ID: 3375762206 Enrollment ID: I20140908002311 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sharon Pettway-stewart |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548679350 PECOS PAC ID: 2466671102 Enrollment ID: I20140911001968 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Radhika S Datar |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1366753642 PECOS PAC ID: 8224257639 Enrollment ID: I20140917001928 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Igor Rojkovskiy |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1588809040 PECOS PAC ID: 2668529710 Enrollment ID: I20140918000529 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kathleen Ellis |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1679902316 PECOS PAC ID: 9739309758 Enrollment ID: I20140925000833 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Crina M Boeras |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1114248853 PECOS PAC ID: 3870713563 Enrollment ID: I20141001000028 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kumuthini Partheepan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1962781997 PECOS PAC ID: 2264652973 Enrollment ID: I20141001000779 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sameer Nagpal |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1912296401 PECOS PAC ID: 4789804295 Enrollment ID: I20141006000852 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jessica L Valsamis |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306252291 PECOS PAC ID: 5294955563 Enrollment ID: I20141008002156 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Leomerto A Somera |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1306118302 PECOS PAC ID: 3072733294 Enrollment ID: I20141009001548 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Manisha Rai |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1467782581 PECOS PAC ID: 7810153434 Enrollment ID: I20141010000577 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Youness Yavari |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1639471162 PECOS PAC ID: 9537389713 Enrollment ID: I20141010001161 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tro Kalayjian |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1558660720 PECOS PAC ID: 5193940948 Enrollment ID: I20141014000775 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nicole E Ortiz |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245644954 PECOS PAC ID: 0749401537 Enrollment ID: I20141020002008 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anisha Advani |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1881836799 PECOS PAC ID: 7719138791 Enrollment ID: I20141022000499 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tuba Khawaja |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1982049805 PECOS PAC ID: 0345461075 Enrollment ID: I20141022002234 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lakshmi Polisetty |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1508158833 PECOS PAC ID: 6901027531 Enrollment ID: I20141024001301 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John T Dunlop |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1124137286 PECOS PAC ID: 5890890115 Enrollment ID: I20141029001299 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alison Tray |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235548876 PECOS PAC ID: 2961624804 Enrollment ID: I20141110001754 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Barbara Weber Chess |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1689643678 PECOS PAC ID: 2062634884 Enrollment ID: I20141112000432 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Barbara S Bacal |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1528460565 PECOS PAC ID: 3072735729 Enrollment ID: I20141112001663 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alana Therese Pomarico |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1639583081 PECOS PAC ID: 9436471885 Enrollment ID: I20141215000410 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cara J Cacciabaudo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780016881 PECOS PAC ID: 6103149349 Enrollment ID: I20141219001530 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sandie Jean Derival |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1508266842 PECOS PAC ID: 4789907619 Enrollment ID: I20141230001494 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Zartashia Shahab |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1306131958 PECOS PAC ID: 1951556570 Enrollment ID: I20150102000565 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Roseann Finiguerra |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1609272251 PECOS PAC ID: 8527382126 Enrollment ID: I20150129001865 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stefanie Guarino |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1205232857 PECOS PAC ID: 0244554863 Enrollment ID: I20150130000156 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Daniela Gidea-addeo |
|---|---|
| Provider Type | Practitioner - Radiation Oncology |
| Provider Identifiers | NPI Number: 1093716862 PECOS PAC ID: 7618948308 Enrollment ID: I20150204002263 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christopher John Winterbottom |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1366761256 PECOS PAC ID: 4183949050 Enrollment ID: I20150217001959 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maryann Mcdonough |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1518278910 PECOS PAC ID: 3870818545 Enrollment ID: I20150221000223 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anderson John Bradbury |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154721074 PECOS PAC ID: 9133445141 Enrollment ID: I20150311000528 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Erica L Lussier |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245662592 PECOS PAC ID: 0648406413 Enrollment ID: I20150311001085 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Caroline Stella |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1952482879 PECOS PAC ID: 6002879723 Enrollment ID: I20150324000033 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shady Elsamra |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1144459785 PECOS PAC ID: 8123345147 Enrollment ID: I20150331001582 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jane M Kanowitz |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1245348929 PECOS PAC ID: 5193704658 Enrollment ID: I20150407002061 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rena Zerbini |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1487050548 PECOS PAC ID: 5597083501 Enrollment ID: I20150422001839 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Veronica Angulo Diaz |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1871848671 PECOS PAC ID: 6103145990 Enrollment ID: I20150429000366 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rahaf Damlakhi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1922395292 PECOS PAC ID: 8022338417 Enrollment ID: I20150527000726 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nnenna C Ogundipe |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1700193281 PECOS PAC ID: 2062600729 Enrollment ID: I20150528000354 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mikheil Verulashvili |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1770908360 PECOS PAC ID: 2264753409 Enrollment ID: I20150601000342 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joy Reyes |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1073900031 PECOS PAC ID: 6002137494 Enrollment ID: I20150611000032 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David Morris |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1245597483 PECOS PAC ID: 5799096681 Enrollment ID: I20150618001960 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Molain Saintilus |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1104189992 PECOS PAC ID: 9931410834 Enrollment ID: I20150618002096 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sandy Cayo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013318914 PECOS PAC ID: 4981925500 Enrollment ID: I20150624001979 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Deepti Canchi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1043572027 PECOS PAC ID: 6800108200 Enrollment ID: I20150626000814 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sauda E Bholat |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1831492081 PECOS PAC ID: 5193045177 Enrollment ID: I20150629002250 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Virginia Cody |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1376801795 PECOS PAC ID: 7113239443 Enrollment ID: I20150630000253 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maura T Le |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1346515657 PECOS PAC ID: 4981916160 Enrollment ID: I20150630002221 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Eric Myer Bader |
|---|---|
| Provider Type | Practitioner - Cardiac Electrophysiology |
| Provider Identifiers | NPI Number: 1831403534 PECOS PAC ID: 2264619568 Enrollment ID: I20150701002505 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Peter B Mcwhorter |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1730349069 PECOS PAC ID: 4082926183 Enrollment ID: I20150702000225 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Dana Anne Cavallo |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1821124157 PECOS PAC ID: 4385969443 Enrollment ID: I20150706001586 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Manpreet Singh |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1760752521 PECOS PAC ID: 7416100508 Enrollment ID: I20150706002714 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sophia Elissa Altin |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1619152154 PECOS PAC ID: 0143445221 Enrollment ID: I20150710000790 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bernardo Lombo Lievano |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1902036031 PECOS PAC ID: 1557674892 Enrollment ID: I20150716000475 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Adil S Bhutta |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1417212721 PECOS PAC ID: 8628206737 Enrollment ID: I20150805007737 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sandra L Byrnes |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1346621612 PECOS PAC ID: 4587979265 Enrollment ID: I20150811004315 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert N Jones |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1659513315 PECOS PAC ID: 3577700210 Enrollment ID: I20150811005415 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sreedhar Ravi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1972865368 PECOS PAC ID: 4082929245 Enrollment ID: I20150817002180 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lisa Licare |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1821300807 PECOS PAC ID: 3072828029 Enrollment ID: I20150819008805 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joon Ho Jang |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1760740088 PECOS PAC ID: 5698080448 Enrollment ID: I20150824000281 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Adam Lee Ackerman |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1497982235 PECOS PAC ID: 7911157193 Enrollment ID: I20150826001978 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael G Buscher |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1275853657 PECOS PAC ID: 0749429793 Enrollment ID: I20150909002510 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jennifer Rockfeld |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1659532091 PECOS PAC ID: 0648592246 Enrollment ID: I20150910000941 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jessica Dean |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1548656291 PECOS PAC ID: 4385951110 Enrollment ID: I20150911000111 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lisa I Ramdhanie |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1952642548 PECOS PAC ID: 2961719216 Enrollment ID: I20150918000198 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Aleksandra Rosinski |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1689932196 PECOS PAC ID: 3274840418 Enrollment ID: I20150921000548 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marina V Polskaya |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1578791745 PECOS PAC ID: 6608928882 Enrollment ID: I20150922001980 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Charles Walcott |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1790043446 PECOS PAC ID: 5092946764 Enrollment ID: I20150923000372 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristen Glasgow |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1942438445 PECOS PAC ID: 9032427919 Enrollment ID: I20150925000710 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Albert Do |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1942575154 PECOS PAC ID: 7315255205 Enrollment ID: I20150925001019 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Minhui Xie |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1811217714 PECOS PAC ID: 4587883517 Enrollment ID: I20150925002508 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Erin L Culbert |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1255607347 PECOS PAC ID: 8123336914 Enrollment ID: I20150928002152 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alla Chesky |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1194707463 PECOS PAC ID: 3870571680 Enrollment ID: I20150930000295 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sarah Dann |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770833170 PECOS PAC ID: 8224346549 Enrollment ID: I20151006000555 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jean Tornatore |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1205867900 PECOS PAC ID: 3577562859 Enrollment ID: I20151006001162 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mae Whelan |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1528388345 PECOS PAC ID: 2365660180 Enrollment ID: I20151014000533 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stephanie G Pettingle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205258605 PECOS PAC ID: 4587882949 Enrollment ID: I20151016000343 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lauren Eddy |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952787699 PECOS PAC ID: 5395054258 Enrollment ID: I20151016001034 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amanda F Zygmant |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1114233509 PECOS PAC ID: 3678882297 Enrollment ID: I20151022000942 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Casey A. Doyle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1184091217 PECOS PAC ID: 2668782756 Enrollment ID: I20151102000832 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amarnath R Annapureddy |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1346552189 PECOS PAC ID: 8426284605 Enrollment ID: I20151104000931 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David K. Hahn |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1053625459 PECOS PAC ID: 7911217724 Enrollment ID: I20151106001648 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Martin Ucanda |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1679709323 PECOS PAC ID: 9436469244 Enrollment ID: I20151106001740 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ryan Bell |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1992787113 PECOS PAC ID: 2769616622 Enrollment ID: I20151113001830 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Aikaterini Fineti |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1376855510 PECOS PAC ID: 2961717756 Enrollment ID: I20151123000065 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rita Rose Amendola |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1184007445 PECOS PAC ID: 8820304413 Enrollment ID: I20151125000815 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jin Xu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1760757827 PECOS PAC ID: 1759681562 Enrollment ID: I20151201001195 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rachelle Andre |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1205112901 PECOS PAC ID: 7719137116 Enrollment ID: I20151215000906 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steven Jack |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1760621577 PECOS PAC ID: 9537325212 Enrollment ID: I20151218000941 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kwasi K Dakwa |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1861788382 PECOS PAC ID: 2264733930 Enrollment ID: I20151222002140 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Carolynn Bruno |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1912159765 PECOS PAC ID: 4587966858 Enrollment ID: I20160104000469 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Chaula K Vora |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1942263033 PECOS PAC ID: 7517996689 Enrollment ID: I20160104002347 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jennifer Lynn Giannettino |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467729566 PECOS PAC ID: 1658699582 Enrollment ID: I20160105002548 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christine Needham |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1366828907 PECOS PAC ID: 8022310937 Enrollment ID: I20160111000135 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ewa T Ruggieri |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1447203393 PECOS PAC ID: 6901932763 Enrollment ID: I20160119001212 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Chinyere Uzoamaka |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1346595337 PECOS PAC ID: 9032412804 Enrollment ID: I20160128001251 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christina Hendry |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1174751754 PECOS PAC ID: 6608032677 Enrollment ID: I20160128002608 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Angela Candelaria |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1689961864 PECOS PAC ID: 3577867076 Enrollment ID: I20160203001710 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sandra Neubig |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1265897938 PECOS PAC ID: 9436453487 Enrollment ID: I20160211000852 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Linda Magnie Amah |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1437415197 PECOS PAC ID: 9830494491 Enrollment ID: I20160219001852 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jessica L Nargi |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1306217302 PECOS PAC ID: 0547565939 Enrollment ID: I20160223001259 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Divya Mangala Kestur Rajasekhar |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1124259858 PECOS PAC ID: 8426353681 Enrollment ID: I20160225001365 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shazi Ali |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1134584535 PECOS PAC ID: 5496052730 Enrollment ID: I20160331000529 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Linda F Pettei |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407976434 PECOS PAC ID: 3779881891 Enrollment ID: I20160406000300 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jessica Sellins |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1083098966 PECOS PAC ID: 4688972599 Enrollment ID: I20160408001882 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bethany Nelson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1134597560 PECOS PAC ID: 8628376332 Enrollment ID: I20160413001810 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kitima Boonvisudhi |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1134198005 PECOS PAC ID: 1456434091 Enrollment ID: I20160428000015 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Samantha Belmont |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1659737914 PECOS PAC ID: 7315236379 Enrollment ID: I20160513000906 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Muhammad S Sharfuddin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1225120744 PECOS PAC ID: 3072520147 Enrollment ID: I20160519000393 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kamraan Madhani |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1437491057 PECOS PAC ID: 8022312396 Enrollment ID: I20160526001945 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Yvonne Ankrah |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1912924762 PECOS PAC ID: 9537160676 Enrollment ID: I20160609000954 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ari T Pollack |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1427374305 PECOS PAC ID: 8628368271 Enrollment ID: I20160609001795 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maureen Leach |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750744546 PECOS PAC ID: 1557652500 Enrollment ID: I20160622000438 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steven V Kardos |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1356668669 PECOS PAC ID: 3577871524 Enrollment ID: I20160627000563 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marie Rosalette Mortel |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1396187472 PECOS PAC ID: 6406147164 Enrollment ID: I20160628000756 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Aileen R Pangilinan |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1861770448 PECOS PAC ID: 4880909399 Enrollment ID: I20160629000595 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karl Langberg |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1285070730 PECOS PAC ID: 7719279124 Enrollment ID: I20160705002005 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Keri A Herzog |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1427292614 PECOS PAC ID: 7810289022 Enrollment ID: I20160708001075 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Thilan Wijesekera |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1417392333 PECOS PAC ID: 7517286750 Enrollment ID: I20160719000971 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mary-agnes N Knoles |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1134134000 PECOS PAC ID: 1254321144 Enrollment ID: I20160720002385 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Laura M Bracale |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194790725 PECOS PAC ID: 7416854914 Enrollment ID: I20160721000021 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Charles Staples |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598122947 PECOS PAC ID: 9830482348 Enrollment ID: I20160721000307 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Wei-teng Yang |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1871932368 PECOS PAC ID: 4284927724 Enrollment ID: I20160721001468 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Romelle Maloney |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1245269091 PECOS PAC ID: 2668472309 Enrollment ID: I20160725002193 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Erin Mcknight |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1306139555 PECOS PAC ID: 2466678339 Enrollment ID: I20160726000661 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gregory K Mulvey |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1497013270 PECOS PAC ID: 7911290002 Enrollment ID: I20160727001048 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Qaayam Pabani |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1174964415 PECOS PAC ID: 9335447192 Enrollment ID: I20160727002107 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Yvonne Chu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1447693189 PECOS PAC ID: 9234361155 Enrollment ID: I20160728000095 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Umer E Malik |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1336589274 PECOS PAC ID: 3173813581 Enrollment ID: I20160812001656 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Neil Gupta |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1639514656 PECOS PAC ID: 6204138274 Enrollment ID: I20160812001726 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David Brill |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1437146404 PECOS PAC ID: 1052308905 Enrollment ID: I20160815002533 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Phyllis Tawiah |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1053575035 PECOS PAC ID: 4082781620 Enrollment ID: I20160822001693 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Heidi Mae Timbol |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1619265741 PECOS PAC ID: 3971822354 Enrollment ID: I20160823000392 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Katherine Nichols |
|---|---|
| Provider Type | Practitioner - Certified Clinical Nurse Specialist (cns) |
| Provider Identifiers | NPI Number: 1013956366 PECOS PAC ID: 7012988504 Enrollment ID: I20160823000613 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elyse Erlich |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1376614750 PECOS PAC ID: 2163519109 Enrollment ID: I20160823001923 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Omair Tahir |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1457792814 PECOS PAC ID: 6204064058 Enrollment ID: I20160830000554 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amanda L Fusco |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689025306 PECOS PAC ID: 0042506529 Enrollment ID: I20160909000332 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Thiago Jabuonski |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1053685107 PECOS PAC ID: 0941596423 Enrollment ID: I20160909000367 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mustafa A Alsaid Alkhreisat |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1205268588 PECOS PAC ID: 3678869153 Enrollment ID: I20160909000378 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Aisha Siddiqi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1144563552 PECOS PAC ID: 9032405287 Enrollment ID: I20160914001558 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Daniel Flynn |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1619237294 PECOS PAC ID: 7517254279 Enrollment ID: I20160922002455 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kimberly C Riquelme |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1619282191 PECOS PAC ID: 9830486471 Enrollment ID: I20160924000209 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shetal Patel Stewart |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1508201583 PECOS PAC ID: 8426345919 Enrollment ID: I20160927002612 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Loretta R Hallock |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1881960201 PECOS PAC ID: 7517254766 Enrollment ID: I20161003000966 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Taylor Gaglia |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528422185 PECOS PAC ID: 0446548564 Enrollment ID: I20161005001604 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pradnya Velankar |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1063732311 PECOS PAC ID: 6103114244 Enrollment ID: I20161005002231 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pavel Teslya |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1962845917 PECOS PAC ID: 6709188667 Enrollment ID: I20161005002336 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Taimur Habib |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1083671861 PECOS PAC ID: 3375624505 Enrollment ID: I20161006001129 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | William E Weber |
|---|---|
| Provider Type | Practitioner - Sleep Medicine |
| Provider Identifiers | NPI Number: 1649410481 PECOS PAC ID: 3375770522 Enrollment ID: I20161012001083 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jenna R Liguori |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1134595366 PECOS PAC ID: 5294023800 Enrollment ID: I20161014001074 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lealani Rodriguez |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1215008420 PECOS PAC ID: 6002814621 Enrollment ID: I20161103000803 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Samuel E. Peckham |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1447301163 PECOS PAC ID: 3173802527 Enrollment ID: I20161108001280 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Matthew Patchett |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1588930275 PECOS PAC ID: 7719206903 Enrollment ID: I20161121000421 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Litchia L Weber |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1184852030 PECOS PAC ID: 9931358207 Enrollment ID: I20161121001095 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rachel West |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1992259733 PECOS PAC ID: 5496035420 Enrollment ID: I20161209000863 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Renu R Boatright |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1407023252 PECOS PAC ID: 4183904949 Enrollment ID: I20161213001946 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Eric M Leibert |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1568400794 PECOS PAC ID: 0840203667 Enrollment ID: I20161215001776 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cullen K. Griffith |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1922331784 PECOS PAC ID: 7214236207 Enrollment ID: I20161216000165 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Caitlin O Harris |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487106316 PECOS PAC ID: 2466733076 Enrollment ID: I20161219002004 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Diane M Donohue |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1740626803 PECOS PAC ID: 5092957399 Enrollment ID: I20170109001872 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Leigh-anne Sastre |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1336683309 PECOS PAC ID: 4486936994 Enrollment ID: I20170118000772 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Thao Thahn Nguyen Rodriguez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922463835 PECOS PAC ID: 7618256074 Enrollment ID: I20170120000149 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shannon P Kukulka |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1982072591 PECOS PAC ID: 8527362045 Enrollment ID: I20170124002591 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Chalina Kamrasyid |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831633379 PECOS PAC ID: 8123300159 Enrollment ID: I20170126001123 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bonnie Elyssa Gould Rothberg |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1306283270 PECOS PAC ID: 9830493071 Enrollment ID: I20170127000068 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Erica F Mcmillian |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952654931 PECOS PAC ID: 5193956068 Enrollment ID: I20170131001693 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christopher M Defrancesco |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1114476546 PECOS PAC ID: 0446533087 Enrollment ID: I20170206002689 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marissa M Lavin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952855942 PECOS PAC ID: 0648553081 Enrollment ID: I20170210000190 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Melanie O Robinson |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1720425564 PECOS PAC ID: 4688958135 Enrollment ID: I20170228001474 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kelley E Mollor |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1629436597 PECOS PAC ID: 7517241961 Enrollment ID: I20170302000329 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristin Leigh Casasanta |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1942469622 PECOS PAC ID: 5092983023 Enrollment ID: I20170303000557 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Moshe Y Schwarz |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1316482813 PECOS PAC ID: 3870877103 Enrollment ID: I20170303001316 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lydia Lee-villarreal |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1366984189 PECOS PAC ID: 5799060612 Enrollment ID: I20170316000046 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Asiya Mahmut |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1275971285 PECOS PAC ID: 9638471782 Enrollment ID: I20170418000401 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Patricia I Abruna |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1023246832 PECOS PAC ID: 3971721549 Enrollment ID: I20170421000013 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kavitha Gopalratnam |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1942641873 PECOS PAC ID: 8527345271 Enrollment ID: I20170505000135 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jaclyn Jermine |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1629528872 PECOS PAC ID: 7416234042 Enrollment ID: I20170508001331 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Douglas Jordan Grunwald |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1154616001 PECOS PAC ID: 0446576417 Enrollment ID: I20170509001639 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alessandra M Capobianco |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1053679431 PECOS PAC ID: 3274854112 Enrollment ID: I20170509002597 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Angela J Kang-giaimo |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1396158499 PECOS PAC ID: 8729307111 Enrollment ID: I20170517002613 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tooba Kazmi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1932365061 PECOS PAC ID: 1759569098 Enrollment ID: I20170518001212 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Antonio Angelo Giaimo |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1578976718 PECOS PAC ID: 6901119916 Enrollment ID: I20170519000321 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Yihan Yang |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1568875748 PECOS PAC ID: 4880907328 Enrollment ID: I20170519000853 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Aubrey Ellen Rauktys |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1437448909 PECOS PAC ID: 8820232374 Enrollment ID: I20170601001287 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Syed F Rizvi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1033452776 PECOS PAC ID: 1456630748 Enrollment ID: I20170605002495 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lauren Einfrank |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1427504331 PECOS PAC ID: 9032487921 Enrollment ID: I20170619000165 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anupama Narla |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1205191889 PECOS PAC ID: 4789952672 Enrollment ID: I20170619000425 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Danielle Rose Saldin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1114226545 PECOS PAC ID: 5597982199 Enrollment ID: I20170620001901 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mohamad Firas Barbour |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1144636879 PECOS PAC ID: 4385966001 Enrollment ID: I20170620001997 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Benigno R Varela |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1730488412 PECOS PAC ID: 7810265485 Enrollment ID: I20170622002802 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rabia Rizwan |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1598171944 PECOS PAC ID: 1355619875 Enrollment ID: I20170623001936 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maria Del Pilar Silva Chuecos |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1982916433 PECOS PAC ID: 9537395108 Enrollment ID: I20170626002214 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert E O'sullivan |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1053751271 PECOS PAC ID: 5496024655 Enrollment ID: I20170630001374 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jean Paul Higuero Sevilla |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1780996595 PECOS PAC ID: 8527380971 Enrollment ID: I20170706000009 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jennifer Zigun |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1912117714 PECOS PAC ID: 0547539199 Enrollment ID: I20170713000666 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christofer John Fort |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1366856817 PECOS PAC ID: 8123312600 Enrollment ID: I20170713001663 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bashar Alkinj |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1497986871 PECOS PAC ID: 9133381031 Enrollment ID: I20170714002435 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Meredith Mcfarland |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1821353012 PECOS PAC ID: 5193095644 Enrollment ID: I20170717002524 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Carol Standish |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598219636 PECOS PAC ID: 8820368970 Enrollment ID: I20170721001672 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kelsey Arshad |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1083155576 PECOS PAC ID: 6305116112 Enrollment ID: I20170726002265 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nadezhda Lomakina |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1639598121 PECOS PAC ID: 3678893153 Enrollment ID: I20170727003244 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael I Gazes |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1962820522 PECOS PAC ID: 8224359849 Enrollment ID: I20170802001938 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steven Smith |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1033538806 PECOS PAC ID: 8022389311 Enrollment ID: I20170804000698 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sankar Chinnu Gounder |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1154735322 PECOS PAC ID: 1759673890 Enrollment ID: I20170814001696 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ashanee Thompson |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1326467820 PECOS PAC ID: 4880914530 Enrollment ID: I20170817000021 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anupama Pani |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1396803359 PECOS PAC ID: 4284627753 Enrollment ID: I20170818001123 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | James R Pallett |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1306251129 PECOS PAC ID: 6406128826 Enrollment ID: I20170821000814 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Piyal Alam |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1609296383 PECOS PAC ID: 4183993421 Enrollment ID: I20170823003857 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Saad A Qadwai |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1578962601 PECOS PAC ID: 1658643572 Enrollment ID: I20170828000397 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jean M Kulas |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811427164 PECOS PAC ID: 6305119041 Enrollment ID: I20170831002335 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Edita Cubatiuk |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1134643430 PECOS PAC ID: 9436422086 Enrollment ID: I20170905000280 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Raquel Canete |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1942594197 PECOS PAC ID: 9133432776 Enrollment ID: I20170908001193 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Matthew Griffin |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1699186064 PECOS PAC ID: 5294056818 Enrollment ID: I20170928003958 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tara M. Meady |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1073990123 PECOS PAC ID: 4880969815 Enrollment ID: I20171002001435 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nicole Denny |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1841709870 PECOS PAC ID: 5294000246 Enrollment ID: I20171002002223 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Eva Wallace |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1962928283 PECOS PAC ID: 0042585762 Enrollment ID: I20171005003074 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Angela R Azor |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1710392444 PECOS PAC ID: 2961778113 Enrollment ID: I20171017000261 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jeremy Estes |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1134657257 PECOS PAC ID: 3678849650 Enrollment ID: I20171018002171 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jennifer A Burns |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1932624814 PECOS PAC ID: 3476829037 Enrollment ID: I20171026000011 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Julia Maia |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1760612162 PECOS PAC ID: 0143376319 Enrollment ID: I20171030002002 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christine M Moore |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336650001 PECOS PAC ID: 8022375419 Enrollment ID: I20171120000633 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Siobhon K Andrews |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1366953457 PECOS PAC ID: 5890052203 Enrollment ID: I20171120001364 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alyssa Gillego |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1659567352 PECOS PAC ID: 0749335214 Enrollment ID: I20171121002444 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Deepak K Kana |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1851710370 PECOS PAC ID: 3678830841 Enrollment ID: I20171122002207 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bibian A. Odhiambo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1386949634 PECOS PAC ID: 7012174287 Enrollment ID: I20171129000762 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Girija Narayanaswamy |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1629079116 PECOS PAC ID: 4082644364 Enrollment ID: I20171129003011 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brittany L Provenzano |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1104341908 PECOS PAC ID: 0749548659 Enrollment ID: I20171226001741 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Heather Czajkowski |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407367113 PECOS PAC ID: 5496013237 Enrollment ID: I20171227001703 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Allison Dell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205349669 PECOS PAC ID: 2466710231 Enrollment ID: I20171227002964 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sana Khan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1093133290 PECOS PAC ID: 1850696709 Enrollment ID: I20180108001378 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Angela N Ventulett |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1093224891 PECOS PAC ID: 3870852148 Enrollment ID: I20180111001986 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Theodore Kutzy |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1619051026 PECOS PAC ID: 8921007527 Enrollment ID: I20180113000018 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ernest Lee Retland |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1295173078 PECOS PAC ID: 5092017624 Enrollment ID: I20180122000115 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Huseyin Nail Aydin |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1548405871 PECOS PAC ID: 1254465321 Enrollment ID: I20180122001946 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ryan Kaple |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1154580694 PECOS PAC ID: 7214240357 Enrollment ID: I20180124002310 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mark T Mauriello |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1255627618 PECOS PAC ID: 5991923849 Enrollment ID: I20180131000811 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ryan Wallace |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1548695075 PECOS PAC ID: 2769703552 Enrollment ID: I20180202000781 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Dandie Gallaher |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1477972396 PECOS PAC ID: 9032481312 Enrollment ID: I20180212001549 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Vera Borkowski |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1962885244 PECOS PAC ID: 3173883014 Enrollment ID: I20180214000639 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Daniel Greenwald |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1578902417 PECOS PAC ID: 2961762737 Enrollment ID: I20180216000894 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Virginie Eklund |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1811401847 PECOS PAC ID: 1355602137 Enrollment ID: I20180220001136 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shean L Barrett |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1568780922 PECOS PAC ID: 2264669001 Enrollment ID: I20180223000498 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sushmitha Fernandes |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1164838934 PECOS PAC ID: 7517228034 Enrollment ID: I20180226001598 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kathryn E Stack |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1326081969 PECOS PAC ID: 4587727292 Enrollment ID: I20180302000172 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Wendy Mariko Awa |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770090789 PECOS PAC ID: 9234490368 Enrollment ID: I20180306000170 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tabassum Firoz |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1396109146 PECOS PAC ID: 9638466840 Enrollment ID: I20180306001084 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brittany Herman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1033624077 PECOS PAC ID: 6800157967 Enrollment ID: I20180306001576 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John Lindsay |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1376930586 PECOS PAC ID: 8022383686 Enrollment ID: I20180307000209 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | James M. Haddon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1447762901 PECOS PAC ID: 5193086114 Enrollment ID: I20180307001618 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Edwin Js Lee |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1972921047 PECOS PAC ID: 3072874056 Enrollment ID: I20180308001370 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karen A Alicea |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225545874 PECOS PAC ID: 6901168699 Enrollment ID: I20180316000178 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John William Tyson |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1649265117 PECOS PAC ID: 1254525611 Enrollment ID: I20180316000905 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Patricia Anne Simpson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013436229 PECOS PAC ID: 5890057467 Enrollment ID: I20180319001482 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Roxana Bustamante |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235598467 PECOS PAC ID: 9537421185 Enrollment ID: I20180320002805 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Janel Elise L'official |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1558592139 PECOS PAC ID: 4789832783 Enrollment ID: I20180321001787 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Safira Hamisu Iddriss |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1821456989 PECOS PAC ID: 2062774466 Enrollment ID: I20180323000653 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Keven Bernard Babbitt |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811441934 PECOS PAC ID: 6103843974 Enrollment ID: I20180329001880 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Janice Jones |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1609931831 PECOS PAC ID: 7911269097 Enrollment ID: I20180330000204 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kathalina Renee Fabian-fontenot |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1386152528 PECOS PAC ID: 1254693393 Enrollment ID: I20180402000863 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Eric M. Festa |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1104349984 PECOS PAC ID: 4789947326 Enrollment ID: I20180413000789 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joseph Renzulli |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1538108832 PECOS PAC ID: 5395757751 Enrollment ID: I20180419001499 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Leonie Rose Bovino |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558894303 PECOS PAC ID: 9335403385 Enrollment ID: I20180430000597 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | James Zachary Porterfield |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1508131640 PECOS PAC ID: 9638433428 Enrollment ID: I20180502001634 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ashley F Coughlin |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1528445871 PECOS PAC ID: 3779847579 Enrollment ID: I20180502002353 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Saira Nasar |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1306220132 PECOS PAC ID: 2668736216 Enrollment ID: I20180507001044 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robyn A Puleo |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1669589701 PECOS PAC ID: 7517916109 Enrollment ID: I20180510002551 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sanjay Aneja |
|---|---|
| Provider Type | Practitioner - Radiation Oncology |
| Provider Identifiers | NPI Number: 1699119628 PECOS PAC ID: 6507178902 Enrollment ID: I20180516000111 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Niloufarsadat Yarandi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1477935971 PECOS PAC ID: 5698042943 Enrollment ID: I20180517001959 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Matthew Louis Goland-van Ryn |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1992047740 PECOS PAC ID: 9931464112 Enrollment ID: I20180518000809 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Benjamin Jospeh Vaccaro |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1295027936 PECOS PAC ID: 8325329386 Enrollment ID: I20180525001673 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sarah M Shipley |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1275929119 PECOS PAC ID: 6507121191 Enrollment ID: I20180601000492 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Allison Catherine Posta |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1831578434 PECOS PAC ID: 7719299056 Enrollment ID: I20180606002223 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alison Thompson |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1558741728 PECOS PAC ID: 5294047866 Enrollment ID: I20180612001003 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tiffany T Chen |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1548603525 PECOS PAC ID: 7517212533 Enrollment ID: I20180615000861 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ilir Maraj |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1962639856 PECOS PAC ID: 8729358189 Enrollment ID: I20180619001086 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nino Gigauri |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1487036802 PECOS PAC ID: 4183970528 Enrollment ID: I20180627002599 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gina Kang |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1790105773 PECOS PAC ID: 1557632247 Enrollment ID: I20180702002223 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Andrew M Beck |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1467710657 PECOS PAC ID: 4183970254 Enrollment ID: I20180702003162 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cristine Connor |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1073027322 PECOS PAC ID: 2163778762 Enrollment ID: I20180712001562 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Chirag Shah |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1174813208 PECOS PAC ID: 0143541615 Enrollment ID: I20180712002344 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kevin Neill O'laughlin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1750762209 PECOS PAC ID: 1557674462 Enrollment ID: I20180716002699 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jonathan Nicholas Pumilia |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1598146607 PECOS PAC ID: 6002121878 Enrollment ID: I20180717000116 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Linda M Trapani |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1306188446 PECOS PAC ID: 7911297809 Enrollment ID: I20180720001417 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nasheena Jiwa |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1629464607 PECOS PAC ID: 4880990449 Enrollment ID: I20180720002648 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Murielle Exantus |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679070387 PECOS PAC ID: 2466709282 Enrollment ID: I20180724003407 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Saeeda Qadri |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1295174993 PECOS PAC ID: 5193010775 Enrollment ID: I20180725000541 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Blerta Green |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1578942215 PECOS PAC ID: 3971815549 Enrollment ID: I20180725002148 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Felix Xavier De Jesus Roman |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1386055069 PECOS PAC ID: 6901104330 Enrollment ID: I20180726000573 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mia Djulbegovic |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1598145013 PECOS PAC ID: 7810201308 Enrollment ID: I20180726001122 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Craig Sauer |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1437577020 PECOS PAC ID: 0547517237 Enrollment ID: I20180726002003 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sabina A Rebis |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1134515299 PECOS PAC ID: 7113275637 Enrollment ID: I20180731002136 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tenzin Palkey |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356832810 PECOS PAC ID: 8921356205 Enrollment ID: I20180802001329 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | James Connolly |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1609255223 PECOS PAC ID: 4688987886 Enrollment ID: I20180803001258 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steve Butala |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1326434424 PECOS PAC ID: 3779831805 Enrollment ID: I20180807001668 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ashok P Sharma |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1205864022 PECOS PAC ID: 1850372103 Enrollment ID: I20180807003219 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sandra L Shipkowitz |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013052430 PECOS PAC ID: 5597013441 Enrollment ID: I20180808003522 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jaime Leahy |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1508249335 PECOS PAC ID: 5799082244 Enrollment ID: I20180813003131 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Daren Spinelle |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1346635315 PECOS PAC ID: 8022312214 Enrollment ID: I20180816000387 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nikko Dunlevy |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1669889705 PECOS PAC ID: 4587913041 Enrollment ID: I20180817000062 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Andrew Peterson Lange |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1487033999 PECOS PAC ID: 6709198047 Enrollment ID: I20180820002261 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amanda L Hall |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1619494846 PECOS PAC ID: 7618239161 Enrollment ID: I20180820002858 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael Seth Kopf |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1669762126 PECOS PAC ID: 9830448919 Enrollment ID: I20180822003136 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Fabiola Fleury |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1649784513 PECOS PAC ID: 7113276130 Enrollment ID: I20180823001628 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alberta Alickaj |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1417184300 PECOS PAC ID: 1850525882 Enrollment ID: I20180824001925 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Saad R Saffo |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1508245291 PECOS PAC ID: 0446562573 Enrollment ID: I20180828002946 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karen A. Malkhasyan |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1760732010 PECOS PAC ID: 8123330123 Enrollment ID: I20180829000307 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lucy A Shamberg |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1083977581 PECOS PAC ID: 4082916689 Enrollment ID: I20180829002278 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Timothy Taeho Kim |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1457633430 PECOS PAC ID: 0749583276 Enrollment ID: I20180829002611 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jennifer Lynn Trocola |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1114417847 PECOS PAC ID: 6608126271 Enrollment ID: I20180830003034 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Regan L Murchison |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1265842959 PECOS PAC ID: 8123327863 Enrollment ID: I20180905002425 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Annette M Bailey |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1568830008 PECOS PAC ID: 9830449255 Enrollment ID: I20180906000448 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nejla Kubilay |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1740662279 PECOS PAC ID: 1355654286 Enrollment ID: I20180907001261 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lily Bayat |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1013275452 PECOS PAC ID: 4688966690 Enrollment ID: I20180907001690 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jana Zielonka |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1649650672 PECOS PAC ID: 8628382215 Enrollment ID: I20180907001984 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anda R Gonciulea |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1225357056 PECOS PAC ID: 3072754852 Enrollment ID: I20180907002730 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Charles R Esposito |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1548359078 PECOS PAC ID: 2062762263 Enrollment ID: I20180910002402 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Laura Tycon Moreines |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225456940 PECOS PAC ID: 6204051816 Enrollment ID: I20180914000281 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kathryn Dzurilla |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922584549 PECOS PAC ID: 6800147794 Enrollment ID: I20180914001238 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sharon Dragich |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1730594821 PECOS PAC ID: 9133470461 Enrollment ID: I20180925002503 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Melissa A Fazzolari |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477041564 PECOS PAC ID: 6901157155 Enrollment ID: I20180926003765 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rohan Arjun Bhojwani |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1578942504 PECOS PAC ID: 3971854159 Enrollment ID: I20180927001093 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Samuel Frederick Webster Clarke |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1558740118 PECOS PAC ID: 1557673050 Enrollment ID: I20180927002088 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Melissa Brandon Weimer |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1972708675 PECOS PAC ID: 8022162726 Enrollment ID: I20181003001957 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ashley Perfetto |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1821579996 PECOS PAC ID: 8628320520 Enrollment ID: I20181003002864 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Megan J O'connell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1891234951 PECOS PAC ID: 6204188139 Enrollment ID: I20181004000367 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marat Kribis |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1609250547 PECOS PAC ID: 2567714421 Enrollment ID: I20181004001754 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bethany Burke |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164901427 PECOS PAC ID: 3375895964 Enrollment ID: I20181009003223 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jamie Dossantos |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1063914232 PECOS PAC ID: 4981956422 Enrollment ID: I20181010001909 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Muhammad Tariq Shakoor |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1952656498 PECOS PAC ID: 7113153099 Enrollment ID: I20181011000127 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kathryn Fahey |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1346663408 PECOS PAC ID: 8224380647 Enrollment ID: I20181015000026 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elizabeth Nadal |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1730508946 PECOS PAC ID: 0840542171 Enrollment ID: I20181015000937 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rui Zhang |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1588008452 PECOS PAC ID: 4183976327 Enrollment ID: I20181016002562 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jamie Elizabeth Charron |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720569379 PECOS PAC ID: 4981956158 Enrollment ID: I20181017000063 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kezia Meyer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1740655422 PECOS PAC ID: 3375847858 Enrollment ID: I20181018000568 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Arielle Ornstein |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1811214026 PECOS PAC ID: 5496008542 Enrollment ID: I20181019000810 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stanley Lyndon |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1578971370 PECOS PAC ID: 6002125168 Enrollment ID: I20181022000901 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marguerite Rao Dillaway |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1821059072 PECOS PAC ID: 6800149832 Enrollment ID: I20181022001577 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tara A Robertson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679069561 PECOS PAC ID: 8426301334 Enrollment ID: I20181023001851 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marianne T Longacre |
|---|---|
| Provider Type | Practitioner - Osteopathic Manipulative Medicine |
| Provider Identifiers | NPI Number: 1396776266 PECOS PAC ID: 3678767787 Enrollment ID: I20181024001302 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jessica Juhee Kim-vaghela |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1114334273 PECOS PAC ID: 1355694027 Enrollment ID: I20181025002261 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cristina Martin |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1164868832 PECOS PAC ID: 9537412242 Enrollment ID: I20181026000890 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Augustine Andoh-duku |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1992010565 PECOS PAC ID: 9335451392 Enrollment ID: I20181027000016 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joy J Liu |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1558742072 PECOS PAC ID: 2668780107 Enrollment ID: I20181029001415 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nicole Parry |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1073099420 PECOS PAC ID: 9830442300 Enrollment ID: I20181030002818 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Megan Paglialunga |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1386138667 PECOS PAC ID: 4587917968 Enrollment ID: I20181101001006 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kaltrina Sedaliu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1952788689 PECOS PAC ID: 1850644105 Enrollment ID: I20181102001254 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elizabeth A Dieckman |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1750727178 PECOS PAC ID: 8325392566 Enrollment ID: I20181107000861 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amy Laura Snyder |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1265535355 PECOS PAC ID: 0648347765 Enrollment ID: I20181109002755 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Darwish Ibrahim Naji |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1164711909 PECOS PAC ID: 0749407617 Enrollment ID: I20181114002185 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ashley C Labonte |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770074957 PECOS PAC ID: 6204180912 Enrollment ID: I20181115002838 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jessica A Kelly-hauser |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144710955 PECOS PAC ID: 0042564767 Enrollment ID: I20181116000126 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Carolyn Brown |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023513132 PECOS PAC ID: 9830443555 Enrollment ID: I20181116000238 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anthony Oduje Isedeh |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1639445539 PECOS PAC ID: 2567688922 Enrollment ID: I20181120001144 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rebecca C Rastetter |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1386725455 PECOS PAC ID: 5597853341 Enrollment ID: I20181120001469 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alyssa E Sharp |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1578937629 PECOS PAC ID: 2163719097 Enrollment ID: I20181126001310 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christopher T Faludi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1497121743 PECOS PAC ID: 1052665700 Enrollment ID: I20181126001339 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John Montojo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1841773694 PECOS PAC ID: 0143574434 Enrollment ID: I20181127000840 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mustafa Khaliqi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1629488994 PECOS PAC ID: 3274808936 Enrollment ID: I20181128002323 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rajat Virmani |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1083029318 PECOS PAC ID: 3274806138 Enrollment ID: I20181130001181 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristin E Sapanaro |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376897454 PECOS PAC ID: 2365786381 Enrollment ID: I20181203001398 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cynthia F. Mann |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1518927367 PECOS PAC ID: 8729322755 Enrollment ID: I20181203001806 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steven H. Forstein |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1922197482 PECOS PAC ID: 7315281268 Enrollment ID: I20181203003032 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alicia M Dias |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1255815247 PECOS PAC ID: 8729322524 Enrollment ID: I20181205002053 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristen Michele Woodard |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1063671394 PECOS PAC ID: 7810231529 Enrollment ID: I20181206003582 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Timothy P Sabol |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1972524213 PECOS PAC ID: 1951627579 Enrollment ID: I20181208000098 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sree Teja Yelamanchili |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1356737803 PECOS PAC ID: 2567706179 Enrollment ID: I20181210001319 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Caren L Kurtz Goodman |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1205949427 PECOS PAC ID: 2466797774 Enrollment ID: I20181214000295 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael Anthony Limosani |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1821570938 PECOS PAC ID: 1951646157 Enrollment ID: I20181217001184 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lazarus O Onwuka |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1700269362 PECOS PAC ID: 2365790383 Enrollment ID: I20181218001268 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ang Zhang |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1003282427 PECOS PAC ID: 0648522631 Enrollment ID: I20181218001594 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Allison Louise Mcateer |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1942373279 PECOS PAC ID: 6608868468 Enrollment ID: I20181219001116 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Foong-yi Lin |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1427184597 PECOS PAC ID: 6800131780 Enrollment ID: I20181220002690 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mark A. Rosenthal |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1144319690 PECOS PAC ID: 3173868981 Enrollment ID: I20181226001768 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maya Bartel |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1962758664 PECOS PAC ID: 4587909247 Enrollment ID: I20181227001886 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Katherine Marie Reeve |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1962790774 PECOS PAC ID: 2062665896 Enrollment ID: I20190102000133 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Susan Mary Paxton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1710455316 PECOS PAC ID: 5092050591 Enrollment ID: I20190102001133 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Allyson Driggers Gallagher |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1144299504 PECOS PAC ID: 1951646488 Enrollment ID: I20190102002132 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristina Belanger |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1962977223 PECOS PAC ID: 4688910144 Enrollment ID: I20190104001053 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jennifer R. Lovin |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1992884001 PECOS PAC ID: 4789920901 Enrollment ID: I20190109001854 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jean Elizabeth White |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1164643110 PECOS PAC ID: 7719134329 Enrollment ID: I20190111001007 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John P Ancona |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1548359060 PECOS PAC ID: 7618214008 Enrollment ID: I20190123001809 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Phyllis Ann Holtzman |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1881783348 PECOS PAC ID: 3971840299 Enrollment ID: I20190124002514 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amanda Elyse Costella |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245705516 PECOS PAC ID: 7618214750 Enrollment ID: I20190128000445 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amy Elizabeth Cram |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1487861761 PECOS PAC ID: 6204171135 Enrollment ID: I20190130000297 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kyle Lynn Blomberg |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689143802 PECOS PAC ID: 1850639139 Enrollment ID: I20190212001273 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Richard Burke |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1538459656 PECOS PAC ID: 9931342151 Enrollment ID: I20190212001575 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sharon Ostfeld-johns |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1588081459 PECOS PAC ID: 6709184070 Enrollment ID: I20190219001716 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stephanie P. Perkins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1083821631 PECOS PAC ID: 9335487149 Enrollment ID: I20190220001153 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristie Nicole Hotchkiss |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144702267 PECOS PAC ID: 7517206220 Enrollment ID: I20190225001039 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nikhil Singh |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1427494715 PECOS PAC ID: 0547581449 Enrollment ID: I20190225002349 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Fady Mohamed Kanaan Abdelghany Elshikh |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1811371081 PECOS PAC ID: 6103174362 Enrollment ID: I20190226001959 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ogechukwu Egini |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1770967754 PECOS PAC ID: 7517206147 Enrollment ID: I20190226003211 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Imran Yousuf Ali |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1093133134 PECOS PAC ID: 1951659598 Enrollment ID: I20190306000130 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Suparna Saha |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1336526110 PECOS PAC ID: 7315286481 Enrollment ID: I20190307001225 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stephen Daniel Socha |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013486034 PECOS PAC ID: 0244125573 Enrollment ID: I20190307002955 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Prim Wabunoha |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750854402 PECOS PAC ID: 5496094468 Enrollment ID: I20190308002208 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Paul Orin Rollins |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1942655493 PECOS PAC ID: 7810241254 Enrollment ID: I20190313001768 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sage Anne Macleod |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1952679177 PECOS PAC ID: 3779741962 Enrollment ID: I20190314000790 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Paulina I Lacossade |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1932579281 PECOS PAC ID: 2769789163 Enrollment ID: I20190322000208 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marvin Graham |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1669930178 PECOS PAC ID: 0749520088 Enrollment ID: I20190322001100 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Yungah Lee |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1245642230 PECOS PAC ID: 1052632825 Enrollment ID: I20190327000696 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Krishna Chaitanya Kilaru |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1598152936 PECOS PAC ID: 4981945516 Enrollment ID: I20190409002411 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Natalya Teslya |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1922492479 PECOS PAC ID: 8628370582 Enrollment ID: I20190412001120 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tamta Chkhikvadze |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1952788663 PECOS PAC ID: 5799031894 Enrollment ID: I20190418000336 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Margaret Wallace |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356885347 PECOS PAC ID: 6901183367 Enrollment ID: I20190423000749 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Luis Gabriel Cedeno Abreu |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1457703977 PECOS PAC ID: 3173865102 Enrollment ID: I20190423002301 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brian T Trezak |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1003913526 PECOS PAC ID: 1759331168 Enrollment ID: I20190502000880 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tania S Sierra |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1356631998 PECOS PAC ID: 9133434400 Enrollment ID: I20190503000240 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marjorie Mathieu |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1447735337 PECOS PAC ID: 3274875646 Enrollment ID: I20190506000212 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pamela D'amico |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194299180 PECOS PAC ID: 8628310935 Enrollment ID: I20190506001977 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jeffrey P Cranford |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1942543111 PECOS PAC ID: 1153663497 Enrollment ID: I20190507000653 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Irene Besser |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1326145749 PECOS PAC ID: 5193823334 Enrollment ID: I20190507002548 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jennifer Robinson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1417459025 PECOS PAC ID: 5890059745 Enrollment ID: I20190514000415 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Benjamin Barbash |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1730525734 PECOS PAC ID: 5890038947 Enrollment ID: I20190514000619 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Akhil Khosla |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1962843847 PECOS PAC ID: 3476851197 Enrollment ID: I20190514001943 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Steven Beckoff |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1255724621 PECOS PAC ID: 7517200504 Enrollment ID: I20190514002581 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shazia Josephine Joseph |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336703586 PECOS PAC ID: 9133462047 Enrollment ID: I20190516001843 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Emily Pinto Taylor |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1053799544 PECOS PAC ID: 0547572760 Enrollment ID: I20190522000435 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Hannah Rosenblum |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1043699135 PECOS PAC ID: 5294048203 Enrollment ID: I20190529001834 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michelle N Watson |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1487743928 PECOS PAC ID: 7416280516 Enrollment ID: I20190604003183 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Daria Viktorovna Madeeva |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1033568753 PECOS PAC ID: 4981998309 Enrollment ID: I20190605001170 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Terance Anderson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306409222 PECOS PAC ID: 3274866330 Enrollment ID: I20190605002368 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mohammad Atiqul Islam |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1679925754 PECOS PAC ID: 6507110301 Enrollment ID: I20190607001168 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Usman Ali Pirzada |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1437506227 PECOS PAC ID: 4486987369 Enrollment ID: I20190607001500 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Thupten Gyaltsen Changbar |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1760836985 PECOS PAC ID: 1355674284 Enrollment ID: I20190610000733 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lynda Amy Romita |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023225687 PECOS PAC ID: 4183957905 Enrollment ID: I20190611001822 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bushra Abid |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1659534469 PECOS PAC ID: 8527206333 Enrollment ID: I20190611003517 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lawrence M Anderson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1942766761 PECOS PAC ID: 4284967878 Enrollment ID: I20190613002274 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rebecca Margalete Wasserman Slotkin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1114374105 PECOS PAC ID: 9133413842 Enrollment ID: I20190613003240 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Andrew Joseph Levin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1457709750 PECOS PAC ID: 6800180795 Enrollment ID: I20190614000567 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rajiv Matthew Mallipudi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1760845747 PECOS PAC ID: 0446583942 Enrollment ID: I20190617001404 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nishant Sharma |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1477909661 PECOS PAC ID: 6608110747 Enrollment ID: I20190618001149 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lyuba Kofler |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1831551464 PECOS PAC ID: 6406180702 Enrollment ID: I20190620000104 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tulasi Annapureddy |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1619327202 PECOS PAC ID: 8527392703 Enrollment ID: I20190621000107 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Katherine P Calaway |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1659727766 PECOS PAC ID: 3476845900 Enrollment ID: I20190621000276 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Abdel Rahman Dajani |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1467906958 PECOS PAC ID: 4486933926 Enrollment ID: I20190624001626 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Adedoyin Adedamola Akinlonu |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1194173336 PECOS PAC ID: 6406180553 Enrollment ID: I20190625000453 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ankit Chhoda |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1538615737 PECOS PAC ID: 8921389974 Enrollment ID: I20190625000479 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kajanan Jana Kukan |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1437519444 PECOS PAC ID: 9931433935 Enrollment ID: I20190625002796 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Camila D. Odio |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1295182277 PECOS PAC ID: 9739473943 Enrollment ID: I20190627002400 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Theodora Vamvouris |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1770937161 PECOS PAC ID: 0941534762 Enrollment ID: I20190628000367 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shashvat Gupta |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1972058717 PECOS PAC ID: 9335473057 Enrollment ID: I20190628000677 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ethan Bernstein |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1265889109 PECOS PAC ID: 8628363017 Enrollment ID: I20190703001274 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jaclyn V Oconnor |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1588026173 PECOS PAC ID: 2365786415 Enrollment ID: I20190708002621 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stefanie M Parks |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1750775847 PECOS PAC ID: 5496066185 Enrollment ID: I20190710001038 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mollie Tucker |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1770930851 PECOS PAC ID: 3476847872 Enrollment ID: I20190710001485 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tuoyo Mene-afejuku |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1184076853 PECOS PAC ID: 3072848209 Enrollment ID: I20190710003417 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Leonidas N Miras |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1285082776 PECOS PAC ID: 7315272374 Enrollment ID: I20190712001025 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Khalil Ian Hussein |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1427442409 PECOS PAC ID: 3476855016 Enrollment ID: I20190715000917 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lavneet K Chawla |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1720531718 PECOS PAC ID: 0648505487 Enrollment ID: I20190716001275 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Priyadarshini Balasubramanian |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1457706426 PECOS PAC ID: 0648514703 Enrollment ID: I20190716001744 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Morana Vojnic |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1942662481 PECOS PAC ID: 3173858891 Enrollment ID: I20190717001041 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bradley Schlussel |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1174927925 PECOS PAC ID: 3476888124 Enrollment ID: I20190717002062 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mrinalini Modak |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1790148633 PECOS PAC ID: 4880988138 Enrollment ID: I20190717002118 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Arafat Shabbir |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1689038952 PECOS PAC ID: 6901131655 Enrollment ID: I20190717002154 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ahmad Nawaz |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1801248455 PECOS PAC ID: 3274829601 Enrollment ID: I20190718000981 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sameer Gupta |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1609238690 PECOS PAC ID: 0446593537 Enrollment ID: I20190718001690 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Allison Mary Giguere |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1306186663 PECOS PAC ID: 5799927018 Enrollment ID: I20190723000726 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Faiza Yasin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1649627704 PECOS PAC ID: 9032403803 Enrollment ID: I20190729001700 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Leila Haghighat |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1396193561 PECOS PAC ID: 5395039135 Enrollment ID: I20190729001990 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Abdelkader Chaar |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1477909315 PECOS PAC ID: 4183916463 Enrollment ID: I20190805002789 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kevin Chen |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1255727160 PECOS PAC ID: 9436486057 Enrollment ID: I20190806000124 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Yamini Krishnan |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1952745978 PECOS PAC ID: 8628357803 Enrollment ID: I20190807000458 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Seppo Aro |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1306209879 PECOS PAC ID: 4688918709 Enrollment ID: I20190808002963 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Arjun Dhawan |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1902253099 PECOS PAC ID: 9234423716 Enrollment ID: I20190813002299 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ethan Balk |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1124535372 PECOS PAC ID: 9739416678 Enrollment ID: I20190814003548 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shanti Patel |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1861944076 PECOS PAC ID: 0446504534 Enrollment ID: I20190816002638 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jing Chen |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1710335880 PECOS PAC ID: 8820338908 Enrollment ID: I20190819001706 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Victor Fossi Nooam |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1922481571 PECOS PAC ID: 3274874763 Enrollment ID: I20190820001847 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Vikram Rao |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1427439249 PECOS PAC ID: 5294070819 Enrollment ID: I20190823000245 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maudry Laurent-rolle |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1124467527 PECOS PAC ID: 9638464191 Enrollment ID: I20190823000555 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Andre Gabriel Philipp |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275091100 PECOS PAC ID: 9335477454 Enrollment ID: I20190827001623 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Osama Kandalaft |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1063868065 PECOS PAC ID: 6608160809 Enrollment ID: I20190827002194 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Eric Taylor Jordan |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1790132835 PECOS PAC ID: 5294029914 Enrollment ID: I20190903002258 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jae Lee |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1598111601 PECOS PAC ID: 6901146687 Enrollment ID: I20190904000271 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Wasnard Victor |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1740634419 PECOS PAC ID: 6305182148 Enrollment ID: I20190904000312 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Omair Sheikh |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1285096305 PECOS PAC ID: 5597059493 Enrollment ID: I20190905003349 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Edward Gaiser |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1508426792 PECOS PAC ID: 6507195096 Enrollment ID: I20190909002685 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Katie Wardowski |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1588226633 PECOS PAC ID: 4082943170 Enrollment ID: I20190916002136 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bozena Malyszko |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1316112279 PECOS PAC ID: 2567633530 Enrollment ID: I20190917002278 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Reshma S Chacko |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1427514611 PECOS PAC ID: 5294065207 Enrollment ID: I20190918000141 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Charlotte Bell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1659835502 PECOS PAC ID: 7315277266 Enrollment ID: I20190919002000 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jessica Dinisco |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1629408596 PECOS PAC ID: 0941518450 Enrollment ID: I20190920000934 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sumit Raman Kumar |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1265889034 PECOS PAC ID: 8022302298 Enrollment ID: I20190923002313 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mhd Yassin Al Mouslmani |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1326593476 PECOS PAC ID: 2264762723 Enrollment ID: I20190925002982 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Melissa Ann Meyer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1649827676 PECOS PAC ID: 8325378847 Enrollment ID: I20190926001401 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kulothungan Gunasekaran |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1295171866 PECOS PAC ID: 2062644784 Enrollment ID: I20190927001354 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shahrukh Arif |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1548613961 PECOS PAC ID: 4284964479 Enrollment ID: I20191002000419 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Chijioke Nnanna Egbujo |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1164601548 PECOS PAC ID: 9830484005 Enrollment ID: I20191003000663 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Carrie L Fijal |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811483787 PECOS PAC ID: 3971854647 Enrollment ID: I20191004000253 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jared Macklin |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1205279247 PECOS PAC ID: 5991099632 Enrollment ID: I20191008000244 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ashley Bellamy |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1952798613 PECOS PAC ID: 8628371259 Enrollment ID: I20191010001754 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Janjenali Villaflor |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1528453511 PECOS PAC ID: 2860781234 Enrollment ID: I20191015002706 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Yan Chen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871152082 PECOS PAC ID: 6507197985 Enrollment ID: I20191016002087 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joseph Bryn Zell |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1952765646 PECOS PAC ID: 4385904911 Enrollment ID: I20191016003353 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Khushbu V Janani |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1528414810 PECOS PAC ID: 6204167539 Enrollment ID: I20191017000451 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Betsy Larose |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851648398 PECOS PAC ID: 7911239199 Enrollment ID: I20191022001390 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elizabeth Wehrli |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1538564976 PECOS PAC ID: 0749512853 Enrollment ID: I20191022003147 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Hardik Bhupendrabhai Patel |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1104216688 PECOS PAC ID: 5597053926 Enrollment ID: I20191023001352 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cullen Michael Taplin |
|---|---|
| Provider Type | Practitioner - Preventive Medicine |
| Provider Identifiers | NPI Number: 1730449927 PECOS PAC ID: 1153675624 Enrollment ID: I20191101000408 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nasreen Kathrada |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1639534092 PECOS PAC ID: 6608174396 Enrollment ID: I20191101002398 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Saddam Ehsan Zaidi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1598127375 PECOS PAC ID: 4385972363 Enrollment ID: I20191104000653 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Katherine M Hughes |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1447523287 PECOS PAC ID: 0840522132 Enrollment ID: I20191106002323 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Zubin Bham |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1407230477 PECOS PAC ID: 7618275231 Enrollment ID: I20191122001721 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Xiaoliang Qiu |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1891142634 PECOS PAC ID: 4385930981 Enrollment ID: I20191122002051 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shanthi Mogali |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1144406802 PECOS PAC ID: 6406289792 Enrollment ID: I20191126002933 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maryjo Vasquez |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1467572479 PECOS PAC ID: 8921991993 Enrollment ID: I20191202001204 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Beth Jennifer Simon |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1972504132 PECOS PAC ID: 6901064997 Enrollment ID: I20191203002751 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kathryn Benson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720084213 PECOS PAC ID: 1850357104 Enrollment ID: I20191206002122 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Katie Elizabeth Zeppieri |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1306496138 PECOS PAC ID: 6709219553 Enrollment ID: I20191209001479 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Yardley Brice |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1043635477 PECOS PAC ID: 8921337999 Enrollment ID: I20191218000310 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Minhee Sung |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1902268188 PECOS PAC ID: 4981999331 Enrollment ID: I20191218001837 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amy W Wen-mcgovern |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1346654951 PECOS PAC ID: 3375856297 Enrollment ID: I20200103001854 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Loni R Belyea |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1801213160 PECOS PAC ID: 6709157076 Enrollment ID: I20200116002102 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christopher Francis D'souza |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1013379619 PECOS PAC ID: 8022303908 Enrollment ID: I20200117000641 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amir Soheil Tolebeyan |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1053762682 PECOS PAC ID: 1052688710 Enrollment ID: I20200120001108 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ashley A. Antonucci |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1003463159 PECOS PAC ID: 9638505332 Enrollment ID: I20200128001551 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amy Weldon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215217203 PECOS PAC ID: 5698947679 Enrollment ID: I20200129000614 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joshua Orabone |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1285927343 PECOS PAC ID: 5799902169 Enrollment ID: I20200130001100 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Evgeny Shkolnik |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1073969325 PECOS PAC ID: 9234473208 Enrollment ID: I20200130002737 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nivedita Agarwal |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1790021848 PECOS PAC ID: 9032356225 Enrollment ID: I20200213000155 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Dania Wilson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164856035 PECOS PAC ID: 6709001860 Enrollment ID: I20200226001168 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Valeria Pazo |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1154648467 PECOS PAC ID: 3173707908 Enrollment ID: I20200304002582 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Zaid Hammoodi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1780047233 PECOS PAC ID: 9830436211 Enrollment ID: I20200312001079 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tabitha Engelberg |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1841835857 PECOS PAC ID: 3274961859 Enrollment ID: I20200313000145 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sayed Mohammad Hosseini |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1598150278 PECOS PAC ID: 2567780091 Enrollment ID: I20200403001300 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Frances Denu |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1124427042 PECOS PAC ID: 1658631619 Enrollment ID: I20200408004256 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Erin Colella |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1326586041 PECOS PAC ID: 4587093695 Enrollment ID: I20200410000062 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ashley Moran Risdon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669016903 PECOS PAC ID: 5698105609 Enrollment ID: I20200415000676 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kathleen P White |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1457326688 PECOS PAC ID: 3173835592 Enrollment ID: I20200424000518 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Manpreet Kaur |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477182566 PECOS PAC ID: 8426488933 Enrollment ID: I20200424000897 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Peter Liu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1891130696 PECOS PAC ID: 6002034691 Enrollment ID: I20200430000978 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Grace Jowoon Kim |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1871910919 PECOS PAC ID: 5193944973 Enrollment ID: I20200508000139 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jennifer Freimund |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1003113762 PECOS PAC ID: 2860711900 Enrollment ID: I20200512001980 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Prashanth Atluri |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1275847949 PECOS PAC ID: 7517195951 Enrollment ID: I20200519002143 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert Legare |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1093731333 PECOS PAC ID: 1759452840 Enrollment ID: I20200520002565 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Emad A Alahiri |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1154783801 PECOS PAC ID: 7214358969 Enrollment ID: I20200604000864 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sachin Sule |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1477573038 PECOS PAC ID: 9537150792 Enrollment ID: I20200604001220 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lindsey Brooke Witham |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1972140796 PECOS PAC ID: 1254752918 Enrollment ID: I20200604001237 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Hyungbok H Jeong |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053947465 PECOS PAC ID: 2860813540 Enrollment ID: I20200604002345 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alexis Points |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598249666 PECOS PAC ID: 1850637158 Enrollment ID: I20200605000683 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sean Kalra |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1578099503 PECOS PAC ID: 1254601362 Enrollment ID: I20200630001803 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ashley Rachelle Christensen |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1164803003 PECOS PAC ID: 0941623607 Enrollment ID: I20200714000981 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sritika Thapa |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1407160880 PECOS PAC ID: 2062651052 Enrollment ID: I20200715000762 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Junjie Liu |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1619356383 PECOS PAC ID: 4284947482 Enrollment ID: I20200715002403 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Vipul Jindal |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1427571983 PECOS PAC ID: 3375889694 Enrollment ID: I20200716000381 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Swapna Anandan |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1598295347 PECOS PAC ID: 8426472960 Enrollment ID: I20200716003808 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | He Sun |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1184112203 PECOS PAC ID: 1456775659 Enrollment ID: I20200721002895 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Vivek Dhungana |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1467805598 PECOS PAC ID: 0143597450 Enrollment ID: I20200722001518 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Melissa A Weekes |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1750813309 PECOS PAC ID: 7517201577 Enrollment ID: I20200724000749 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Zeeshan Solangi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1982005450 PECOS PAC ID: 3072885235 Enrollment ID: I20200728000932 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Oluwole O Jegede |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1063717775 PECOS PAC ID: 1759527542 Enrollment ID: I20200729000963 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tetyana Dushenkovska |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1104366293 PECOS PAC ID: 8820413453 Enrollment ID: I20200730000249 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Eunna Cho |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1417485277 PECOS PAC ID: 1254756810 Enrollment ID: I20200730001633 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gerardo Elias Tolentino |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1053849976 PECOS PAC ID: 8820413313 Enrollment ID: I20200730002643 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Daniel Pievsky |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1346669462 PECOS PAC ID: 6204251770 Enrollment ID: I20200730002737 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Adriana Olariu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1114333689 PECOS PAC ID: 9335369933 Enrollment ID: I20200803000208 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sameer Khan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1205364759 PECOS PAC ID: 3173892957 Enrollment ID: I20200804000284 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nathaniel David Robinson |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1235665571 PECOS PAC ID: 0244655488 Enrollment ID: I20200804003003 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anton Stolear |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1881055325 PECOS PAC ID: 2668768516 Enrollment ID: I20200805000696 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marya Haq |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1396265013 PECOS PAC ID: 7416217104 Enrollment ID: I20200806000446 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Adriana Olariu |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1114333689 PECOS PAC ID: 9335369933 Enrollment ID: I20200806000614 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mariano Rizzo |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1548530181 PECOS PAC ID: 2769609718 Enrollment ID: I20200807001463 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kathleen Mary Mcmahon-brown |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679199095 PECOS PAC ID: 0042635906 Enrollment ID: I20200810001268 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tai Hang Ho |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1093080145 PECOS PAC ID: 0749594083 Enrollment ID: I20200811000787 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lindsey Scierka |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1538697727 PECOS PAC ID: 8921378969 Enrollment ID: I20200812003101 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Laura Belland |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1043697238 PECOS PAC ID: 0345584884 Enrollment ID: I20200813001277 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jessica Dolman |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1043748171 PECOS PAC ID: 8921377532 Enrollment ID: I20200814002444 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Dina Ibrahim |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1386165801 PECOS PAC ID: 4082974779 Enrollment ID: I20200818001152 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ami Belmont |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1295183226 PECOS PAC ID: 9537454095 Enrollment ID: I20200821000408 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Paul Nowak |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1497109466 PECOS PAC ID: 6608292511 Enrollment ID: I20200821001172 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Hisham Al Kukhun |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1497273239 PECOS PAC ID: 2163797424 Enrollment ID: I20200825003228 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Dachi Chelidze |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1467973263 PECOS PAC ID: 4284051053 Enrollment ID: I20200826000488 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John Huston |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1508393513 PECOS PAC ID: 4183993751 Enrollment ID: I20200826001206 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alan Alex |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1326571886 PECOS PAC ID: 2062784242 Enrollment ID: I20200826003107 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mufti Mushfiqur Rahman |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1720509433 PECOS PAC ID: 1355601212 Enrollment ID: I20200827002287 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ariel Jaffe |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1609296334 PECOS PAC ID: 4284908146 Enrollment ID: I20200901003395 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joseph Xavier Canarie |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1801243217 PECOS PAC ID: 2365736659 Enrollment ID: I20200902002532 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Hiam Naiditch |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1083142509 PECOS PAC ID: 6406126770 Enrollment ID: I20200903002040 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Stephanie Zhu |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1649892647 PECOS PAC ID: 4385061324 Enrollment ID: I20200904000732 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rachel Schrier |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1649707795 PECOS PAC ID: 9032488838 Enrollment ID: I20200904001077 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Uzma Malik |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1992237564 PECOS PAC ID: 6800133232 Enrollment ID: I20200914000230 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ryan Keenan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1003425331 PECOS PAC ID: 2365860004 Enrollment ID: I20200914000642 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Eric Tsung |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1255758132 PECOS PAC ID: 6002138971 Enrollment ID: I20200915001606 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jeffrey Kwan |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1851439848 PECOS PAC ID: 5698872935 Enrollment ID: I20200917000416 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tiffany Teixeira |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215564026 PECOS PAC ID: 8426476524 Enrollment ID: I20200921002808 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Laura Bienashski |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730797549 PECOS PAC ID: 0648699637 Enrollment ID: I20200924000886 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Hassan Shahid |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1619387040 PECOS PAC ID: 5991096224 Enrollment ID: I20200925001734 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Erika Schaeffer |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1962859405 PECOS PAC ID: 2466796859 Enrollment ID: I20201001002315 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michelle Pievsky |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1548884638 PECOS PAC ID: 3072932524 Enrollment ID: I20201001002403 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Loren Greenberg |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1730241357 PECOS PAC ID: 5991763278 Enrollment ID: I20201005000773 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joshua Bilsborrow |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1942645403 PECOS PAC ID: 1153632278 Enrollment ID: I20201006002653 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Molly Renehan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356968143 PECOS PAC ID: 5395165294 Enrollment ID: I20201014002930 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Urvika Choksey |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1770939217 PECOS PAC ID: 0244523744 Enrollment ID: I20201015001723 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Scott Navarrett |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1043690795 PECOS PAC ID: 2668727629 Enrollment ID: I20201021002878 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sanya Virani |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1548623093 PECOS PAC ID: 3971840497 Enrollment ID: I20201022003742 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Peter Kahn |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1619403680 PECOS PAC ID: 6608146022 Enrollment ID: I20201026002405 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Azem Dushaj |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1295094480 PECOS PAC ID: 6204140452 Enrollment ID: I20201027002360 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amed Logrono |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1942737119 PECOS PAC ID: 1850661893 Enrollment ID: I20201028000750 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Justin Gauthier |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1417362955 PECOS PAC ID: 9830449446 Enrollment ID: I20201028002563 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nidhi Shah |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1497060222 PECOS PAC ID: 3375851561 Enrollment ID: I20201030000725 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Naiha Nadeem |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1912448333 PECOS PAC ID: 4385983204 Enrollment ID: I20201103001447 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Andrew Abovian |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1669909107 PECOS PAC ID: 8820367626 Enrollment ID: I20201104002694 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alyssa Garza |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164030565 PECOS PAC ID: 2860802634 Enrollment ID: I20201105002121 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Oluremi Ajala |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1629412325 PECOS PAC ID: 7719129808 Enrollment ID: I20201109002225 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shawne L Baker |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1659705028 PECOS PAC ID: 8022428606 Enrollment ID: I20201110003035 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pallavi Joshi |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1750765442 PECOS PAC ID: 1759626260 Enrollment ID: I20201112002074 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jessica Deanne Yentz |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1609493311 PECOS PAC ID: 0446660872 Enrollment ID: I20201113000320 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mikhail Krotovskiy |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1326663261 PECOS PAC ID: 2860802220 Enrollment ID: I20201113001504 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sahil Goyal |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1376963355 PECOS PAC ID: 7012239957 Enrollment ID: I20201113001942 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Giorgi Kveladze |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1942734058 PECOS PAC ID: 6507101698 Enrollment ID: I20201116002267 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marissa Meegan Sanca |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467068551 PECOS PAC ID: 4981015369 Enrollment ID: I20201117000674 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Yukiko Kunitomo |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1013444009 PECOS PAC ID: 2860762291 Enrollment ID: I20201123002832 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Dawn Lukose |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1013449487 PECOS PAC ID: 8729499645 Enrollment ID: I20201125002590 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gregory M Rose |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1740664689 PECOS PAC ID: 0840520813 Enrollment ID: I20201130001774 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristin Holly Van Horn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1326546839 PECOS PAC ID: 5193136984 Enrollment ID: I20201130002529 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Angela Henderson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1295348449 PECOS PAC ID: 5294146841 Enrollment ID: I20201202003238 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pedro Miguel Alvarez Soto |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1609220698 PECOS PAC ID: 0648682005 Enrollment ID: I20201209002294 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jing Du |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1114439437 PECOS PAC ID: 1254743610 Enrollment ID: I20201209002430 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Danielle Fresen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922606086 PECOS PAC ID: 3375955628 Enrollment ID: I20201210002347 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Patti Mugo |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1013272988 PECOS PAC ID: 4385968932 Enrollment ID: I20201215001438 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kiersten Rooney |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1124638382 PECOS PAC ID: 7214349240 Enrollment ID: I20201216002524 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karlen Rebecca Katz |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215547534 PECOS PAC ID: 5799197661 Enrollment ID: I20201217001295 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robert Wilson |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1922554682 PECOS PAC ID: 9335420777 Enrollment ID: I20201224000597 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Manuel De Aguirre |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1477882967 PECOS PAC ID: 1153637640 Enrollment ID: I20210111002569 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tomor Sedaliu |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1003355850 PECOS PAC ID: 5193138113 Enrollment ID: I20210113000888 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alyssa E Gruen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851919567 PECOS PAC ID: 5496168221 Enrollment ID: I20210115000275 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pamela Martin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1073629663 PECOS PAC ID: 6002818200 Enrollment ID: I20210115000977 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amy Nylund |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598138042 PECOS PAC ID: 9032412374 Enrollment ID: I20210115001113 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anna Maria Clabby |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1992306138 PECOS PAC ID: 9032522743 Enrollment ID: I20210119000571 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Harmandeep Tinna |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1881045359 PECOS PAC ID: 1557656113 Enrollment ID: I20210120001733 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Richard Bain |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1104809805 PECOS PAC ID: 3476585738 Enrollment ID: I20210127001981 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nadia Nowak |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306238126 PECOS PAC ID: 6204240146 Enrollment ID: I20210204000620 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Reinie Varkey |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952905150 PECOS PAC ID: 6406261353 Enrollment ID: I20210226001692 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kathryne E Doria |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790374536 PECOS PAC ID: 4587070420 Enrollment ID: I20210301002302 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nicholas Tsamparlis |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1164515383 PECOS PAC ID: 4385667765 Enrollment ID: I20210302000111 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Julianne Elizabeth Vesciglio |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1295355360 PECOS PAC ID: 2163838962 Enrollment ID: I20210302002226 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Beklen Kerimoglu |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1205013117 PECOS PAC ID: 1951465699 Enrollment ID: I20210309001279 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michelle C Douglas |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1801252549 PECOS PAC ID: 2365740917 Enrollment ID: I20210312001136 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Luke J Ackroyd |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1982640348 PECOS PAC ID: 5092720417 Enrollment ID: I20210322000481 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amy L Hammer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568838894 PECOS PAC ID: 6901213438 Enrollment ID: I20210330002478 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Evens Mesadieu |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1023587144 PECOS PAC ID: 4284975855 Enrollment ID: I20210405001682 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sherry Pruitt |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902481179 PECOS PAC ID: 6103233275 Enrollment ID: I20210408000400 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ashley Sabbatini |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1992228928 PECOS PAC ID: 2163781758 Enrollment ID: I20210412002173 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elisabeth Dodds |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1427585710 PECOS PAC ID: 7517236540 Enrollment ID: I20210413001146 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Erin Mullaney Keane |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1609046143 PECOS PAC ID: 1456482678 Enrollment ID: I20210414000676 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | William M Junior |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1255743290 PECOS PAC ID: 1557602141 Enrollment ID: I20210423000457 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karyn Marie Ertel |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1932184504 PECOS PAC ID: 8022065929 Enrollment ID: I20210426001114 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jennifer O'day |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1215522578 PECOS PAC ID: 4385052687 Enrollment ID: I20210427001606 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ashley Kaminski |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528680063 PECOS PAC ID: 4688083116 Enrollment ID: I20210512002461 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tara Thompson Felix |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1053762468 PECOS PAC ID: 5395037170 Enrollment ID: I20210519001980 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David Narotsky |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1831469832 PECOS PAC ID: 0648504423 Enrollment ID: I20210521002233 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ryan Quirk |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1871026732 PECOS PAC ID: 6305185075 Enrollment ID: I20210526002975 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Muhammad Kumail Shah |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1376922930 PECOS PAC ID: 4284984386 Enrollment ID: I20210603002193 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Janet Olevsky |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1679834923 PECOS PAC ID: 4880828623 Enrollment ID: I20210604001198 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sharmin Akhter |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1548765779 PECOS PAC ID: 6507112364 Enrollment ID: I20210604001905 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Danielle Langer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1043822794 PECOS PAC ID: 9335549732 Enrollment ID: I20210607000732 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Matthew Michael D'angelo |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1982100442 PECOS PAC ID: 9638427552 Enrollment ID: I20210607000960 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nicholaus Christian |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1497276620 PECOS PAC ID: 8123442928 Enrollment ID: I20210609000489 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Caroline Carreras |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1558893305 PECOS PAC ID: 1850661083 Enrollment ID: I20210609003543 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rolinsay Weaver |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1881275220 PECOS PAC ID: 9335549435 Enrollment ID: I20210610003037 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shariful Alam |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1518451962 PECOS PAC ID: 2163822016 Enrollment ID: I20210614002911 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael R Oneill |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1356873319 PECOS PAC ID: 6204103492 Enrollment ID: I20210615001762 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lynn Guibbory |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1578147153 PECOS PAC ID: 5395145114 Enrollment ID: I20210616002084 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Carolyn Heins |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1447604202 PECOS PAC ID: 2163757568 Enrollment ID: I20210617000196 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Olaniyi O Olayinka |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1356865208 PECOS PAC ID: 4486055886 Enrollment ID: I20210623000790 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Devesh Dalmia |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1104314160 PECOS PAC ID: 0345641205 Enrollment ID: I20210629002635 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Avinainder Singh |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1811492408 PECOS PAC ID: 7012265531 Enrollment ID: I20210701003711 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Daniel Le Bui |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1629567227 PECOS PAC ID: 9133474901 Enrollment ID: I20210706000703 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Aaditya B Kiri |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1528564499 PECOS PAC ID: 1153665310 Enrollment ID: I20210706000728 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bohm Kywe |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1952888646 PECOS PAC ID: 7315299104 Enrollment ID: I20210707001167 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cheng-hung Tai |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1003310434 PECOS PAC ID: 3678817251 Enrollment ID: I20210708001212 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Caroline Jane Coffee |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336488675 PECOS PAC ID: 2961804000 Enrollment ID: I20210712001973 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Clifford B Locke |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1437654266 PECOS PAC ID: 8921355272 Enrollment ID: I20210712002138 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alan Zakko |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1982194130 PECOS PAC ID: 7911252523 Enrollment ID: I20210712002368 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Benjamin Michael Gold |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1174903769 PECOS PAC ID: 1557763620 Enrollment ID: I20210712003175 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jenna L Ulrich |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1639675630 PECOS PAC ID: 4688918717 Enrollment ID: I20210712003510 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Urielle Marseille |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1477059509 PECOS PAC ID: 2365787470 Enrollment ID: I20210713003897 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tamara Samardzic |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1235629320 PECOS PAC ID: 4082969688 Enrollment ID: I20210714001107 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Allyson Hughes |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1306333257 PECOS PAC ID: 4385047000 Enrollment ID: I20210719002400 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Samuel L Dengler |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1376993618 PECOS PAC ID: 6800299520 Enrollment ID: I20210719002501 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tamar Cherkezishvili |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1154818573 PECOS PAC ID: 7810245685 Enrollment ID: I20210721000372 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sharon Beesley |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1801466404 PECOS PAC ID: 4183027634 Enrollment ID: I20210722000100 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Giulio Rottaro Castejon |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1235659434 PECOS PAC ID: 0446524326 Enrollment ID: I20210728000910 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Eileen Cheryl Libove |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1386133882 PECOS PAC ID: 1557616141 Enrollment ID: I20210805000230 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jessica Patel |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1073959797 PECOS PAC ID: 3375808686 Enrollment ID: I20210805000349 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Erin Gombos |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1437649506 PECOS PAC ID: 4284980673 Enrollment ID: I20210805000610 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Datson M Pereira |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1750886859 PECOS PAC ID: 0042554164 Enrollment ID: I20210805000625 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nathaniel Parker |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1124511753 PECOS PAC ID: 6800145210 Enrollment ID: I20210806002014 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Camilla Powierza |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1801386057 PECOS PAC ID: 7719233063 Enrollment ID: I20210809001282 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mathew Kottarathara |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1932563889 PECOS PAC ID: 1153666417 Enrollment ID: I20210809002930 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joan Mortarotti |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013485879 PECOS PAC ID: 1850634536 Enrollment ID: I20210811002462 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amy Tran |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1659862688 PECOS PAC ID: 1254735350 Enrollment ID: I20210811004134 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sarah Fiallo |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1780189092 PECOS PAC ID: 7113321142 Enrollment ID: I20210812001189 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Melissa A Hanson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568034940 PECOS PAC ID: 7618371535 Enrollment ID: I20210813001308 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jie Min |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1417480039 PECOS PAC ID: 1658775598 Enrollment ID: I20210813002155 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Samira Fisayo |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1740851112 PECOS PAC ID: 6800291683 Enrollment ID: I20210817000811 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Benjamin Perea |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1184154106 PECOS PAC ID: 0648540856 Enrollment ID: I20210818000432 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jared Moreines |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1154811164 PECOS PAC ID: 3971859356 Enrollment ID: I20210819001824 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alina V Rakhuba |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1013403807 PECOS PAC ID: 9830441609 Enrollment ID: I20210827000316 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Haley Kathleen Dennis |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1518632496 PECOS PAC ID: 8325443476 Enrollment ID: I20210827000370 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Carlee Lynn Putnam |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1992378939 PECOS PAC ID: 0840695805 Enrollment ID: I20210830001076 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tony Roy |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1386132249 PECOS PAC ID: 0244584456 Enrollment ID: I20210831000447 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Arun Nachiappan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1023512811 PECOS PAC ID: 0840534996 Enrollment ID: I20210908002935 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bryan Terry |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1184157216 PECOS PAC ID: 7517204811 Enrollment ID: I20210908003860 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Calvin T Berg |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1295305944 PECOS PAC ID: 8921404369 Enrollment ID: I20210909002176 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Omolola Aragbada |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831601939 PECOS PAC ID: 8921404302 Enrollment ID: I20210909003580 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Zaffar K Haque |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1912059502 PECOS PAC ID: 9830236124 Enrollment ID: I20210913001420 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Madelyn Robertson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1548937089 PECOS PAC ID: 1355747478 Enrollment ID: I20210914003489 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gaurav Narula |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1720241342 PECOS PAC ID: 1456475607 Enrollment ID: I20210915000234 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kimberly T Hoang |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1124694708 PECOS PAC ID: 3678979747 Enrollment ID: I20210915001670 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marietta Khalil |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902570302 PECOS PAC ID: 1052718707 Enrollment ID: I20210922001364 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kelli Donovan-wright |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1932507647 PECOS PAC ID: 5698172302 Enrollment ID: I20210923000491 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sarah Malik |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1720585250 PECOS PAC ID: 9931447331 Enrollment ID: I20210923003289 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Thanh Van Mai |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1528552411 PECOS PAC ID: 6305243635 Enrollment ID: I20210929000393 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Linda Mitchell |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1700296142 PECOS PAC ID: 2860782281 Enrollment ID: I20211001000600 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | George Alexiades Stamatiades |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1902300122 PECOS PAC ID: 1355685470 Enrollment ID: I20211004001723 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robin Ganter |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1124420484 PECOS PAC ID: 8426456112 Enrollment ID: I20211011001938 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ryan Buckley |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1508399874 PECOS PAC ID: 1254600836 Enrollment ID: I20211020001032 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alexander J Adami |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1780180968 PECOS PAC ID: 0648526087 Enrollment ID: I20211021002824 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nickesha Mckenzie |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1881223394 PECOS PAC ID: 8325469026 Enrollment ID: I20211022001495 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Luanyi Elizabeth Li |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1619644291 PECOS PAC ID: 4981092970 Enrollment ID: I20211025000970 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nicole Weber |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1104023829 PECOS PAC ID: 9830244318 Enrollment ID: I20211028000925 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christi Kim |
|---|---|
| Provider Type | Practitioner - Medical Oncology |
| Provider Identifiers | NPI Number: 1053475673 PECOS PAC ID: 6901900885 Enrollment ID: I20211102000398 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mark Steven Mcfarland |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1750813051 PECOS PAC ID: 5193069904 Enrollment ID: I20211102000482 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Morgan Mccracken |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1366010100 PECOS PAC ID: 2264820877 Enrollment ID: I20211102000573 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Suzanne Yoder |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1790809051 PECOS PAC ID: 8921072885 Enrollment ID: I20211108002031 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Emily Jordan Kopas |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1942809512 PECOS PAC ID: 1759770019 Enrollment ID: I20211109000197 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Paul Wojcieszek |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1316442650 PECOS PAC ID: 9032517826 Enrollment ID: I20211109000812 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael P White |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1831570738 PECOS PAC ID: 2264785237 Enrollment ID: I20211111002473 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | James Kaus |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1285029413 PECOS PAC ID: 2961750583 Enrollment ID: I20211123001502 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Catherine M Carlson |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1568425056 PECOS PAC ID: 9234230160 Enrollment ID: I20211201000527 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alexa Canavan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669134045 PECOS PAC ID: 9739579822 Enrollment ID: I20211203001314 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mikail Kamal |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1124529953 PECOS PAC ID: 6406246305 Enrollment ID: I20211208002594 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Evan Minkin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225558133 PECOS PAC ID: 8820353253 Enrollment ID: I20211209001730 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jinbao Zhao |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225704257 PECOS PAC ID: 7719377415 Enrollment ID: I20211213002182 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ann Catherine Dyke |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174295125 PECOS PAC ID: 0749670396 Enrollment ID: I20211214001321 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christelle Nimba |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1841955663 PECOS PAC ID: 0345631842 Enrollment ID: I20211216001724 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kelsie Eileen Trillo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780348151 PECOS PAC ID: 4789075292 Enrollment ID: I20211216002404 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Fabiola Molina |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1730679135 PECOS PAC ID: 6406108448 Enrollment ID: I20220104002098 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lady Paula Dejesus |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1558643221 PECOS PAC ID: 5193990521 Enrollment ID: I20220110002356 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Patricia Rosa Martins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558930727 PECOS PAC ID: 6103218748 Enrollment ID: I20220112000040 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Melane Ninonuevo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1417504846 PECOS PAC ID: 7315339496 Enrollment ID: I20220124000126 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jessica Tuan |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1285098178 PECOS PAC ID: 2567756422 Enrollment ID: I20220126000821 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amy Ann Ralph |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1083365175 PECOS PAC ID: 7315339165 Enrollment ID: I20220128000185 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kimberly Renee Eberle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457944704 PECOS PAC ID: 9133512783 Enrollment ID: I20220203001717 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sandeep Nayak |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1447609177 PECOS PAC ID: 0345655395 Enrollment ID: I20220207002193 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Danielle Monique-grenier Moraniec |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174289094 PECOS PAC ID: 9931593654 Enrollment ID: I20220223001004 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kenneth Barshop |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1316396690 PECOS PAC ID: 2163716317 Enrollment ID: I20220225001875 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Julie Earls |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1073122941 PECOS PAC ID: 0648664706 Enrollment ID: I20220307001002 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Piyush Gupta |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1780945212 PECOS PAC ID: 6305063330 Enrollment ID: I20220308000796 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christopher Johnson |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1295232684 PECOS PAC ID: 9931594934 Enrollment ID: I20220309001506 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ariane Joy Loutoo |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1427553288 PECOS PAC ID: 6204180698 Enrollment ID: I20220316003219 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Vesna Buntak |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1942721709 PECOS PAC ID: 7517352131 Enrollment ID: I20220317002682 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jenny Jing Xiang |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1689164923 PECOS PAC ID: 6406101997 Enrollment ID: I20220331000735 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rebecca Rauch |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1295482305 PECOS PAC ID: 0941696488 Enrollment ID: I20220408001064 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michelle Morris |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1891189015 PECOS PAC ID: 7416293964 Enrollment ID: I20220420000598 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ayodeji B Olawale |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598395725 PECOS PAC ID: 1759711278 Enrollment ID: I20220421000442 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jenna Gunnell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1427659069 PECOS PAC ID: 2062809726 Enrollment ID: I20220427001262 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Paul Niedbala |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194474122 PECOS PAC ID: 5597152017 Enrollment ID: I20220429001845 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Denise Mohess |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1295935583 PECOS PAC ID: 9133254535 Enrollment ID: I20220511001067 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anna Phoebe Chang |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1558868752 PECOS PAC ID: 4284011321 Enrollment ID: I20220511002024 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sarah Violette |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1619619244 PECOS PAC ID: 8123406162 Enrollment ID: I20220603001887 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michael Andrew Fuery |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1427614999 PECOS PAC ID: 8224362074 Enrollment ID: I20220603001928 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alissa Stephanie Chen |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1548825326 PECOS PAC ID: 0840526141 Enrollment ID: I20220606002061 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pavan Ganapathiraju |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1023469988 PECOS PAC ID: 0244618742 Enrollment ID: I20220610001563 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mandeep Singh Rahi |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1902289473 PECOS PAC ID: 3173859089 Enrollment ID: I20220615000204 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mojtaba Mirzaei |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1841753225 PECOS PAC ID: 5193050664 Enrollment ID: I20220615001498 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Dalya Al Qaysi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1841786019 PECOS PAC ID: 4385079466 Enrollment ID: I20220616001197 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | August William Lindmark |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1578128195 PECOS PAC ID: 6002141827 Enrollment ID: I20220617001943 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joshua Maxwell Onyango |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1851957906 PECOS PAC ID: 7113252206 Enrollment ID: I20220621000600 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cassandra Cotter |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831834035 PECOS PAC ID: 6709266133 Enrollment ID: I20220701001889 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Vladislav Turov |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1134680432 PECOS PAC ID: 7911233812 Enrollment ID: I20220705000783 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gini Priyadharshini Jeyashanmugaraja |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1508361056 PECOS PAC ID: 1658615778 Enrollment ID: I20220705001614 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Roshni Patel |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1629633425 PECOS PAC ID: 0244564029 Enrollment ID: I20220705002684 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | John Vaughn |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1649690884 PECOS PAC ID: 1355668369 Enrollment ID: I20220706000119 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ulysses King Gopez |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1801457270 PECOS PAC ID: 6901133511 Enrollment ID: I20220707003152 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Prachi Pednekar |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1790246866 PECOS PAC ID: 4183950041 Enrollment ID: I20220711001992 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mary C Ricci |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1982168217 PECOS PAC ID: 3476893496 Enrollment ID: I20220711002133 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Haripriya Andanamala |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1689134041 PECOS PAC ID: 9739414053 Enrollment ID: I20220712001301 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sunil Bhatt |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1073178737 PECOS PAC ID: 2567796337 Enrollment ID: I20220712003015 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Syed Muhammad Hammad Zaidi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1528587052 PECOS PAC ID: 3274870886 Enrollment ID: I20220712003085 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rusudan Matcharashvili |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1992357206 PECOS PAC ID: 4880924158 Enrollment ID: I20220713001390 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brooke Rice |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1164982609 PECOS PAC ID: 4587998349 Enrollment ID: I20220714002292 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Michelle Valente Costa |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1588307235 PECOS PAC ID: 6103207568 Enrollment ID: I20220715001444 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mariah Evarts |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1558927939 PECOS PAC ID: 0840527768 Enrollment ID: I20220719001092 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bryan T Lawlor |
|---|---|
| Provider Type | Practitioner - Cardiac Electrophysiology |
| Provider Identifiers | NPI Number: 1659790293 PECOS PAC ID: 0840419768 Enrollment ID: I20220719002035 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elana C Cook |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1508421264 PECOS PAC ID: 6406181718 Enrollment ID: I20220720002246 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Matthew Seigerman |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1164817623 PECOS PAC ID: 6507247665 Enrollment ID: I20220720002456 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Vadim Zaytsev |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1780146340 PECOS PAC ID: 1153657036 Enrollment ID: I20220720002864 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lindsay G Moore |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1154959765 PECOS PAC ID: 9234510306 Enrollment ID: I20220720002900 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christina Farrell |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1982260337 PECOS PAC ID: 9830424837 Enrollment ID: I20220720003465 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nasreen Bagwan Malik |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1457606576 PECOS PAC ID: 3577865112 Enrollment ID: I20220721002940 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Matthew Spilka |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1538807771 PECOS PAC ID: 1153702063 Enrollment ID: I20220722001076 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Xintong Zuo |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1255835112 PECOS PAC ID: 9335521145 Enrollment ID: I20220726002636 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Aboluwade Adewumi |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1841619624 PECOS PAC ID: 4183969421 Enrollment ID: I20220726003045 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Aliza Cook |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1205492212 PECOS PAC ID: 3577898576 Enrollment ID: I20220727001623 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Eshana Shah |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1104183227 PECOS PAC ID: 6103059787 Enrollment ID: I20220727003396 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Abhishek Verma |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1962994384 PECOS PAC ID: 3375881030 Enrollment ID: I20220728001521 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Raksha Madhavan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1629634704 PECOS PAC ID: 4880920164 Enrollment ID: I20220728002351 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christina Dimopoulos |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1053976738 PECOS PAC ID: 3678807500 Enrollment ID: I20220801000784 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Leilei Teng |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1619430865 PECOS PAC ID: 9638551187 Enrollment ID: I20220801002280 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lakshmi Mahali |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1265973515 PECOS PAC ID: 2769720457 Enrollment ID: I20220802002270 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pavan Kumar Challa |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1417416660 PECOS PAC ID: 6901131085 Enrollment ID: I20220802002584 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kevin Gardner |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1407242373 PECOS PAC ID: 6709152234 Enrollment ID: I20220803001184 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Danielle Rizzini |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1124523071 PECOS PAC ID: 9133465677 Enrollment ID: I20220803002101 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ashleigh Frank |
|---|---|
| Provider Type | Practitioner - Osteopathic Manipulative Medicine |
| Provider Identifiers | NPI Number: 1679954697 PECOS PAC ID: 6507152873 Enrollment ID: I20220809001374 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ahtsham Yousaf Chaudhary |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1295398899 PECOS PAC ID: 6204219033 Enrollment ID: I20220811002007 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Debora Zamora-olivencia |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1871098376 PECOS PAC ID: 7315320157 Enrollment ID: I20220811002403 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Katharine Grace Straw |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174001309 PECOS PAC ID: 3870976541 Enrollment ID: I20220812000252 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Colleen Weiss |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1083268742 PECOS PAC ID: 4981936408 Enrollment ID: I20220815001138 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jianxiang Xia |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1144789454 PECOS PAC ID: 2264769587 Enrollment ID: I20220815001439 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Magdalena Zuzek |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1487113395 PECOS PAC ID: 3476889387 Enrollment ID: I20220815001441 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shelja Patel |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1598226649 PECOS PAC ID: 3274916739 Enrollment ID: I20220816001013 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Omar Majeed |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154065423 PECOS PAC ID: 6901289396 Enrollment ID: I20220817003361 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | George Carey |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1689164055 PECOS PAC ID: 4284980574 Enrollment ID: I20220823001298 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sungsil Cho |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1437611696 PECOS PAC ID: 8820471907 Enrollment ID: I20220823001715 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bashar Adel Kadhim |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1881125102 PECOS PAC ID: 4385028083 Enrollment ID: I20220830001099 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Avielle Movsas |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1538728571 PECOS PAC ID: 0042545394 Enrollment ID: I20220908001053 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ahmed Ewida |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1720462021 PECOS PAC ID: 2264781764 Enrollment ID: I20220908002171 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | William Dutton |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1720103187 PECOS PAC ID: 9638222672 Enrollment ID: I20220908003210 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Abra Aziagbe-zilevu |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1689237703 PECOS PAC ID: 7719361807 Enrollment ID: I20220909000503 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rex Huang |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1194256875 PECOS PAC ID: 3678847977 Enrollment ID: I20220909001055 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Heather Huribal |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1235428624 PECOS PAC ID: 4385967835 Enrollment ID: I20220909002488 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Simmy Varghese |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1386846673 PECOS PAC ID: 9335282490 Enrollment ID: I20220915000829 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Chelsea Sarah Huskins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487903431 PECOS PAC ID: 4284019928 Enrollment ID: I20220916002103 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Zahraa Ibrahem |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1740841766 PECOS PAC ID: 9133504772 Enrollment ID: I20220916002369 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Wesley M Nilsson |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1639674120 PECOS PAC ID: 7012251119 Enrollment ID: I20220916002895 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Guido Nodal |
|---|---|
| Provider Type | Practitioner - Geriatric Psychiatry |
| Provider Identifiers | NPI Number: 1427064435 PECOS PAC ID: 7911999404 Enrollment ID: I20220920002593 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jin Woo Yoo |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1144886110 PECOS PAC ID: 6800122268 Enrollment ID: I20220921001335 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Obinna Anosike |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1043871957 PECOS PAC ID: 2365827656 Enrollment ID: I20220922003322 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Candice Williams |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1821725540 PECOS PAC ID: 6406232347 Enrollment ID: I20220930000347 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Valerie Kay Williams |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1861123804 PECOS PAC ID: 2769868520 Enrollment ID: I20220930001896 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Justine Henao |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1902808645 PECOS PAC ID: 2769458561 Enrollment ID: I20221004002705 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Neslyne B Augustin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1245729631 PECOS PAC ID: 4789080045 Enrollment ID: I20221005000578 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Betsy Hausknecht Clachko |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1669688040 PECOS PAC ID: 3577949874 Enrollment ID: I20221010001259 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Anant Shukla |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1053873018 PECOS PAC ID: 3072840909 Enrollment ID: I20221014002885 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ali Habeeb |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1528414653 PECOS PAC ID: 2062839236 Enrollment ID: I20221018001838 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Darcy Dornbos |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023403458 PECOS PAC ID: 2365753134 Enrollment ID: I20221019000562 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kristen Lorraine Mankus |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407576176 PECOS PAC ID: 1153797931 Enrollment ID: I20221019001603 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lori Ann Sfakios |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922734847 PECOS PAC ID: 8325414881 Enrollment ID: I20221025001547 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kimberly Sue Crabbe |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154991297 PECOS PAC ID: 1951777440 Enrollment ID: I20221025002501 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Velma Campbell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477995157 PECOS PAC ID: 3779950118 Enrollment ID: I20221027002883 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maria Juliana Arbelaez Linero |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407587041 PECOS PAC ID: 0749657039 Enrollment ID: I20221028001901 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amber Gomes |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780306399 PECOS PAC ID: 8123495397 Enrollment ID: I20221031002336 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brett Prestia |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1083118566 PECOS PAC ID: 6103176326 Enrollment ID: I20221031002592 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Timothy Sullivan Mcgehee |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548992399 PECOS PAC ID: 3072980036 Enrollment ID: I20221103001098 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Yevgeniya Foster |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1669817003 PECOS PAC ID: 0042508509 Enrollment ID: I20221108001099 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Matthew Austin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1730591397 PECOS PAC ID: 4183841679 Enrollment ID: I20221108003325 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Hannah Aundrea Murphy |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1912623091 PECOS PAC ID: 6002284312 Enrollment ID: I20221117001308 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Meliza Sharma |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1659311280 PECOS PAC ID: 7618980871 Enrollment ID: I20221117002055 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Dileep Cholamanaunnikrishnan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1366829301 PECOS PAC ID: 0244608214 Enrollment ID: I20221122002920 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alessandra Musso |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336866581 PECOS PAC ID: 7517336134 Enrollment ID: I20221202002505 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Uzodinma Emerenini |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1912188640 PECOS PAC ID: 3476691775 Enrollment ID: I20221206000293 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Haruna Asafotei |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669080933 PECOS PAC ID: 9032523964 Enrollment ID: I20221206000435 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Danielle Petrowski |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1891417242 PECOS PAC ID: 2860861317 Enrollment ID: I20221206001252 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shiv K Gandhi |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1710423520 PECOS PAC ID: 3173879277 Enrollment ID: I20221216000225 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Patrick Flynn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336869205 PECOS PAC ID: 0446629190 Enrollment ID: I20221220000654 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pamela Saenger |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1215355136 PECOS PAC ID: 1254605850 Enrollment ID: I20221220002020 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David Chin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1477935906 PECOS PAC ID: 0941505804 Enrollment ID: I20221221001466 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Angela N Vita |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1518503770 PECOS PAC ID: 2668842246 Enrollment ID: I20221222000888 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nonyelum Nwachukwu |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1992437081 PECOS PAC ID: 5799155198 Enrollment ID: I20221229001319 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Carl Violano |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1518151596 PECOS PAC ID: 0446317390 Enrollment ID: I20221229001596 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maida Khan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1972165751 PECOS PAC ID: 3375913791 Enrollment ID: I20221229002179 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Wendy Baier Cartier |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1194322883 PECOS PAC ID: 4981074143 Enrollment ID: I20230104000547 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Hussein Dakhlallah |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1851049399 PECOS PAC ID: 7810375516 Enrollment ID: I20230106001589 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lyndsey Lukas |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568197424 PECOS PAC ID: 3173993979 Enrollment ID: I20230111001599 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christopher Borrego |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1811999543 PECOS PAC ID: 5890769780 Enrollment ID: I20230112000402 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christine Flood |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1861028839 PECOS PAC ID: 9335556059 Enrollment ID: I20230112002450 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Miwa Victoria Taylor |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1780092833 PECOS PAC ID: 2668843327 Enrollment ID: I20230118000054 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Norman Penarrieta |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568170140 PECOS PAC ID: 4789055302 Enrollment ID: I20230118002753 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Valerie Carter |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1255780383 PECOS PAC ID: 0345535522 Enrollment ID: I20230119003094 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Arielle Spigarelli |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306556352 PECOS PAC ID: 9133590581 Enrollment ID: I20230120002509 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Adaobi Igboeli |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174569081 PECOS PAC ID: 6406890631 Enrollment ID: I20230125002119 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kayla Noel Johnson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730805128 PECOS PAC ID: 3476924473 Enrollment ID: I20230131001496 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tushaar Vishal Shrimanker |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1417586611 PECOS PAC ID: 7416329347 Enrollment ID: I20230202001104 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Thomas Knuth |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1922023837 PECOS PAC ID: 1850325739 Enrollment ID: I20230203001327 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Aisha Rush |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1932330511 PECOS PAC ID: 7416175716 Enrollment ID: I20230203001808 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Maxwell Bressman |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1578094876 PECOS PAC ID: 8325460827 Enrollment ID: I20230207002480 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Emma Grace Crocamo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1881309979 PECOS PAC ID: 4981076320 Enrollment ID: I20230210000795 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sasa Ivanovic |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1881072106 PECOS PAC ID: 4688041890 Enrollment ID: I20230213000056 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elisabeth Rond |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598483299 PECOS PAC ID: 4486026853 Enrollment ID: I20230213000351 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Verene Denise Guthrie-noel |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1932839933 PECOS PAC ID: 7012389307 Enrollment ID: I20230215000416 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Colleen Murphy |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1275038788 PECOS PAC ID: 4385988344 Enrollment ID: I20230309000885 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jean Turner |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1295995009 PECOS PAC ID: 0941457816 Enrollment ID: I20230314002250 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Haakon Ronald Weyel |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1427766864 PECOS PAC ID: 2668846437 Enrollment ID: I20230317000191 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Max Goldstein |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1003489683 PECOS PAC ID: 4486044831 Enrollment ID: I20230321000298 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Laura Anne Ritter |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457067944 PECOS PAC ID: 9830563204 Enrollment ID: I20230327000609 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Emily Hancock |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1790132454 PECOS PAC ID: 0547634750 Enrollment ID: I20230329001108 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lucinda Horspool |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1124736863 PECOS PAC ID: 8729453923 Enrollment ID: I20230330002476 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Yolanda Lorena Vasquez |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1811606072 PECOS PAC ID: 9335514496 Enrollment ID: I20230404000913 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Karen Allyson Manor |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548757578 PECOS PAC ID: 3678948320 Enrollment ID: I20230411000862 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Paul Casinelli |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1013086552 PECOS PAC ID: 5294892378 Enrollment ID: I20230411001018 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Theresa Bonanomi |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1003365222 PECOS PAC ID: 0648263822 Enrollment ID: I20230427000527 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jennifer Nicole Mazzucco |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1346969136 PECOS PAC ID: 9032574843 Enrollment ID: I20230501001980 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jana Ott |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1174674063 PECOS PAC ID: 2567650385 Enrollment ID: I20230508001391 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elizabeth Kovac |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1659721330 PECOS PAC ID: 4183910482 Enrollment ID: I20230509001715 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Imran Khan Gaad |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1336766716 PECOS PAC ID: 8729444609 Enrollment ID: I20230518002413 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Andrew Wakeman |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1609353408 PECOS PAC ID: 6709116296 Enrollment ID: I20230518002987 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Chloe Michaelis |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497441968 PECOS PAC ID: 7315303989 Enrollment ID: I20230524001405 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christina Johns |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1679138374 PECOS PAC ID: 3476889817 Enrollment ID: I20230526002065 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rahul Kapil |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1336662196 PECOS PAC ID: 5597020925 Enrollment ID: I20230531002503 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marie Anjeliese Rodriguez |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1003420977 PECOS PAC ID: 7113338401 Enrollment ID: I20230602001057 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lucia Plichtova |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1013537281 PECOS PAC ID: 2163889098 Enrollment ID: I20230607002003 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David Louis |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1306294186 PECOS PAC ID: 4587959754 Enrollment ID: I20230612001408 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kimberly Delano |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1013970730 PECOS PAC ID: 2961503784 Enrollment ID: I20230612002630 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ahmad Toumar |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1669081899 PECOS PAC ID: 9931526852 Enrollment ID: I20230613002695 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Monika Gautam |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1871104083 PECOS PAC ID: 3476911058 Enrollment ID: I20230614003323 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mustafa Khan |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1952891509 PECOS PAC ID: 8921417973 Enrollment ID: I20230615002039 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Corydon Siffring |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1891728887 PECOS PAC ID: 7517964398 Enrollment ID: I20230616001035 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Benjamin Rudnick |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1316392228 PECOS PAC ID: 8426347766 Enrollment ID: I20230616002950 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jillian Angelina Dolan |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1326509423 PECOS PAC ID: 0941668263 Enrollment ID: I20230620000184 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Inshiya Lowai Dawoodi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1790305159 PECOS PAC ID: 8729446042 Enrollment ID: I20230620000330 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sharda Belcher |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689370041 PECOS PAC ID: 8224496385 Enrollment ID: I20230621003001 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nisarg Thakker |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1487263497 PECOS PAC ID: 0547628224 Enrollment ID: I20230628002006 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kasandra Erazo |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1629607817 PECOS PAC ID: 1658730239 Enrollment ID: I20230629001429 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Melissa Holzbauer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275244667 PECOS PAC ID: 3476912791 Enrollment ID: I20230705002720 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alexandra Nicole Schwann |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1992334155 PECOS PAC ID: 4587087820 Enrollment ID: I20230706000559 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kevin Titus |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1205451945 PECOS PAC ID: 1658794649 Enrollment ID: I20230711001589 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Radhika Voleti |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1003222449 PECOS PAC ID: 2264792621 Enrollment ID: I20230711004060 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amy Cheesman |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1407951007 PECOS PAC ID: 3274514385 Enrollment ID: I20230711004173 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kelly Garcia |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1790304996 PECOS PAC ID: 7214350354 Enrollment ID: I20230717001591 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mary Chandy |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1871867333 PECOS PAC ID: 9638395288 Enrollment ID: I20230717002631 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Paul Stockhammer |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1679195275 PECOS PAC ID: 7618337031 Enrollment ID: I20230718000442 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Omar T Sobh |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1396208526 PECOS PAC ID: 1456686492 Enrollment ID: I20230719001522 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jorge Gutierrez |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1053971259 PECOS PAC ID: 5294145157 Enrollment ID: I20230720000900 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Elizabeth Pavao |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1932202082 PECOS PAC ID: 3678566684 Enrollment ID: I20230721000852 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mahmudur Rahman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1518595370 PECOS PAC ID: 3173945862 Enrollment ID: I20230724001005 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Julissa Hok |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1467790121 PECOS PAC ID: 1850752635 Enrollment ID: I20230726000956 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sanjiv Gollakota |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1568845220 PECOS PAC ID: 3577818095 Enrollment ID: I20230726003390 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kevin M Wheelock |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1932738374 PECOS PAC ID: 5799109179 Enrollment ID: I20230727002686 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | David Maglakelidze |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1912516337 PECOS PAC ID: 1355702002 Enrollment ID: I20230728000571 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Fatima Motiwala |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1871082701 PECOS PAC ID: 6103173422 Enrollment ID: I20230731003257 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Charu Ramchandani |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1831487321 PECOS PAC ID: 8022234269 Enrollment ID: I20230801000337 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Katlin Davitt |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1679065064 PECOS PAC ID: 4789921586 Enrollment ID: I20230801003461 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Daniel Gurrieri |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1083102909 PECOS PAC ID: 6204230451 Enrollment ID: I20230802001414 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sanford Edwards |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1134617681 PECOS PAC ID: 8921358516 Enrollment ID: I20230803003070 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mridula Venkatesh Nadamuni |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1770015604 PECOS PAC ID: 3577972645 Enrollment ID: I20230807001807 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Raquel Rozner |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1396276366 PECOS PAC ID: 0042635211 Enrollment ID: I20230807003858 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Domingos Martins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528769189 PECOS PAC ID: 4486016482 Enrollment ID: I20230808001593 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Mahmoud Abdelrahman |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1467072868 PECOS PAC ID: 1254793284 Enrollment ID: I20230808002838 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alison Lorraine Allen |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1992481550 PECOS PAC ID: 8527420421 Enrollment ID: I20230809001558 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Feliks Reikhrud |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1487759098 PECOS PAC ID: 3779564877 Enrollment ID: I20230810000956 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tess Rebecca Hoerle |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1356907299 PECOS PAC ID: 7315309010 Enrollment ID: I20230811002563 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Nathan Paul Heller |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1528689163 PECOS PAC ID: 6002278694 Enrollment ID: I20230814003096 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Gerber De Leon |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1609496348 PECOS PAC ID: 8325409980 Enrollment ID: I20230816003141 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Damianos Kokkinidis |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1477084838 PECOS PAC ID: 2062837099 Enrollment ID: I20230817001540 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | James Henry Laird |
|---|---|
| Provider Type | Practitioner - Radiation Oncology |
| Provider Identifiers | NPI Number: 1487158853 PECOS PAC ID: 5496099079 Enrollment ID: I20230817001802 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rafael Augusto Contreras |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1952937070 PECOS PAC ID: 2365804663 Enrollment ID: I20230818000844 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ramya Manasvini Kaushik |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1194344309 PECOS PAC ID: 1153744404 Enrollment ID: I20230821002398 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kendal Glynn |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1497382295 PECOS PAC ID: 2264894336 Enrollment ID: I20230822001635 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Neha Augustine |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1316407901 PECOS PAC ID: 1355679895 Enrollment ID: I20230822001916 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Molly Hanna |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1760080071 PECOS PAC ID: 5991113813 Enrollment ID: I20230822002340 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Aaron Joseph Kho Tiu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1659996601 PECOS PAC ID: 0446676506 Enrollment ID: I20230822002508 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sarah Marie Warzecha |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1295416204 PECOS PAC ID: 7517320385 Enrollment ID: I20230825002526 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | James Doran |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1437682481 PECOS PAC ID: 2961774708 Enrollment ID: I20230825002809 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Henly Hewan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1508421306 PECOS PAC ID: 4688908437 Enrollment ID: I20230829003659 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lia Nadine Cesar |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1770104887 PECOS PAC ID: 8123481777 Enrollment ID: I20230829003952 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Geetali Mohan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1073779856 PECOS PAC ID: 2365598109 Enrollment ID: I20230905001577 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jean Alexandra Pavlakis |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1306474515 PECOS PAC ID: 3577926864 Enrollment ID: I20230905001672 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rebecca Jonas |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1265964266 PECOS PAC ID: 1254675820 Enrollment ID: I20230906002418 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Freja Burger |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952075475 PECOS PAC ID: 1052709243 Enrollment ID: I20230908001613 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Hannah Hill |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1477041093 PECOS PAC ID: 8426459017 Enrollment ID: I20230912000515 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | James Kiage |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1013409937 PECOS PAC ID: 5597162545 Enrollment ID: I20230912000576 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jana Petelle |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1396194643 PECOS PAC ID: 7315282845 Enrollment ID: I20230914002796 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Lilly Kemm |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154905065 PECOS PAC ID: 4789048265 Enrollment ID: I20230918000609 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Weitao Liu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1710583927 PECOS PAC ID: 2668878570 Enrollment ID: I20230921001221 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joyce Wong |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1366005795 PECOS PAC ID: 9638406317 Enrollment ID: I20230922000280 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Charlene Ashley Liao |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1700414042 PECOS PAC ID: 8628422896 Enrollment ID: I20230922000914 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kayla Rose Ashton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1992305437 PECOS PAC ID: 8921452939 Enrollment ID: I20230925003328 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Benjamin Arturo Diaz Duarte |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1174218184 PECOS PAC ID: 1951755701 Enrollment ID: I20230927001801 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Muhammad Tasawar Latif |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1417575192 PECOS PAC ID: 7214352343 Enrollment ID: I20231003000243 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Matthew Michael Scott |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1144859612 PECOS PAC ID: 6608221072 Enrollment ID: I20231005001034 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shivani Myer |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1518171255 PECOS PAC ID: 1557419926 Enrollment ID: I20231006002783 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Morgan Rae Lohman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1801596986 PECOS PAC ID: 3476908088 Enrollment ID: I20231017000310 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Fadeke Longe |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1407411309 PECOS PAC ID: 1254792229 Enrollment ID: I20231018002638 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Omar Yasser Abed Shakhtour |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1033722004 PECOS PAC ID: 1355797853 Enrollment ID: I20231019000708 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sun-joo Jang |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1659900595 PECOS PAC ID: 0941624134 Enrollment ID: I20231019002492 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amy Bopp |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1518539113 PECOS PAC ID: 0446657563 Enrollment ID: I20231023002164 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pooja Gajare |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1518596659 PECOS PAC ID: 9537515648 Enrollment ID: I20231026000339 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Ali Tesoriero Saslafsky |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700567039 PECOS PAC ID: 8820444763 Enrollment ID: I20231027002990 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Casey Ann Oliver |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1134833486 PECOS PAC ID: 4880040658 Enrollment ID: I20231031000899 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Colin Daniel Brien |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1649822347 PECOS PAC ID: 6901252634 Enrollment ID: I20231031003560 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Olivia Patrice Ford |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1144922238 PECOS PAC ID: 2365898020 Enrollment ID: I20231101000845 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sovit Dahal |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1437767134 PECOS PAC ID: 8426405085 Enrollment ID: I20231103002759 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Daniela Signorello |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1366227662 PECOS PAC ID: 9638526775 Enrollment ID: I20231110000109 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | George Turini |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1508095936 PECOS PAC ID: 3870719651 Enrollment ID: I20231128001638 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Muhsina Moushumi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1578337192 PECOS PAC ID: 2163870197 Enrollment ID: I20231130002478 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Marie Woolery |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1912550054 PECOS PAC ID: 5799017281 Enrollment ID: I20231204001931 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Amy Stevens |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1235421181 PECOS PAC ID: 3971897869 Enrollment ID: I20231205002017 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Brian Hornby |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730878448 PECOS PAC ID: 8628427044 Enrollment ID: I20231211003347 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Eva Viorica Mcfarland |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1760265078 PECOS PAC ID: 8123477551 Enrollment ID: I20231211003616 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Erin Milner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053196303 PECOS PAC ID: 7618326950 Enrollment ID: I20231212000504 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Rachel Volke |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1720514425 PECOS PAC ID: 4789959792 Enrollment ID: I20231212002834 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Emma Watkins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528659612 PECOS PAC ID: 1658778782 Enrollment ID: I20231218002513 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Alyssa Marie Gambardella |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154109718 PECOS PAC ID: 3072963750 Enrollment ID: I20231220003532 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Joshua Dunn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1003236449 PECOS PAC ID: 2567786098 Enrollment ID: I20231226001390 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Freda Kennedy |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1619310943 PECOS PAC ID: 6002143450 Enrollment ID: I20231228001737 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christopher Miller |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1073391777 PECOS PAC ID: 9638529738 Enrollment ID: I20240102003688 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Katryn Vosburg |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1649056839 PECOS PAC ID: 1355791336 Enrollment ID: I20240103002874 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Indra Daniels |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1740266493 PECOS PAC ID: 9537071998 Enrollment ID: I20240111001946 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Bethsaida Torres |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1639455942 PECOS PAC ID: 9335591387 Enrollment ID: I20240116002049 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Jazzlynn M Bennett |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750160206 PECOS PAC ID: 5496107989 Enrollment ID: I20240119003643 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Theresa Laggis |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376081570 PECOS PAC ID: 4587017652 Enrollment ID: I20240125002236 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Andrew Kohler |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1568993475 PECOS PAC ID: 5991078354 Enrollment ID: I20240205002556 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Daniyal Ameen |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1740818889 PECOS PAC ID: 5890138028 Enrollment ID: I20240205003238 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Christine Nicole Koval |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1962148007 PECOS PAC ID: 5294178018 Enrollment ID: I20240208003342 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Shenider Dufort |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1811777006 PECOS PAC ID: 0941643621 Enrollment ID: I20240209000931 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Kathleen Ellis |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1679902316 PECOS PAC ID: 9739309758 Enrollment ID: I20240215000203 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Robin Dana |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1255402996 PECOS PAC ID: 3375987449 Enrollment ID: I20240216000613 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Pranitha Mantrala |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1578843496 PECOS PAC ID: 5294955902 Enrollment ID: I20240219000563 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Judith L Fabricant |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1598862153 PECOS PAC ID: 6103260880 Enrollment ID: I20240221002280 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Sonya Barrs |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1124597091 PECOS PAC ID: 7618311234 Enrollment ID: I20240221004020 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Cheryl Murray |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1821724022 PECOS PAC ID: 7416391032 Enrollment ID: I20240221004096 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tara Peters Basile |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1326552407 PECOS PAC ID: 2860844305 Enrollment ID: I20240228002370 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Tom Gugel |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1417719626 PECOS PAC ID: 0143665000 Enrollment ID: I20240301000224 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
| Provider Name | Chadi Berjaoui |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1366893281 PECOS PAC ID: 2163716556 Enrollment ID: I20240304001052 |
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
News Archive
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
UC Davis researchers have identified the molecular interactions that allow capsaicin to activate the body's primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain. Their study appeared online June 8 in the journal Nature Chemical Biology.
For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back.
Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.
› Verified 9 days ago
The Child And Family Guidance Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 180 Fairfield Ave, Bridgeport, CT 06604 Phone: 203-394-6529 | |
Nova Vita Health Services Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3180 Main St, Bridgeport, CT 06606 Phone: 203-870-1616 Fax: 203-870-1615 | |
South- West Community Health Center, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1046 Fairfield Ave, Bridgeport, CT 06605 Phone: 203-330-6000 Fax: 203-331-4716 | |
Embrace Your Path, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 4270 Main St, Bridgeport, CT 06606 Phone: 203-301-8852 Fax: 203-301-8852 | |
Eprine Community Services Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1450 Barnum Ave Ste 202, Bridgeport, CT 06610 Phone: 718-255-5946 | |
Muck Mudd Inc. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 955 Connecticut Ave Ste 5202, Bridgeport, CT 06607 Phone: 203-440-5170 |